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A bstract
The imprinted Igf2 and H19 genes lie within a lOOkb region of mouse chromosome 7 and 
its syntenic region 1 lpl5.5, disruptions of which have been implicated in the paediatric 
overgrowth disorder Beckwith Wiedemann syndrome. Both genes are expressed co- 
ordinately in a wide range of embryonic and extraembryonic tissues from a single parental 
allele. The Igf2 gene is expressed predominantly from the paternally derived allele, and 
H I9 from the maternally derived allele. The mechanisms by which the two genes achieve 
their spatial, temporal, and allele-specific expression patterns are not fully understood, but 
are thought to be at least partially dependent upon cis-acting genomic elements which lie 
within the immediate chromosomal domain.
A candidate for such an element, the centrally conserved domain (CCD) was 
initially identified in a study that scanned approximately 130kb of the genomic region 
containing the H19 and Igf2 genes for regions that were sensitive to the nuclease DNasel.
A region 32kb upstream of the H19 gene was found to display a high level of nuclease 
sensitivity on both parental alleles. This region was also found to be hypomethylated in 
comparison to surrounding DNA, and to be conserved in a number of mammalian species. 
This region could function as a tissue specific enhancer or silencer, or a further imprinting 
element at this locus. The purpose of this work is to investigate the role of the CCD in the 
tissue-specific expression and imprinting of the H19 and Igf2 genes, by utilising a panel of 
transgenic mice bearing putative and known Igf2/H19 control elements fused in cis with 
the reporter gene firefly luciferase. Luciferase reporter assays performed on neonatal 
transgenic mice have revealed that this region can drive reporter gene expression in the 
brain, specifically in the exchange tissues. In the brain, Igf2 gene expression is 
concentrated in the exchange tissues, i.e., the choroid plexus and leptomeninges. This 
expression is from both parental alleles, and persists into adult life.
A tissue culture system, primary culture of cells derived from the mouse choroid 
plexus, has been set up in order to dissect the function of the CCD in vitro, and preliminary 
work done to derive an immortal cell line from these cells. Such a cell line may form a 
model system by which to study how Igf2 escapes imprinting in the choroid plexus and 
leptomeninges of the brain.
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C hapter 1: Introduction
Imprinting 
General
Nuclear transplantation experiments that produced mouse embryos with only maternal or 
paternal chromosomes, while maintaining the normal diploid number, revealed that such
embryos are not viable 1, 2, 3 These experiments showed that both parental genomes are 
required for normal development. The cause of this ‘non-complementation’ phenomenon 
has been found to be due to the existence of imprinted genes, i.e., those genes whose 
expression status depends upon their parental origin. To date, more than 30 imprinted 
genes have been discovered in the mammalian genome, with a large proportion of these
genes conserving their imprinted status between mouse and man 4. it is unclear whether all 
imprinted genes share a common mechanism by which they acquire a parental allele- 
specific mode of expression, or whether different genes within this class have manipulated 
different epigenetic systems within the cell to reach the same end. Each imprinted gene 
identified to date shares one or more of a set of features which has come to characterise 
imprinted genes. These features, and their implications in the understanding of the 
mechanism/s of imprinting are discussed below.
Features of imprinted genes
Imprinted genes as a class have been suggested to share several common features, 
including; association with regions of parental-allele specific methylation and/or chromatin 
structure, the presence of antisense or overlapping transcripts, linkage to G-rich repeat 
sequences, the tendency to be clustered in chromosomal domains, as well as in regions 
with allele-specific differences in DNA replication timing, and the association of such 
genes with a role in embryonic growth.
DNA methylation
The necessity of correct genome methylation from early development for the 
correct allele-specific expression has been demonstrated for most imprinted genes. One 
important exception is the Mash2 gene, where the manipulation of levels of the major de-
novo methyltransferase (Dnmtl) gene has no effect upon its imprinted expression 5. Many
10
imprinted genes contain, or are flanked by regions that are differentially methylated in an 
allele-specific manner (e.g., the insulin-like growth factor 2 (Igf2) gene 6, 7} 8? f j j g 9, the 
insulin-like growth factor 2 receptor (Igf2r) gene 1®, KvLQTl 11, SNRPN 12). The role of 
methylation in the imprinting mechanism is discussed in greater detail below.
Antisense transcripts
Antisense transcripts overlapping the coding sequence of several imprinted genes
have been identified at several loci, including Igf2r 13, Igf2, 6, 14s KvLQTl, 15, 11,
UBE3A 16, Xist 17 and reviewed in 18. In all cases these antisense RNAs are imprinted 
themselves, and with the exception of the Igf2 antisense transcript, in the opposite direction 
to the coding genes which they overlap. As these antisense RNAs also tend to be expressed 
in the same tissues as their sense equivalents, it has been suggested that they may exist to
regulate these genes by a competition mechanism 19, i.e., that a cell can only transcribe the 
sense or the antisense gene at a particular locus, and that the imprint acts to dictate which 
of the two transcripts will ‘win’, in an allele specific manner. Such a mechanism can not 
explain how the parental alleles are distinguished, and it has not formally been 
demonstrated that transcription of a gene will downregulate expression from an 
overlapping partner. In fact, the Igf2r antisense transcript (Air) overlaps but does not 
imprint the neighbouring Masl gene 20.
Clustering of imprinted genes
The tendency of imprinted genes to be clustered raises the question of whether a 
common ‘imprinting control region’ is required to regulate the allele-specific regulation of 
multiple genes in-cis. Such an imprinting centre appears to exist to regulate the genes at the 
Prader-Willi/Angelman Syndrome (PWS/AS) region on human chromosome 15 (21, 22^  
and references therein). 15ql l-ql3 contains at least four paternally expressed genes, 
SNRPN, ZNF127, NDN and IPW as well as two paternally expressed sequences, PARI and 
PAR5. Absence of paternally inherited 15ql l-ql3 causes PWS. This region also contains 
one maternally expressed gene, UBE3A, mutations in which cause AS. Co-ordinate control 
of imprinting at this cluster is caused by the imprinting centre (IC), which is also 
functionally conserved in the mouse. This centre has been localised to a 100 kilobase (kb) 
region containing the SNRPN gene, which is deleted in both PWS and AS patients. This
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element may have a bipartite structure, as in AS families the smallest deletion overlap is 
approximately 1.2kb and maps to 40kb upstream of SNRPN, whereas in PWS families the 
common deletion spans the SNRPN gene 18 The IC controls a large imprinting domain, 
and mutations in this region appear to block the resetting of the imprint in the germline 23 ? 
as well as the maintenance of the paternal epigenotype 24.
Another intensively studied imprinting cluster is the Beckwith-Weidemann 
Syndrome (BWS) region on human chromosome 1 lpl5.5, and its syntenic region in the 
mouse on distal chromosome 7. This cluster in the mouse spans approximately 1Mb, and 
contains at least 10 imprinted genes, four of which are paternally expressed (Igf2, 
Igf2AS/PEG8, Ins2, LIT1), and the remainder of which are maternally expressed (HI 9,
Mash2, p57KIP2, Ipl and KvLQTl, 25f and see references therein). The human cluster is 
similar in size, and the relative transcriptional orientation of the genes appears to be
conserved between the two species 25. The cluster contains within it several genes which
have been found not to be imprinted in all tissues analysed (TSSC4, TSSC6, 26)? though the 
tissue, and developmental specificity of the imprinting status of most imprinted genes 
makes it problematic to rule out that these genes may show allele specific expression in 
some tissues. The BWS cluster does not appear to contain a single imprinting centre, 
though deletion of a 13kb region including the H I9 gene can lead to loss of imprinting of
the linked Igf2, Ins2 genes 27? see below), but not further genes in this cluster 5. Mutations 
in the KvLQTl and the overlapping LIT1 gene have been implicated in the loss of
imprinting of IGF2 in some cases of BWS 11, and this region has also been proposed to
direct the maternal expression of the neighbouring p57Kip2 gene 28. While a single IC has 
not been characterised in this region, neighbouring genes are clearly co-ordinately 
regulated to some extent.
Analogous to the PWS/AS imprinting centre is the X-inactivation centre (Xic). 
Deletions in this region of the X chromosome prevent X inactivation in cis, leading to
inappropriate expression of genes along the chromosome (reviewed in 29). Silencing of the 
inactive X chromosome is reliant upon the spread of constitutive heterochromatin from the 
inactivation centre, and is dependent upon transcription of the Xist gene which maps within
this region 20. The Xist transcript coats the inactive chromosome 21, though Xist RNA 
levels are relatively low (approximately 100 molecules/cell) in some tissues, requiring a
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single Xist molecule to inactivate approximately 1% of the X chromosome 29. Binding of 
Xist is not thought to be sufficient to silence genes over such distances, therefore 
Brockdorff et. al. 29 have proposed that the spread of heterochromatin is aided by ‘booster’ 
elements or ‘way stations’, i.e., sequences that facilitate the spread of higher-order 
chromatin packaging. Lyon 32 has proposed that long interspersed repeat elements
(LINE)-l (LI) as a candidate for these ‘booster’ elements. Bailey et. al. 33 have studied the 
distribution of LI repetitive elements on human chromosomes, and found that the X 
chromosome is enriched 2-fold for these elements (as compared to autosomes). 
Furthermore, regional analysis of the X chromosome revealed that the most significant 
clustering of LI sequences is at the X inactivation centre, and regions harbouring genes 
that escape X inactivation are significantly poorer in these repetitive elements.
Repetitive sequences
Interestingly, imprinted genes are often associated with repetitive DNA (Igf2 and 
Ins2 6, H I9 34,7g/2r 20? KvLQTl 13, pS7Kip2 35), suggesting that such regions are 
required in imprinted domains, perhaps to stabilise gene silencing. In addition, there 
appears to be a necessity for multiple elements to stabilise the imprinting mechanism. 
Transgenes constructed containing elements from imprinted gene regions generally only 
reproducibly exhibit stable patterns of imprinted gene expression either when they are very 
large 36, 13), or present at high copy number 37, 38? 39. The presence of ‘booster’ 
elements, which have a partial but cumulative effect upon the maintenance of an epigenetic 
state, is reminiscent of the mechanism of Polycomb-mediated gene silencing in 
Drosophila. At the Ultrabithorax (Ubx) gene, for example, binding sites for Polycomb- 
group proteins are dispersed over a wide area, and act in combination to create an
epigenetically silent domain (in the appropriate tissues), encompassing their target gene 40. 
It is interesting to note that the imprinting status of many genes is also tissue specific, and 
that cis factors that mediate gene silencing in such contexts must therefore be tissue 
responsive.
Replication timing
A further feature of imprinted genes is their tendency to manifest allele-specific 
differences in DNA replication timing at S-phase. At the PWS/AS cluster, at the Igf2 locus
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and the Igf2r locus, in both mouse and humans, the paternal chromosome replicates earlier 
in S-phase than the maternal chromosome 41,42 Asynchronous replication of these 
chromosomal domains is evident from the earliest stages of embryogenesis, and persists
throughout development 43. The establishment of allele specific replication timing occurs 
in the gametes, preceding fertilisation, therefore the events that mark the cell cycle 
specific-timing of DNA replication in imprinted regions must reflect an early event in the 
formation of an imprinting mark. However, this mark is not allele-specific, as both 
paternally and maternally imprinted genes reside in regions that are early replicating on the 
paternal chromosome. Asynchronously replicating regions may mark areas of the genome 
that are competent for monoallelic gene expression, as the randomly inactivated X
chromosome is late replicating (reviewed in 44)  ^as are inactive alleles of the monoallelic 
(but non-imprinted) olfactory receptor loci 43. Cis deletions that disrupt the imprinting of 
neighbouring genes (such as PWS/AS IC 42), and the H19 gene region 45) ieacj to 
synchronous replication, providing a direct link between imprinting and asynchronous 
replication timing. It is not known whether this phenomenon is a necessary feature of the 
mechanism of monoallelic expression i.e., it has been suggested that DNA binding factors 
necessary for monoallelic expression may only be present in a restricted time-window of
the cell cycle 46. Alternatively, asynchronous replication of parental alleles could be a 
secondary effect of changes in chromatin structure that accompany imprinted genes. 
Manipulation of chromatin structure, brought about by treatment of cells with histone
deacetylase inhibitors, leads to synchronous replication of imprinted gene regions 47. 
Functional relatedness and imprinting theories
The products of many imprinted genes play a role in growth, either by effects on 
cell proliferation (p57Kip2 35, NOEY2 48} ZAC/PLAGL1 49); embryonic and placental 
growth (PWS/AS genes 21, Igf2 50  ^lgf2r 51, Mash2 52, Peg/Mest 53, 54? 55} £ sxj  56; 
and/or a role in the insulin growth factor signalling pathway (Igf2 50, Igf2r 51, GrblO 57? 
Insl, Ins2 58 and ZAC/PLAGL1 49. The superficial similarity of the type of genes that tend 
to be imprinted has led many to assume that there must be a connection between function 
of imprinting and growth.
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An organism that preferentially inactivates a subset of its genes becomes
functionally haploid at those loci. Spencer et. al. 59 have shown by mathematical 
modelling that without some direct advantage to imprinting, any modifier gene causing its 
target locus to be imprinted, but having no direct fitness benefits will be eliminated from a 
population. A number of theories have been proposed to describe the evolution of 
imprinting, many of which can be rejected on the basis that they do not explain the 
available facts (such as growth effects, parental direction of imprinting, species specificity, 
etc), (reviewed in 60).
Early observations of uniparental disomies (UPD) in mice and humans (such as 
human paternal UPD 1 lpl5.5) suggested that paternal UPD tended to lead to increased 
embryonic growth, whereas individuals with maternal UPD tended to be smaller in size
throughout development. This led Moore and Haig 61 to propose one of the most widely 
accepted theories of the evolution of imprinting, the parental conflict model. This model 
states that, in a species where a female takes more than one mate, there is a conflict 
between the strategies employed by males and females to maximise their reproductive 
fitness. As the female is equally related to all of her offspring, she will provide each of her 
brood sufficient resources to survive, without compromising her future reproductive 
potential. The father, however, has no stake in his current mates’ future offspring, so will 
try to divert maternal resources to his offspring, even at a large cost to his mate. Moore and
Haig 61 stated that if a locus has preferential paternal expression, it will function to 
increase nutrient demands on the mother, whereas maternally expressed genes will act to 
decrease these demands. The success of this model lies in its ability to predict the existence 
of imprinting over random gene inactivation, the role of imprinted genes in growth 
pathways, and the species specificity of this phenomenon.
The major prediction of the conflict model is that paternally expressed genes should 
promote growth, whereas maternally expressed genes should suppress it. This prediction
was certainly borne out for the first imprinted genes discovered (Igf2 50, and Igf2r 51), and 
the early uniparental disomy data (reviewed in 61). A comprehensive study of the growth 
effects associated with uniparental disomies 62, concluded that much of the data did not 
support the conflict hypothesis. While maternal UPDs did tend to be growth suppressing 
(as would be expected from the absence of paternal growth enhancers, or a double dose of
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maternal growth suppressors), so also did paternal UPDs. However, the authors did suggest 
that, as imprinted genes occur in clusters, the dramatic changes in gene expression brought 
about by alterations in the imprinted status of several genes might well have complicated 
the analysis. Studies of the effects of deletions in individual imprinted loci also do not 
always produce the outcome predicted by the parental conflict model. While some
paternally expressed genes are growth enhancing (e.g. Igf2 50, Mest 54 (though the adult
behavioural phenotype is unexpected), and Peg3 63); in the case of some maternal genes,
although implicated in cell proliferation (e.g.,p57Kip2 35, NOEY2 48), their loss of function 
has no overt growth phenotype.
Moore and Haig 61 have suggested that one of the main sites for parental conflict 
should be the placenta, as this is the site for acquisition of maternal resources by the foetus. 
For the parental conflict model to be supported, imprinted genes expressed in the placenta 
should act to divert resources to the embryo. The imprinted expression of two placental
genes appear to confound this assumption, as maternal deletions of Mash2 52 and the X-
linked Esxl 56 lead to placental malformation and growth retardation of the embryo. The 
implication that the expression patterns of these genes contradicts the conflict model could 
be due to a poor understanding of the relationship between placental and foetal growth.
The notion that large placentas are associated with large embryos has been shown not to 
hold for both some cases of paternal UPD, (which have large placentas but small embryos,
60), and in experiments that manipulate placental size by generating interspecific crosses 
of mouse strains. Some intercrosses between Mus musculus and Mus spretus show a large 
variation in placental size 64, which is not correlated to embryo size. The authors 
conclude, however, that the severe morphological changes present in many large placentas 
may skew the analysis.
The conflict model predicts that imprinting should be confined to those species 
where offspring are nourished directly from maternal tissues. This prediction is largely 
supported by observation, imprinting is found in mammals and angiosperms, as well as 
marsupials, and parthenogenesis has been reported in all major groups of vertebrates
except mammals 61. However, parental allele-specific differences in gene expression have
been reported in Drosophila 65, 66? ancj jn the zebrafish Danio rerio 67, so while both
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parental genomes are not required for viability in these species, imprinting mechanisms 
may exist.
Further criticisms of the conflict model include the observation that imprinted 
genes are not fast evolving, as might be expected if an ‘arms race’ existed between
maternal and paternal genomes 68. Furthermore, the theory fails to explain why some, but
not all embryonic growth factors are imprinted 60. In spite of this, the conflict model 
provides a close fit with many of the observed features of imprinted genes.
The \gi2JH19 gene pair
Igf2 and H19 lie within a lOOkb region at the telomeric end of mouse chromosome 7, and
in humans in the syntenic region 1 lpl5.5, within a large cluster of imprinted genes (25, 
and references therein). The two genes are also closely linked in the marsupial (the tamar
wallaby, Macropus eugeni 69).
Igf2
IGF2 is a mitogenic growth factor, structurally related to the hormone insulin. The 
Igfl gene is expressed from early development in a wide range of embryonic and 
extraembryonic tissues (see below), in most cases only from the paternally-derived 
chromosome 70. LqSS 0f expression of Igfl leads to a marked reduction in growth. Mice 
carrying a paternal deletion of this gene are proportionate dwarfs, of approximately 60% of 
the body weight of their wild-type littermates 60. Overexpression of IGF2 in humans, due 
to inappropriate activation of the maternal allele, has been associated with the fetal 
overgrowth syndrome Beckwith-Weidemann Syndrome. Mouse models in which Igf2 is 
overexpressed display some of the diagnostic features of these syndromes, such as pre- and 
postnatal overgrowth, polyhydramnios (excess fluid in the amniotic cavity),
disproportionate organ overgrowth including macroglossia, and skeletal abnormalities 71. 
The full range of phenotypes for this syndrome can be demonstrated in a mouse model in 
which Igfl is overexpressed, and the linked p57Klp2 tumour suppressor gene function is lost 
72, 73 ^  addition, loss of imprinting, and biallelic expression of IGF2 has been found in
over 70% of solid tumours where examined (reviewed in 74).
The mouse and human Igf2 genes have a similar gene structure, with expression
from four promoters (named PI to P4 in humans, P0 to P3 in mouse, see Figure 1) 75. The
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human PI and exon 1 have no mouse homologue, and transcripts initiating from this site
are found in adult liver 76. in the mouse, no postnatal liver expression has been detected.
The PO promoter in the mouse is the site of initiation of a placental-specific transcript 6. 
The remaining promoters are highly conserved between mouse and humans, and transcripts 
arising from them show a similar pattern of spatial and temporal expression during 
development. The coding sequences for the IGF2 peptide are contained in the three 3’
exons (see Figure 2), and the structural gene is highly conserved across the two species 75. 
H19
The H I9 gene encodes one of the most abundant RNA polymerase II transcripts in the 
mouse embryo. H I9 transcripts accumulate to greater than 1% of total mRNA in some 
foetal tissues 77.
The mouse H I9 gene consists of five exons and four very small introns (see Figure
2), and encodes a 2.5kb transcript that is spliced and polyadenylated 78. The human gene is
very similar in structure to the mouse gene 77. There is some evidence, however, that an
allele-specific splice variant exists in humans, which results in the excision of exon 4 79.
HI 9 lies in cis to Igf2 on mouse chromosome 7 80. H19 is oppositely imprinted to 
Igf2, i.e., it is transcribed from the maternally derived allele only, in the majority of tissues
in which it is expressed 81.
The H19 gene product is generally thought to function as an RNA. Although 
several open reading frames can be found within the mouse sequence, none of these are 
conserved in the human sequence. Despite this, a generally high level of sequence 
conservation can be found between the two species, particularly across the 3’ region of
exon 1, and in exon 2, which is also highly conserved in rat 82? and chicken 77. Additional 
evidence that H19 is not translated comes from a report that states that though H19 mRNA 
is present in the cytoplasm, it does not associate with ribosomes. Instead the mRNA is
though to co-localise with a high molecular weight protein fraction of the cytoplasm 77. a
conflicting study 83 asserts that H I9 mRNA does associate with polysomes in a variety of 
cell types in both mouse and human, but suggests that here the function of the RNA may 
be to regulate IGF2 mRNA, with which H I9 mRNA co-localises.
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Figure 1, Schematic diagram of the ~100kb mouse genomic domain containing the Igf2 
and H19 genes. Grey boxes represent exons of the genes, Igf2 contains eight exons in 
mouse, including upstream exons 1 and 2 (ul and u2), and six additional exons. The H I9 
gene contains five exons separated by four small introns. The four Igfl promoters (P0-P3), 
and single H19 promoter are shown as horizontal arrows. Vertical arrows above the line 
represent regions of nuclease hypersensitivity, and horizontal black bars below the line 
represent regions of differential CpG methylation (DMRs). A detailed description of these 
regions, and the relevant references are contained within the text.
The regions within this domain which are present in luciferase reporter gene 
constructs analysed in this work, are highlighted below, and discussed within the text. In 
order these elements are: DMR (Igfl DMR1, approximately 2.8kb EcoRI-BamHI 
fragment); P3 (Igfl promoter 3, nucleotides -162 to +74 with respect to the trancription 
start); CCD (a nuclease hypersensitive region lying midway between Igfl and H I9, 2kb 
EcoRI-EcoRI fragment); the H19 promoter, (a 2kb BamHI-Nhel fragment); the H19 
enhancers (2.7kb Spel-Bglll fragment).
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At present the role of the H19 gene in development remains elusive, but its 
abundance and strict sequence conservation 82 argue that this gene must be functional. 
Despite this, loss of expression of the H19 coding region 84} 85} or overexpression of the 
gene from multicopy transgenes 37, 38? 39} have no obvious phenotype.
Tissue specific expression
The Igf2 and H19 genes are expressed broadly and at high levels in the developing embryo, 
and in the extraembryonic tissues. While strikingly similar in their tissue specificity, 
differences exist in the expression patterns of these two genes. Both the similarity and the 
differences in the expression patterns of the Igf2 and H19 genes during embryogenesis are 
discussed below.
Extraembryonic gene expression
Basal levels of Igf2 RNA can be detected from the earliest stages of pre-implantation
mouse development 86. Abundant expression of Igf2 is first detected in the trophectoderm 
at embryonic day 5.5 (e5.5). The first expression is seen in the polar trophectoderm 
(extraembryonic ectoderm and ectoplacental cone), with the mural trophectoderm lagging 
slightly behind. The first derivative of the epiblast to express Igf2 is the extraembryonic 
mesoderm (e6.5-e7.0), which will form the allantois and visceral yolk sac. In these tissues, 
Igf2 gene expression is detected from the earliest stage of formation of the amniotic folds
87. At e9.5 the rodent yolk sac placenta converts into the chorioallantoic placenta. During 
this process the allantois fuses with the roof of the ectoplacental cone to form the allantoic 
plate, and later the labyrinthe. From this stage the allantoic mesoderm and constituent 
blood vessels emerge as the strongest expressers of Igf2 in the murine placenta 88. By 
e l2.5 the labyrinthine trophoblast expresses Igf2 at greater levels than the 
spongiotrophoblast, where expression declines completely as a subset of these cell 
differentiate into glycogen cells and secondary giant cells. From el4.5, the glycogen cells 
progressively infiltrate the maternal decidua, becoming concentrated around the large 
maternal arteries. These cells retain Igf2 expression until birth. This extraembryonic 
expression pattern of Igf2 is also observed in the rat, where the predominant sites of 
expression of IGFII are in the allantoic plate, and later the labyrinthine zone; and in the
glycogen and giant cells that form from the spongiotrophoblast 89.
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In human development high level induction of IGF-II mRNA again coincides with 
implantation (90, 91)? where the gene is expressed in the trophectoderm. IGF-II mRNA 
continues to be expressed in the proliferative regions of the placenta, i.e. in the 
cytotrophoblast shell and intermediate trophoblasts (which are functionally equivalent to 
the murine early spongiotrophoblast and glycogen cells, respectively 88) throughout 
development 92.
In contrast to Igf2y HI 9 gene expression cannot be detected until late blastocyst 
stages. At e4.5 low levels of mRNA are transcribed in the trophectoderm. Following 
implantation, H19 expression increases sharply, in the ectoplacental cone, the trophoblast 
giant cells, the extraembryonic ectoderm and the extraembryonic endoderm. H I9 mRNA 
cannot be detected in the allantoic folds of the extraembryonic mesoderm, which express 
high levels of Igf2 mRNA. In subsequent stages of development, however, H19 gene 
expression is very similar, if not identical, to that of Igf2 93. The expression of H19 in 
human placental development also closely resembles that of IGFII94.
Embryonic gene expression
The embryonic expression patterns of Igf2 and HI 9 have mostly been studied in the mouse 
and the rat, though the expression patterns of these genes in the human foetus are broadly 
similar 94.
The first Igf2 transcripts detected in the embryo proper in mouse are found at late 
primitive streak stage (e7.5) in the developing anterior and lateral mesoderm, which is 
continuous with the extraembryonic mesoderm. By e8.0, the strongest Igf2 expression is 
found in the developing heart, and the head mesenchyme. The first endodermal expression 
in the embryo is observed at this stage, with significant expression of Igf2 mRNA in the
lining of the foregut 87.
The late-embryonic expression pattern of Igf2 is most comprehensively
documented in the rat 95? though this expression is at least superficially equivalent to the
mouse 70. in mesoderm, Igf2 transcripts can be detected in all three subdivisions of the 
somites (sclerotome, dermatome, and myotome) from elO. As development proceeds in 
myotome, Igf2 transcript levels are high throughout the formation of myoblasts and their 
differentiation into myotubules. In sclerotome, Igft mRNA levels increase as mesodermal 
cells differentiate into cartilage, and remain high in chondrocytes, but transcript levels 
decrease dramatically immediately prior to ossification. Further mesodermal expression of
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Igf2 includes face muscle and tongue, the connective tissue and smooth muscle cells of the 
viscera and blood vessels, and in both the epicardium and myocardium of the heart.
Igf2 is expressed widely in tissues derived of endodermal origin 95. in the lung,
Igf2 transcripts can be detected in the cuboidal epithelia surrounding the bronchioles. High 
levels of expression are observed in the liver from the earliest stages of its development,
and in humans this expression persists into adulthood 96. Other sites of Igf2 expression in 
endodermally derived tissues include the gastrointestinal tract epithelium, pancreas,
salivary gland thyroid and thymus 95.
Stylianpoulou et. al. 97 observed a strong hybridisation signal for rat Igf2 mRNA 
localised within each of the four cerebral hemispheres of the adult rat brain. On closer 
examination this staining pattern was found to be localised to choroid plexus epithelial 
cells and possibly the stromal blood vessels within; and the pia mater and arachnoid mater, 
the leptomeningial layers lining the cerebral hemispheres, the cerebellum and the brain 
stem. In mouse late-gestation embryos (el4-18) Igf2 mRNA was found at high levels in the 
choroid plexus epithelium and stroma, as well as in the pia mater and arachnoid mater of
the meninges 98? suggesting that Igf2 expression in rat and mouse are directly comparable. 
The brain-specific activity of Igf2 appears to be mainly confined to the exchange tissues 
during development, though expression has been reported in other structures arising from
the neurepithelium, in both rat 95? and mouse 99. These tissues include the fetal otic 
vesicle, Rathke’s pouch, and in the postnatal mouse cerebellum, localised to the 
parenchyma and peaking at 3-4 days after birth 1®®. Adult expression of Igf2 is confined to 
the choroid plexus and leptomeninges in rodents 97} with the addition of liver expression 
in man 101, 96 Expression of this gene in the remaining tissues declines shortly after birth 
95.
The onset of expression of the H19 gene lags slightly behind that of 7g/2, and is 
first observed in the embryo proper at e8.5, in the developing mesoderm. In later 
development, H19 transcripts are broadly distributed in the derivatives of the mesodermal 
and endodermal germ layers, such as in the liver, cartilage, intestine, heart, tongue, 
mesenchyme, kidney and the urogenital ridges. The most significant expression of H19 is 
seen in those tissues of mesodermal origin, where the transcript is very abundant. While 
H19 is transcribed in cartilage, like Igf2 no transcripts are detected in the ossification
centres 93. JJ19 is expressed in the choroid plexus and leptomeninges of the brain in
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rodents 98? 102^  but not jn man 94 ^  the adult, H19 continues to be expressed in skeletal 
muscle (though at approximately 10-fold lower levels than in foetal muscle), whereas in all 
other tissues the expression of this gene cannot be detected beyond a few days post partum 
93.
Cis-elements responsible for Igf2/H19 gene expression
While the expression patterns of the Igf2 and H I9 genes during embryonic and post- 
embryonic development has been extensively studied, in a range of mammalian species, 
the identification of enhancer elements responsible for these expression patterns have not 
yet been fully resolved. The only enhancer elements demonstrated at present to drive 
tissue-specific expression at the Igf2/H19 locus were isolated in a region at +9 to +1 lkb 
relative to the start of H19 transcription 103, designated here as the H I9 enhancers.
Yoo-Warren et. al. 103 used an in-vitro system to define sequences downstream of 
the H19 gene that were able to drive gene expression above basal levels in a cell culture 
system. This 3kb region was found to be able to significantly upregulate the H19 promoter 
and the tk promoter in the transformed liver cell line Hep3B. The region exerted this 
activity in either orientation, one of the classical definitions of enhancer sequences. Further 
characterisation revealed two blocks of enhancer activity, with an additive effect on gene 
expression. These enhancers demonstrated tissue specificity, i.e., the upregulation of 
reporter gene expression could not be recapitulated in HeLa cells, which do not express 
H19. The endoderm specificity of these elements was tested by transient transfection into 
PCI3 cells. This murine embryonal carcinoma line differentiates into visceral endoderm in 
the presence of retinoic acid. Low levels of tagged H19 expression was observed when the 
construct was transfected into undifferentiated PCI3 cells. This level was substantially 
increased when the cells were differentiated. The H I9 enhancers therefore demonstrated 
tissue- and developmental stage- specificity.
The in vivo function of these enhancer elements was clarified by a germline
knockout of their endogenous location 104. On maternal transmission of the deletion, H I9 
expression was severely downregulated in a subset of embryonic and neonatal tissues. In 
the reciprocal experiment, when the deletion was inherited from the paternal allele, an 
apparently identical pattern of tissue-specific down-regulation of the Igf2 gene was 
observed. Thus the H I9 enhancers were necessary for upregulation of both H I9 and Igf2 in 
cis, in a subset of tissues.
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The study attempted to quantitate the extent of the loss of gene expression 
following deletion of the enhancers, and found a pattern consistent with the in-vitro 
characterisation of the H19 enhancers. The reduction in gene expression of either Igf2 or 
H I9 correlated roughly with the proportion of endodermally derived tissue present in the 
sample. In neonatal liver samples, which are thought to be almost entirely derived from the 
endoderm, gene expression was reduced to approximately 10% of wild-type levels when 
the deletion was in-cis. In gut, kidney and lung, where the endodermal component of the 
tissue is thought to be lower, 25-30% of wild-type expression levels remained. In-situ 
hybridisation analysis for lgj2 and HI9 mRNA on e l3.5 embryos confirmed that 
expression of these genes was only affected in cells of endodermal origin. For example, in 
gut wild-type animals express H19 RNA at high levels in the gastric epithelial cells that 
line the lumen, and in the smooth muscle that surrounds it. When the enhancer deletion 
was transmitted maternally, only the smooth muscle expression of H I9 was retained.
This study also observed that there was very little decline in gene expression in 
skeletal muscle, brain, yolk sac or placenta following deletion of the enhancers.
A transgene composed of an internally deleted H I9 gene and the H I9 enhancers 
105 expressed a tagged H19 gene in neonatal liver, gut and yolk sac. These findings are in 
contradiction with the previous study, where yolk-sac expression was not lost following 
the enhancer deletion. This could be explained by the groups’ analysis of different 
developmental stages, or that the presence of reporter gene expression is more easily 
detectable than a partial absence of gene activity, which might even be compensated for by 
other elements.
Mice that carried a transgene construct containing the Igf2 promoter 2 to promoter 
3 region, fused to a LacZ reporter gene and driven by the HI 9 enhancers 106 reproducibly 
expressed p-galactosidase in liver, the epithelial layer of the gut, sclerotome, neural tube 
and the placodes of the cranial nerves of el 1.5 embryos.
While the endoderm-specific activity of the H19 enhancers has been well 
demonstrated, it is clear from the studies cited above that these enhancers are not sufficient 
to account for the abundant activity of Igf2 and H19 in non-endodermal tissues, but may 
have some activity there.
While a single element may not be responsible for the entirety of Igf2 (and perhaps 
H I9) expression in these mesodermally derived tissues, no Igf2/H19 cis sequences to date 
have been demonstrated to be mesodermal enhancers. Such elements are thought to lie in-
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cis to the genes that they control, as a 130kb transgene 36f 107? containing sequences from 
the PI promoter of Igf2 to 35kb downstream of H I9 was expressed in many mesodermal 
cell types, such as skeletal muscle and tongue. This study confirms that there is no single 
mesodermal enhancer, as the heart expression of Igf2 was not demonstrated by this 
transgene.
The role of the H I9 enhancers in the brain-specific expression of Igf2 is unclear, as 
some HI 9 enhancer-driven transgenes appear to express reporter genes in the exchange 
tissues 108, 109 whereas others do not 106 As mentioned above, the deletion of these 
enhancers in-cis does not appear to diminish the expression of Igf2 in brain tissues.
Tissue specificity of Igf2/H19 imprinting
It is a common feature of imprinted genes that their imprinting is not maintained in all 
tissues at all developmental time points. Igf2 and H19 follow this pattern, and show a 
dynamic pattern of imprinting throughout development.
The Igf2 gene is biallelically expressed in the leptomeninges and choroid plexus in 
rodents 70^  102 ancj jn man 101 ? jn rodents these tissues provide the only sites of Igf2 
expression after birth. In the rat, the expression of Igf2 in the choroid plexus is at first 
monoallelic, (transcription from the paternal allele only was detected at days 13.5 and 15.5 
of gestation, when the tissue is well differentiated); with a subsequent switch to biallelic 
expression by day 18.5. Thereafter equivalent expression from both alleles was evident
until at least three months of age 102 Biallelic expression of Igf2 was first reported at e l6 
in the mouse foetus 70? which corresponds to approximately day 18 in rat development. 
Whether the same developmental switch in allele specific expression of Igf2 occurs in the 
mouse is unclear, as earlier developmental stages have not been analysed. The imprinting
of the H19 gene is preserved in the choroid plexus and leptomeninges in the mouse 98 and 
rat but not in humans where H19 is silent 101.
In humans Igf2 is expressed postnatally, and biallelically in the liver. The adult 
liver transcript of Igf2 is transcribed from the PI promoter which is human-specific 96.
The PI promoter is always expressed biallelically 76. While the expression of Igf2 in the 
exchange tissues also occurs postnatally, the mechanism by which the gene escapes 
imprinting in these tissues appears to differ from the mechanism in human liver. The adult 
liver transcript in humans is strictly PI derived, whereas exchange tissue-specific
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expression originates from all four human promoters, with a very minimal contribution
from PI 101. Additionally, an equivalent promoter to PI has not been found in rodents.
The Igf2 gene is expressed with a paternal bias from its earliest expression (at low
levels in post-zygotic activation 4-cell embryos) 86. However, expression from the
maternal allele of Igf2 has been reported in blastocysts 86, an(j m embryonic stem cells (ES
cells, 110), but expression levels were generally very low at these stages 86. in later stages 
of development, Igf2 mRNA levels from the maternal allele have been predicted at
approximately 5% of total Igf2 mRNA 8; though one report 111 has estimated the level of 
maternal transcripts to be as high as 25% of the total expression of Igf2, in foetal liver cells 
at el3.5.
For H19, expression appears to be biallelic from its onset at implantation stages 86? 
with equal transcription from both alleles in embryonic and extraembryonic tissues. ES 
cells have also been shown to express H19 biallelically 11^ 110? though the expression of 
the paternal allele has been reported to be the result of prolonged culture of embryos in 
vitro
Expression from the paternal H19 allele has been reported to persist in embryonic
and amniotic tissues until el0.5, and in the extraembryonic tissues up to at least el6.5 86.
It is of interest to note that the relaxation in the imprinting status of HI 9 in cultured
embryos 113 was confined to the extraembryonic tissues, particularly the trophectoderm.
In human first trimester placentas, paternal H19 transcripts can be detected in the 
extravillous cytotrophoblast cells 114. The extravillous cytotrophoblast component of 
Complete Hydatidiform Moles, which represent human androgenetic conceptuses, also 
express H I9 113. In the villous cytotrophoblast, from which the extravillous cells are 
derived, H I9 is expressed only from the maternal allele, suggesting that H I9 imprinting is 
relaxed in this tissue as development proceeds. A similar situation is observed in the 
mouse, where the primary giant cells of the e7 placenta have been shown to express the 
paternal allele of H I9 at high levels in a mosaic pattern. Transcription of the paternal allele 
in these cells progressively diminishes as development proceeds 116.
While reports are contradictory, the evidence seems to favour an initial phase of 
biallelic expression of H19, which either persists, or is re-introduced in a tissue-specific 
manner in later development. Transcription of the paternal allele of H19 is confined to the 
extraembryonic tissues in later development, in both the mouse and in humans.
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Conversely, while a low level of maternal lgf2 expression can be detected at all stages of 
development, a strong bias toward paternal allele transcription is evident from the earliest 
stages of expression of this gene.
Epigenetic modifications
An imprinting mark, i.e., that primary modification of DNA that distinguishes the parental 
alleles of a gene, must conform to certain criteria:
i) It must be a reversible modification of DNA, which can be erased in the germline 
of the parent, then reset according to that parent's sex.
ii) The mark must be stable throughout subsequent cell divisions, being inherited from 
one chromosome to its daughter chromosomes.
iii) It must direct the transcriptional state of the gene that it controls.
DNA methylation
DNA methylation in mammals occurs predominantly at the 5’ position of Cytosine 
residues in CpG doublets. This modification of DNA is clonally heritable, as the 
recognition site for the major mammalian maintenance methylase, Dnmtl is palindromic,
and the preferred substrate for this enzyme is hemi-methylated DNA (reviewed in 1 17).
CpG methylation is important for development as mouse embryos homozygous for 
a partially inactivated allele of Dnmtl die before e l0.5, and a null allele causes lethality at 
the 5-somite stage. ES cells homozygous for either of the alleles proliferate normally, with
their genomic DNA highly demethylated, but die upon the induction of differentiation 118. 
The expression of imprinted genes is disrupted in mice lacking functional Dnmtl, for 
example, the H19 gene becomes activated on both parental alleles whereas Igf2 is silenced 
119. xhe inappropriate expression of imprinted genes cannot in all cases be restored by 
reintroducing a functional copy of Dnmtl at postimplantation stages. Embryos derived 
from ES cells expressing an integrated Dnmtl cDNA in a Dnmtl'/' background do not 
regain allele specific expression of imprinted genes, despite remethylation of bulk genomic
DNA 12°.
The experiments in which Dnmtl is inactivated in mouse development clearly show 
that methylation plays a role in the imprinting mechanism. The case proposing CpG 
methylation as an imprinting mark is strengthened by the observation that regions within or
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near most imprinted genes are methylated in a parent of origin dependent manner 
(reviewed in 21)
CpG methylation levels of DNA are highly dynamic during development, and male 
and female gametes differ markedly with respect to global levels of DNA methylation 
(121; and reviewed 122). in the male germ-line, germ cells are relatively unmethylated, but 
maturing gametes acquire methylation as spermatogenesis progresses. Mature sperm have 
very high levels of methylated CpGs. Conversely, mature oocytes attain a much lower 
level of genome methylation during their development. At fertilisation, and until the late 2- 
cell stage, paternal and maternal chromatin can be distinguished on the basis of their 
methylation status. Immediately following fertilisation, paternally derived chromatin is 
highly methylated, but during the first cell division the paternal genome is rapidly
demethylated 21, 123? presumably due to the action of a demethylase protein 124. The 
maternal genome shows moderate levels of methylation at fertilisation, and these levels 
decline during the first few cell divisions at a rate suggestive of a loss of maintenance 
methylation, rather than the active demethylation observed in paternal chromatin 21, 123 
By the blastocyst stage of development both genomes are grossly indistinguishable, and 
almost completely demethylated. Remethylation of the genome is initiated after 
implantation, and levels slowly rise during subsequent development. Extraembryonic 
tissues maintain lower levels of global genome methylation than embryonic tissues
throughout development, and germ cells remain unmethylated 121.
During early development the maternal and paternal genomes are clearly 
distinguishable in terms of their methylation status, thus CpG methylation provides a good 
candidate for a parental allele specific imprint. This imprint must persist, however, 
throughout the genome wide changes in methylation status in the early embryo.
Methylation also provides a candidate for the maintenance of a silent 
transcriptional state found on the inactive allele of imprinted genes. There is a general 
correlation between methylation of promoters, and gene inactivation 125. Though the 
genome is globally remethylated during implantation stages, the CpG islands associated 
with housekeeping genes escape modification, and at later stages of embryogenesis the 
promoters of tissue specific genes are demethylated in the cell types in which they are 
expressed (reviewed in 126). CpG methylation is also found on the inactive allele of the X
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chromosome 122 Furthermore, microinjection of methylated gene sequences into in vitro
cell culture systems results in the formation of inactive chromatin (reviewed in 127)
Methylation at CpG residues therefore provides many of the necessary qualities of 
an imprinting mark; it can distinguish the maternally and paternally derived genomes, can 
be stably inherited at cell division, and can mediate changes in gene activity.
Methylated regions at Igf2/H19
DNA methylation was shown to be involved with imprinting at the Igf2/H19 locus by
analysis of mice containing deletions in the DNA methyltransferase gene Dnmtl 119. 
When homozygous mutant embryos were examined for expression of H I9 and Igf2, the 
normally silent paternal H19 allele was found to be activated, whereas the expression of 
Igf2 was repressed. Thus the loss of DNA methylation had opposite effects on the two 
genes.
Several regions within the locus including the Igf2 and H I9 genes differ in respect 
to the methylation status between their parental alleles. In order for a region of differential 
methylation to qualify as an imprinting mark, the appropriate residues must be methylated 
in the maternal or paternal genome while the two genomes are separated. This separation 
extends from the onset of gametogenesis until syngamy of male and female pronuclei, just 
prior to the first cell division of the 1-cell embryo. The modification must then persist 
throughout development, i.e., one allele must resist the genome-wide demethylation in the 
blastocyst, and the other allele must resist the de-novo methylation at implantation stage.
Three differentially methylated regions (DMRs) have been identified close to, or 
within the Igf2 gene, and are depicted in Figure 2a.
DMRO 6, is immediately 5' to Igf2 upstream exon 1. This region exhibits maternal 
allele-specific methylation in placental tissue, though both alleles are methylated in the
foetus. This region is associated with the start of transcription of both a sense 6 and an 
antisense 6, 14 jgf2 transcript, which are both expressed in the placenta from the paternal 
allele.
DMR1, an element located between upstream-exon2 and exon 1, was first
discovered to be differentially methylated by Sasaki et. al. 8, who compared the digestion 
of this region by methylation-sensitive enzymes between normal embryos, and MatDi7 
embryos (those with two copies of maternal chromosome 7, and no paternal chromosome 
7). MatDi7 embryos showed a pattern of complete digestion in this region, indicating that
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maternal DNA is unmethylated, but normal embryos showed some protected fragments
which must correspond to paternal, methylated residues. Brandeis et. al. 128 further refined 
this region to ~600bp approximately 3kb upstream of Igf2 promoter 1 (PI). Using inter­
specific crosses of Mus musculus and Mus spretus in order to identify parental alleles by 
sequence polymorphisms, four CpGs were identified which were partially methylated on 
the paternal allele and completely unmethylated on the maternal allele in adult liver and 
embryos at el 5-el 8. In sperm and oocytes, all four sites were methylated. In the 16-32 cell 
morula, this region was unmethylated on both alleles except for one site (site 3), which was 
more highly methylated on the paternal allele. The differential methylation pattern 
observed in somatic cells must be established during post-fertilisation development, which 
disqualifies this region as a site for the primary imprinting mark.
A systematic study of the methylation status of all of the CpGs in this region was
carried out using the bisulphite sequencing technique. Feil et. al. 7 found a gradient of 
methylation over 13CpG dinucleotides in this region, from almost complete methylation of 
CpG 1 (near to upstream exon 2) to virtually no methylation at CpG 13 (most proximal to 
PI). Overall, maternal chromosomes were less methylated than paternal chromosomes 
(23% and 38% respectively), though no single CpG was always methylated paternally and 
unmethylated maternally. For CpGs 1 to 4 (of which site 3 above is one) the differences 
between parental alleles was most pronounced, with -50% more paternal methylation than 
maternal-specific methylation. In adult choroid plexus this region is highly methylated on 
both alleles.
DMR2 was initially described as three differentially methylated Hpall restriction 
sites, one within intron 4 directly upstream of exon 5, one within exon 5, and one located 
within the coding sequences of exon 6. These sites were found to be more methylated on 
the expressed paternal allele than on the repressed maternal allele. In fetal brain this region 
is almost entirely unmethylated, while in fetal liver there is a high level of paternal 
methylation. In adult choroid plexus this region is methylated on both chromosomes. The 
pattern of methylation of this region is thought to correspond to the expression status of
Igf2 7. DMR2 is conserved in horse and man, and in horse and mouse it has been shown to 
form a stable stem-loop structure. The equine stem-loop motif was shown to bind a 
specific protein fraction from neonatal liver nuclear extracts, of both horse and mouse, in 
gel-mobility shift assays. Protein binding was reduced upon methylation of the CpGs in the 
stem loop area 129.
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Figure 2a. Schematic representation of the Igf2 gene region showing regions of allele 
specific methylation (black horizontal bars, DMR 0, 1, 2). The eight exons of Igf2 are 
depicted as grey boxes (ul, u2, and El-6).The four promoters are depicted as arrows above 
the exons.
The table below indicates at which points in development these regions are 
methylated (++, highly methylated; +, methylated; - ,  unmethylated, nd represents those 
time points where information is not available). A detailed description of this region, with 
the corresponding references is contained within the text.
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The H19 gene region also contains several regions of differential methylation, which are 
depicted in Figure 2b.
The H19 gene and promoter-proximal region. Ferguson-Smith et. al. ^ first identified two 
Hpall sites within the first exon of the H19 gene which were fully unmethylated in MatDi7 
embryos, 50% digested in normal embryos. They found the remainder of the gene to 
exhibit the same methylation pattern in normal and MatDi7 embryos, notably at the 3’ end 
of the gene near the enhancers. This analysis was extended (38, 128) t0 include further 
CpG residues within the gene. These studies revealed that HI 9 is modified in the first exon 
of the gene on the paternal allele regardless of expression status, being methylated in the 
brain, adult liver and in embryonic stem cells where H19 is known not to be expressed. An 
exception to this is in the adult choroid plexus where both alleles of the HI 9 gene are fully
methylated 7. Sperm DNA is highly methylated in this region, but there is no differential 
methylation during morula and blastula stages of development, which rules out the H I9 
gene methylation as a candidate for the primary imprinting mark (38, 34} 130)
The H I9 promoter contains a CpG island which is highly methylated on the 
paternal allele, and undermethylated on the maternal allele 9. This promoter region acts in 
a manner typical of CpG islands in that it is unmethylated in sperm and in blastocysts, 9, 
128, 38)? ancj js remethylated in the genome-wide de-novo methylation in postimplantation 
development 113, 121. Methylation of the promoter of the paternal H I9 allele appears to 
correlate closely with H19 gene silencing. This region is progressively methylated in the 
embryo during postimplantation development 128, 113^  corresponding to the gradual 
silencing of the paternal H19 allele during this phase of embryogenesis 86. The 
progression of methylation at the paternal H I9 promoter is more protracted in the 
extraembryonic lineages, especially in the trophoblast 113, where expression from the 
paternal H I9 allele is most pronounced 86, 116 Furthermore, this region is methylated on
the paternal allele in the choroid plexus 2, demonstrating that the methylation of this region 
corresponds to the imprinting status of the H I9 gene, and not that of Igf2. While the lack of 
methylation of this region in early embryogenesis disqualifies the H I9 promoter as a 
candidate imprinting mark, its methylation closely parallels the silencing of the paternal 
H I9 allele, and gives an indication that the marking and silencing of imprinted genes may 
be separable processes.
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F igure 2b. Schematic representation o f the H19 gene region showing regions o f allele 
specific methylation (black horizontal bars, D M D A , D M D B , the H 19 prom oter and gene), 
and the regions that are hypersensitive to nucleases on the maternal allele (H S l and HS2, 
white boxes).
The table below indicates at which points in development these regions are 
methylated (++, highly methylated; +, methylated; - ,  unmethylated, nd represents those 
time points where information is not available). A detailed description o f this region, with 
the corresponding references is contained within the text.
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H19 5’ region (DMD). The region encompassing lOkb upstream of the H I9 
promoter shows all of the features of an imprinting mark. This region is heavily methylated 
on the paternal allele in neonatal mice, and in sperm DNA 38} 34} 130 a  more detailed 
analysis of this region reveals two blocks of CpG dinucleotides which show paternal 
specific methylation in neonatal and adult tissues, as well as in pre-implantation
development and in sperm 1^1. These two blocks; DMDA (which spans from -4.1 to -  
3.8kb of H I9 transcription start, see Figure 2b) contains 11 CpG dinucleotides which were 
shown by bisulphite sequencing to be highly methylated in sperm, almost entirely 
unmethylated in mature oocytes, and 50% methylated from the fertilised egg through to 
adult tissues. This region contains the Hpall and Hhal restriction sites initially shown by 
Tremblay et. al. 34 to fulfil the criteria of an imprinting mark. Bisulphite sequencing of 24 
CpGs in DMDB (from -2.6 to -2.1kb of H19 transcription start, see Figure 2b) shows that 
this region is highly methylated in sperm, unmethylated in oocytes, and throughout early 
development the paternal allele is more highly methylated than the maternal allele. There is 
a low level of maternal methylation that is again consistent with the methylation pattern of
Hpall sites found by Tremblay et. al. 34 jn this region.
Resetting the imprint
Imprinted genes are thought to re-establish their sex-specific imprint during 
gametogenesis, as at these stages the male and female genomes are separated. Many 
studies have attempted to correlate methylation changes at imprinted loci to a sex-specific 
difference in germ cell potency. If methylation is the ‘imprinting mark’, i.e. the epigenetic 
modification which is causal in the establishment of differential gene expression between 
parental alleles, then certain predictions can be made about the temporal changes in 
methylation status at imprinted genes as development proceeds. It would be predicted that 
in germ cell development the methylation patterns of the previous generation should be 
erased, and then replaced with a methylation pattern specific to the sex of that germ cell. In 
support of this, it is known that primordial germ cells (PGCs) are markedly
undermethylated globally, as compared to other embryonic tissues, from at least el 1.5 121.
As discussed above the H19 DMD displays all of the characteristics of an 
‘imprinting mark’, i.e., this region is differentially methylated in mature gametes, and the 
differences in methylation status persist throughout subsequent development.
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What is the time-scale of the establishment of paternal specific methylation at the
H19 locus? In contrast to many other imprinted genes 132> the somatic pattern of H19 
methylation is not lost until late in PGC development. In cells derived from e l2.5 PGCs, 
CpG residues in the H I9 DMD and promoter-proximal region had the somatic pattern of 
methylation, i.e., the paternal allele was hypermethylated and the maternal allele was 
hypomethylated. By el4, this somatic methylation pattern is lost, as judged by an 
experiment in which the nucleus from el4-16 PGCs were transferred into enucleated
oocytes 133 ^  embryos derived from these cells, H19 is biallelically expressed at e9.5 
(the latest stage of embryo recovery), suggesting that the correct paternal-specific 
modification was never established, and the gene was unmethylated at the DMD.
Bisulphite sequencing of the DMD and promoter-proximal regions of the H19 gene in
male PGCs 134 at e l3.5 revealed that these regions were undermethylated on both parental 
alleles. If the parental imprint had been erased by this stage (el3-el4), both alleles should 
be equivalent. It appears, however, that differences between parental genomes persist until 
late into spermatogenesis, with both alleles of H19 becoming truly equivalent in meiotic
spermatocytes 135. in mitotic spermatogonia the maternal allele of H I9 is significantly 
less methylated than the paternal allele at the DMD and promoter-proximal region. During 
the meiotic stages of spermatogenesis the maternal allele comes to resemble the paternal 
allele, until the round spermatid stage of post-meiotic spermatogenesis, when the origin of 
the two alleles cannot be distinguished by their methylation status.
It appears then that though the two parental alleles become equivalent in terms of 
their demethylation in embryonic PGCs, differences still exist between the alleles, which 
affect the ability of each to acquire the sperm-specific methylation pattern. Further CpG 
residues could exist outside the regions examined, that retain their paternal methylation 
pattern and thus distinguish the parental alleles; or the two alleles could be identical in 
terms of their undermethylated state in late gestation PGCs, but other epigenetic 
modifications could still exist.
Analysis of the expression of both the Igf2 and H19 genes during gametogenesis 
and in early embryogenesis suggests that the expression of these genes is decoupled from 
methylation at the DMD. Igf2 and H19 are biallelically expressed (at low levels) in meiotic 
germ cells from both sexes 136? jn pre-implantation embryos 86, and m ES cens 112? when 
differences in the methylation status between parental alleles has been demonstrated.
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Chromatin modification
The simplest repeating structure of chromatin is the nucleosome, which consists of ~200bp 
of DNA wrapped approximately 2 turns around an octomer of the highly conserved core 
histones H2A, H2B, H3 and H4.
The arrangement of DNA into nucleosomes is thought to have a generally 
repressive effect upon transcription, and this repression must then be overcome at specific 
loci by positive acting transcriptional regulatory proteins. In yeast, inhibition of histone 
synthesis leads to constitutive activation of many genes, even in the absence of their 
specific activator proteins (reviewed in 137).
Alterations in chromatin structure can be observed at sites of active genes, prior to 
the onset of transcription, which can be visualised by the altered sensitivity of such regions 
to cleavage by nucleases (the endonuclease DNase I is most commonly used), and termed 
DNase sensitive regions. Early studies of the avian globin, lysozyme and ovalbumin loci 
revealed that DNase sensitivity extends across these loci in cells which are competent to 
transcribe the genes (reviewed in 138) ^  contrast, heterochromatic regions of the genome, 
where transcription is repressed, are extremely insensitive to nucleases.
Sensitivity to nucleases delineates domains in which transcription of genes occurs. 
Within these regions, sequences that show an even greater sensitivity to nucleases 
(nuclease hypersensitive sites, HS) often correspond to promoters, transcription factor
binding sites, and enhancers 137 Like the generalised nuclease sensitivity in active gene 
regions, the formation of HSs at the regulatory regions of genes appears to be a 
prerequisite for transcriptional initiation, and represents an early step in gene activation.
Regions of active transcription with increased sensitivity to nucleases often 
correspond to regions with high levels of histone acetylation. Acetylation occurs at Lysine 
residues of the amino-terminal ‘tails’ of the core histones. The acetylation status of histone 
H4 has been most extensively studied. H4 can be acetylated at four Lysine residues at the 
amino-terminus, and in mammals the order in which these residues are modified occurs in 
a fixed order. Lysine 16 is modified first, followed by Lysines 12 or 8, and finally Lysine 
5. Acetylation of Lysine 5 therefore can be used as a marker for hyperacetylated histones 
139
The histone acetylation status of localised chromatin domains provides a 
mechanism for the propagation of imprinting marks. Though replication disrupts 
nucleosome association, the disruption is transient and the histones originally associated
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with a region of replicating DNA will remain associated with that region and reassemble 
after the passing of the replication fork. Modifications of histone proteins will therefore 
remain in contact with their particular genes and are stably propagated within their local 
environments (reviewed in 140)
The acetylation status of histones is highly dynamic during preimplantation 
development. Sperm chromatin is packaged with protamines rather than histones. 
Immediately upon sperm entry the paternally derived chromatin sheds the protamines, and 
replaces them with histones. The source of these histones is the oocyte cytoplasm, which 
contains a large store of acetylated histones. The maternally-derived chromatin is relatively 
underacetylated in oocytes, and remains so until the onset of the first round of DNA 
synthesis, just prior to syngamy 141.
The male chromatin aquires a high proportion of acetylated H4 after fertilisation, 
but the female chromatin does not, unless the oocyte is artificially activated. In 
parthenogenetic embryos, all chromatin aquires high levels of acetylated H4. There is a 
high turnover of histone acetylation and deacetylation at these early developmental stages. 
Inhibition of histone deacetylases by Trichostatin A (TS A) results in female chromatin 
becoming hyperacetylated. These observations suggest that the dynamics of acquisition 
and maintenance of histone acetylation differ between male and female chromatin in the
zygote 141. Such differences could provide the basis of a mark that distinguishes the 
alleles of imprinted genes.
Acetylation of H4, in general, occurs in regions known to be enriched in coding 
DNA, and furthermore, chromatin fractions enriched for sequences characteristic of CpG 
islands also contain highly acetylated histones. Conversely, H4 in heterochromatic regions
is consistently underacetylated, for example in centric heterochromatin 139f and on the
inactive X chromosome of mouse and man 142.
How does histone acetylation affect gene expression? Acetylation of histones is 
thought to neutralise the positive charge of the Lysine tails, and thereby reduce the affinity 
of the histone octomer for DNA. Acetylation therefore provides a mechanism by which 
DNA can be rendered generally accessible to trans- acting factors while still maintaining a 
nucleosomal structure. Transcriptional control requires the binding of multiple sequence- 
specific transcription factors to regulatory elements in cis to the transcriptional start site. 
Activation domains within these factors recruit co-activators, which, in turn, facilitate the 
activity of the basal transcriptional machinery (reviewed in 143). Proteins with histone
38
acetylase activity have been identified, which previously have been characterised as 
components of the RNA Polymerase II (Pol II) transcription machinery, as proteins that 
associate with transcription factors, and proteins that positively affect transcription in vivo 
(reviewed by Struhl, 1998). Examples of this are: the TAF130/150 histone acetylase, 
which is a subunit of the TEUD complex, a basic component of the Pol II transcriptional 
machinery in all eukaryotes; p300/CBP histone acetylase was described initially as a 
transcriptional co-activator that functions by interacting with a wide variety of enhancer 
binding proteins, including the glucocorticoid receptor.
The best described histone deacetylases are members of a gene family that includes 
the human deacetylase HDAC1, and yeast Rpd3. HDAC1 and Rpd3 are found in large 
multiprotein complexes that include the Sin3 co-repressors, and other negative regulatory 
proteins such as Mad and NCoR 144.
Recently a connection has been discovered between methylation at CpG residues 
and gene silencing by the mSin3A/NCoR/HDACl complex, mediated by the methyl- 
binding protein MeCP2 145} 146 MeCP2 is a member of a family of proteins containing a
methyl CpG-binding domain (MBD), (reviewed in 147) MeCP2 binds preferentially to 
methylated CpG doublets via the MBD, in any sequence context. In general, there are 
approximately 5xl06 molecules of MeCP2 per nucleus in the mouse, corresponding to one 
molecule per 5-20 nucleosomes 148, indicating that MeCP2 is an important structural 
component of chromatin. MeCP2 contains a transcriptional repression domain (TRD) that 
can confer silencing upon reporter constructs when fused to a GAL4 DNA-binding 
domain, and can operate over several hundred base pairs to silence transcription. The 
transcriptional repression can be alleviated by addition of the histone deacetylase inhibitor
TSA 147 ft is the TRD which interacts directly with mSin3A, and thereby recruit histone
deacetylases to DNA marked by methylation 145. Methylation of critical regulatory 
regions of imprinted genes may act to recruit chromatin remodelling factors in an allele- 
specific manner, leading to the downregulation of target genes.
Proteins which modify the histone acetylation status of chromatin therefore appear 
to act both generally upon the basal transcriptional machinery, and can be recruited to 
specific promoters/chromosomal regions, bringing about local changes in chromatin 
conformation which directly affect the transcriptional status of specific genes. As with 
MeCP2, the recruitment of chromatin remodelling factors may require the marking of 
suitable sequences by CpG methylation, but this is by no means the only mechanism, as
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the mSin3/NCoR/HDACl complex can also act to silence genes by a methylation 
independent mechanism 145
CpG methylation does not provide the only candidate for an epigenetic mark that is 
stable through DNA replication. The proteins involved in the formation of open or closed 
chromatin are intimately connected to DNA, and are very likely to co-segregate with their 
respective binding sequences during chromosome replication and division. Chromatin 
proteins are known to recruit other members of their multiprotein complexes, therefore 
fully competent chromatin complexes can be formed from a small number of components 
after cell division. In this manner, the association of specific protein complexes with DNA 
could constitute an epigenetic mark, which is heritable through multiple cell divisions. In 
Drosophila melanogaster, where there is no genome methylation to provide epigenetic
marks, heterochromatin at centromeres and telomeres is stably inherited 149 Repressive 
complexes at the homeotic genes, which are mediated by the Polycomb group proteins are 
stably inherited, by a mechanism which does not require the formation of canonical 
heterochromatin (reviewed in 40} 150)
Chromatin structure at Igf2/H19
Several regions of nuclease HS have been identified at the Igf2!H19 locus (see Figure 1), 
and the acetylation status of the histones has also been ascertained in some cases, though 
the developmental profile for the formation of such regions is less well defined than the 
regions of differential methylation.
In the mouse the Igf2 gene region displays a number of HSs, the strongest within
the CpG island at P2, with others within exon 2, at P3 and within exon 3 8. These HSs can 
be found in tissues that express Igf2, but not in adult spleen, which does not express the 
gene. A comparison of DNase I HSs at these sites between MatDi7 and normal embryos 
reveals that there are no allele specific differences in chromatin compaction within the Igf2 
coding region, and that both alleles are equally accessible to nuclear factors. The region 
encompassing DMRO displays a constitutive HS, which may mark the promoter of the
placental-specific transcript of Igf2 6. The region including DMR1 has been found to be 
accessible to nucleases 151, with no difference in sensitivity between parental alleles. Feil 
et. al. 152 founcj four HSs partially overlapping the DMR1 region, which were equally 
DNase I hypersensitive in androgenetic and parthenogenetic ES cells, as well as in 
embryonic chromatin. These HSs do not persist in neonatal liver, however, which suggests
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that nuclease sensitivity within this region does not generally reflect Igf2 expression. Feil 
et. al. 152 have suggested that the HSs at DMR1 may correlate with the expression of the 
antisense transcripts 14, 6 that are transcribed from the upstream region of Igf2. The 
DMR2 region does not display enhanced sensitivity to nucleases in any tissues assayed to 
date 151, 152
In a systematic analysis of 130kb including Igf2 and H19 for regions of nuclease 
sensitivity, a region approximately 32kb upstream of the H19 start site was found which 
displayed a high level of nuclease sensitivity on both alleles. This region was 
hypomethylated with respect to the surrounding DNA, and found to be conserved in a
range of mammalian species 151. This region is the main subject of this report, and is 
designated the CCD (for centrally conserved domain).
The H19 gene differs in respect to Igf2 in that the inactive allele is insensitive to 
nucleases. The promoter region is marked by a strong HS, but only on the active, maternal
allele 9. There are also several HSs downstream of the coding region, three of which 
correspond to the location of the H19 enhancers. These 3’ HSs are all hypersensitive to 
nucleases on both parental alleles in chromatin derived from embryos at midgestation 9,
151.
The region approximately 2-4kb 5’ to the H I9 transcriptional start site (the DMD) 
has been extensively studied in terms of its chromatin structure. Hark and Tilghman 153 
discovered two blocks of nuclease hypersensitivity corresponding to two regions of 
extensive paternal CpG methylation (HSl and HS2 in Figure 2b). These HSs (at 
approximately -3.8kb and -2.5kb) are present only on the maternal allele, in tissues known 
to express H19, and in non-expressing tissues. A fine mapping study of this region 154 
detected five HS in chromatin derived from adult brain, liver and kidney, and seven sites in 
ES cells. These HSs map within the regions of nuclease sensitivity described by Hark and
Tilghman 153. Furthermore, Khosla et. al. 154 treated chromatin derived from the tissues 
detailed above with micrococcal nuclease (MNase). MNase digests DNA preferentially at 
the linker regions between the nucleosomes. The most usual positioning of nucleosomes is 
in ~200bp arrays, and digestion of such DNA with MNase gives rise to a distinctive 
laddered digestion pattern. When the maternal 5’ DMD region was subjected to this 
treatment a digestion pattern resulted that did not match that of a canonical nucleosome 
array, and the resultant pattern was suggestive of a chromatin structure in which the core
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histones had been displaced. The areas of MNase sensitivity matched very closely to those 
determined previously as DNase I HSs. The paternal allele showed an identical MNase 
digestion pattern in this region to that of a non-imprinted gene, with the characteristic 
laddered pattern. The maternal MNase digestion pattern was also found in the DMD region 
in parthenogenetic ES cells, suggesting that the underlying chromatin conformation
responsible for such a pattern is acquired early in development. Khosla et. al. 154 suggest 
that this ‘unusual chromatin’ conformation of maternal chromatin at the DMD reflects an 
opposite epigenetic state to the hypermethylated paternal allele, and may protect the 
maternal allele from de-novo methylation at implantation. Further work will be needed to 
determine if this region displays the same irregular chromatin structure in oocytes, and 
could thereby constitute a dominant epigenetic mark of the maternal genome. Kanduri et.
al. 155 aiso reported maternal allele specific MNase hypersensitive sites within this region,
two of which correspond to sites reported by Khosla et. al. 154 ^  contrast to the previous 
report, however, the authors suggest that the MNase sensitive regions map to sites 
corresponding to the linker regions between histones, and that the previous evidence of a 
nucleosome free region was artefactual. Furthermore, these nuclease hypersensitive sites 
were found to overlap with the 21 bp repeat elements identified previously as sites of 
sequence homology between the human, rat and mouse differentially methylated regions 
156
Further studies in the epigenetic status of this region have revealed that the 
promoter of the maternal allele of the H19 gene is more readily bound by transcription 
factors in early development than the paternal allele. Transcription factors bound to 
promoter elements could outcompete nucleosomes and DNA methyltransferase, and 
thereby inhibit methylation, thus stabilising the expression differences between the alleles 
in later stages of development 157
A 1.2kb fragment of the DMD containing HS2 has been shown to function as a 
silencer in Drosophila, suggesting a conserved mechanism in the silencing of the H I9 
gene, and gene silencing in Drosophila. As Drosophila lacks genome methylation, this 
region may be recognised by different factors than in mouse (since it is the methylated 
form of this region which is linked to silencing of H19), to bring about a similar
downstream event 158 Alternatively, methylation of this region may not be related to its 
role in the imprinting mechanism.
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Chromatin prepared from primary fibroblasts (which display correct imprinting of 
Igf2 and HI 9) was immunoprecipitated with antibodies raised against the acetylated forms 
of histones H3 and H4. Maternal chromatin from the HI 9 locus was found to be acetylated 
at much higher levels that paternal chromatin. Igf2 is acetylated at comparable levels on 
both parental chromosomes 1^9 This result confirms the earlier observation that the alleles 
of the Igf2 gene are equivalent in terms of their potential transcriptional status 8, whereas
the paternal allele of H19 is silenced via a mechanism involving chromatin compaction 9. 
There is some evidence that chromatin compaction of the inactive H I9 locus is most likely 
a gradual process. Firstly, the paternal allele of H19 is known to be expressed at relatively 
high levels in early development 86f particularly in the extraembryonic tissues 86? 116 
Secondly, when e7.5 embryos were cultured in-vitro in the presence of the histone 
deacetylase inhibitor TSA, the paternal allele of HI 9 was reactivated in a stochastic 
fashion (reminiscent of position effect variegation), giving rise to a small subpopulation of
cells in the trophectoderm which expressed H I9 biallelically 11(>. This experiment 
provides direct evidence that the silencing of paternal H I9 depends directly upon 
chromatin modifications, at least in the extraembryonic tissues.
In summary, studies of the epigenetic modifications of the Igf2 and H19 genes 
show that despite very similar spatial and temporal patterns of regulation, the mechanism 
mediating the imprinting of these two genes, while linked, may be quite different. The Igf2 
gene is transcribed with a paternal bias from the earliest stages of its expression, is in an 
‘active’ chromatin conformation on both alleles (as judged by accessibility to nucleases, 
and hyperacetylation of histones H3 and H4), and is marked by methylation on the active, 
paternal chromosome. On the other hand, the H I9 gene displays biallelic transcription 
from its first expression, and expression levels remain high from the ‘silent’ paternal allele 
up to midgestational stages in the extraembryonic tissues. The inactive, paternal allele of 
H19 is generally nuclease insensitive, methylated at the promoter, and within the 5’ portion 
of the gene, and underacetylated.
Mechanisms of lgf2IH19 imprinting
As was discussed above, a large number of structural studies have isolated regions in cis to 
the Igf2 and H19 genes that are distinctive in terms of their chromatin structure, and 
patterns of CpG methylation. While correlations can be found between, for example, levels 
of CpG methylation at a gene region and the expression levels of that gene, such analyses
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do not causally link the two phenomena. In order to provide such a link, two major 
experimental strategies have been adopted in order to resolve the role of c/s-acting 
elements in the mechanism/s of Igf2 and H I9 imprinting.
The first of these strategies is the creation of transgenic mice bearing integrated 
constructs containing cis elements of the imprinting domain fused to reporter genes. An 
advantage of this approach is that, once found, active sequences can be characterised fairly 
easily. The disadvantages stem from the observation that the site of transgene integration 
can have a large effect upon the activity of the experimental construct, thus necessitating a 
comparison of several transgenic lines. In addition, the critical regions examined in 
transgene constructs may require a larger genome context in which to act.
The second approach is that of the generation of targeted germline deletions of 
candidate regions by homologous recombination, i.e., the creation of knockout mice. While 
the use of this approach ensures that the action of a particular element will be examined in 
an appropriate genome context, in a complex or redundant system compensating elements 
may mask the effects of removal of one element. Experiments utilising a transgenic 
approach therefore identify those regions, which are sufficient, for (in this case) the 
imprinting phenomenon, whereas experiments using a knockout approach identify those 
sequences which are necessary for the effect.
Elements required for H19 imprinting
Are any of the regions defined by nuclease HSs and/or differential methylation able to 
confer imprinting at ectopic loci? This question has been answered in part by a series of 
experiments involving transgenic mice bearing H19 transgenes.
H19 transgenes which include 4kb upstream sequences, the H19 structural gene, 
and 7kb downstream sequence are expressed when transmitted maternally, and silenced 
when transmitted through the paternal genome 37, 38} 39 jf the transgenes are present at 
high copy number. Low copy number transgenes are always silenced. The transgenes 
contain much of the sequence of the 5’ DMD CpGs, as well as the 3’ H19 enhancers.
These imprinted transgenes are methylated on paternal CpGs in the 5’ region as well as in 
the gene itself in a manner similar to the endogenous H I9 gene.
In transgenes that bear internal deletions removing the 3’ part of exon 1, exon 2 and
the 5’ part of exon 3, the imprinting is maintained 37? 38 Removal of the 2kb DMD at the 
5’ end of the construct leads to biallelic expression of the transgenes. A 3’ truncation of the 
construct which removes the enhancers also results in loss of transgene imprinting, though
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expression is also lost, and imprinting status is instead measured by transgene methylation. 
Deletion of a 451 bp region containing the G-rich repeat element ~1.5kb upstream of HI 9 
start results in biallelic expression of the transgene, but curiously monoallelic expression is
restored if 1.7kb additional 5’ sequence is added to this deleted construct 1^6 
Replacement of the H I9 coding region with a luciferase reporter gene gives rise to biallelic 
expression of the transgene, as does a deletion which removes the first 700bp of the H19 
coding sequence (which includes the differentially methylated region of the H19 gene) 39e 
The manipulations described above demonstrate that imprinting of the H19 gene at 
ectopic loci is probably a multifactorial process. That the imprinting and expression status 
of these transgenes is very delicate is implied by the need for many copies of the transgene, 
perhaps to insulate the region. Removal of i) the DMD, ii) the G-rich repeat, iii) exon 1 of 
H19 and iv) the H19 enhancers can all result in the loss of monoallelic expression, 
suggesting that many factors act co-operatively to give a stochastic pattern of expression.
This delicacy of the imprinting status of H19 is indirectly supported by the 
observation that the only transgene created to date which gives rise to stable imprinting of
H19 at low copy number is a 130kb YAC 36# It is also possible that the YAC transgenes 
contained regions required to stabilise H19 imprinting which are not present in the smaller 
transgenes, but which can be functionally substituted for by multiple copies of those 
elements which are present.
The enhancer competition model
The observation of extremely similar temporal and spatial patterns of gene expression of 
Igf2 and H I9 led to the idea that the two genes may be co-ordinately regulated, and that 
their imprinting might be mechanistically linked.
Deletion of the genomic region containing the H19 enhancers demonstrated that the 
expression of the two genes is dependent upon a shared element, at least in a subset of
tissues 104. This led to the investigation of whether the imprinting mechanism too was 
shared by the two genes, and seemed to be confirmed by an experiment in which the H19
gene, as well as approximately 7kb of flanking sequence was deleted 27. When the 
deletion was transmitted from the male parent, both H I9 and Igf2 gene expression was 
unaffected. Maternal transmission of the deletion resulted in activation of the Igf2 allele in 
cis to the deletion. This experiment led to the proposal of the ‘enhancer competition’ 
model, which states that Igf2 and H19 are in competition for shared enhancers. On the
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maternal chromosome, the H19 ‘wins’, either due to its closer proximity to the enhancers, 
or due to superior promoter strength. On the paternal chromosome the H19 gene is 
methylated, which leads to its inactivation and allows Igf2 to be expressed. Support for this 
model came from the observation that the Igf2 gene is in an open chromatin conformation, 
and therefore competent for transcription on both alleles 8, whereas the inactive allele of
H19 is insensitive to nucleases from early in development 9,
A necessary consequence of the enhancer competition model is that Igf2 and H I9 
cannot be expressed from the same chromosome. Mounting evidence suggested that the 
two genes could in fact be active in cis. Firstly, ES cells and early embryos in some cases 
expressed both Igf2 and H I9 biallelically 1 *3, 86; and in the choroid plexus Igf2
expression is biallelic and H19 expression monoallelic 98. Secondly, when the H19 gene 
deleted and replaced by a luciferase reporter gene (with an intact H19 promoter), paternal 
transmission of the new allele resulted in some cases in a high level of expression of 
luciferase. In the same individuals Igf2 was expressed as normal, independent of the level
of gene expression from the reporter gene on the same chromosome 160 This and further
deletions of the H I9 coding region 84^  85 have demonstrated that neither the presence of 
the H19 gene product, nor transcription of a gene in cis to Igf2 affects its ability to utilise 
enhancer sequences.
The cases cited above do not directly disprove the existence of competition 
between H19 and Igf2 for shared enhancers, as biallelic expression of both genes in the 
same cell had not been demonstrated. This definitive refutation of the model came from an 
experiment in which allele specific transcription of the two genes was resolved at the
single cell level 111. Allele-specific in-situ hybridisation for Jgf2 and H19 mRNA was 
performed on cells derived from midgestation mouse liver. While monoallelic expression 
of both genes on different chromosomes was the most frequent observation, a significant 
proportion of cells (approximately 20%) expressed the two genes from the same 
chromosome. Loss of imprinting of one member of this gene pair, but not the other, 
provides additional evidence that the mechanisms by which these genes are imprinted must 
be separable.
The role of the H19 5 ' flanking region
As discussed previously, the 5’ flanking region of the H19 gene can confer 
monoallelic expression upon multicopy transgenes 3 7 38} 39 a  2kb fragment within this
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region is a site of developmentally stable differentially methylated DNA 38f 34^  130? ancj 
complex chromatin structure 163, 154? 155 Thorvaldsen et. al. 161 created a deletion of 
1.6kb of this region (the DMD) containing the majority of the methylated domain.. 
Transmission of the DMD deletion through the paternal germline led to the activation of 
H19 in cis, with a corresponding lack of H19 promoter methylation. There was little effect 
on Igf2 expression. Conversely, when the deletion was transmitted maternally, Igf2 
imprinting was lost. The DMD is therefore necessary for the correct regulation of both 
genes.
To examine the developmental specificity of the DMD region, an allele of HI 9 was 
created in which 7kb of the upstream region, including the DMD was flanked by loxP 
sitessuch that upon the induction of Cre recombinase, a conditional deletion could be
created 162. Deletions of the upstream region were created at three different time points: i) 
in the parental generation, to examine if the region was necessary for germline 
transmission of the imprint; ii) in early development, to examine if the region was required 
to maintain the imprint during cell division; and iii) in differentiated cells, to determine if 
the region is required constantly for correct gene regulation. It was found that, for the H19 
gene, deletion of the paternal 5’ flanking region at the first two stages resulted in a 
relaxation of imprinting, similar to the DMD deletion, but when this region was deleted in 
cis to H19 in differentiated cells, monoallelic expression was maintained. If the 7kb region 
was deleted on the maternal chromosome at any of the three developmental stages, Igf2 
imprinting was lost. The experimenters concluded that two activities were present in the 
region, one that is required to direct the silencing of the paternal H I9 allele, and one to 
silence Igf2 on the maternal allele. The H I9 silencer was suggested to act via DNA 
methylation of the paternal H19 promoter in early development, possibly to set up the 
‘closed’ chromatin conformation of the paternal allele, which is then stable through 
subsequent cell divisions. The second activity, which is required in cis at all time points to 
silence the Igf2 gene, has been proposed to constitute a methylation-dependent chromatin 
boundary element 27, 163.
An allele-specific silencer of H19
As discussed above, a 1.2kb fragment of the DMD containing DMDB and HS2 {Figure 
2b) has been shown to function as a silencer in Drosophila 168. Deletion of this 1.2kb 
fragment in the mouse by gene targeting 164 results in upregulation of the HI 9 gene from
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the paternal allele when the deletion is in-cis. The normally silent paternal allele is not 
activated in all of the tissues that express H19, and instead is limited to the subset of tissues 
where gene expression is known to be upregulated by the H19 enhancers. The authors 
suggest that this 1.2kb region harbours an allele-specific silencer, which interacts 
specifically with H19 enhancer elements. This element resides in a differentially 
methylated domain, and therefore this modification may play some role in the allele- 
specificity of the silencer. However, as the 1.2kb region can act as a silencer in Drosophila
where there is no genome methylation 158, other modifications may be responsible. In 
addition, deletion of this element does not alter the methylation of either the remainder of 
the DMD region (containing DMDA and HS1, see Figure 2b), or of the promoter- 
proximal or gene-specific H19 methylation. While under normal circumstances H19- 
proximal methylation on the paternal allele correlates very well with gene silencing (see 
above), in this case high levels of H19 expression can occur in the presence of promoter 
and gene methylation. Deletion of the 1.2kb region has no obvious effect either in-cis or 
in-trans on Igf2 expression or imprinting, strengthening the proposal by Srivastava et. al.
162 that the mechanisms by which the Igf2 and H I9 genes are imprinted are separable.
Boundary elements and Igf2 imprinting
Boundary elements have been described in many developmental systems (reviewed 
in 165)f including the gypsy transposon of D. melanogaster 166? at the silent mating-type 
loci in yeast 167, and at the chicken p-globin locus control region 168 These elements act 
by insulating genes from local chromatin, thus ensuring discrete transcriptional boundaries 
between neighbouring genes, and preventing inactivation of adjacent genes by the spread 
of heterochromatin. A consequence of this boundary activity is that, when placed between 
an enhancer element and the promoter of a gene, the boundary element will prevent the 
activation of transcription by the enhancer. Placing the boundary at a location adjacent to, 
but not between the two elements does not prevent transcription, demonstrating that the 
activity of these elements is position dependent.
Evidence that a similar activity may be present at the Igf2/H19 locus came from a 
study in which mutant mice were created in which the H I9 enhancers had been moved to a 
location in the intergenic region, downstream of Igf2 and upstream of the DMD 163. Mice 
in which the enhancers were placed in the intergenic region expressed Igf2 biallelically, 
and did not express the H I9 gene. The location of the enhancers is therefore critical in the
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imprinting mechanism of Igf2. It was proposed that the 5’ flanking region of H19 is critical 
for this position effect, i.e., that on the maternal chromosome, the upstream region provides 
a boundary between the enhancers and the Igf2 promoter. On the paternal allele an imprint, 
most probably CpG methylation, acts to prevent the enhancer blocking activity and hence 
allow access of the Igf2 promoter to downstream enhancers. The enhancer blocking
activity of the DMD region has been tested in a transgenic system 169. Reporter gene 
expression levels were compared between two transgene constructs, one which contained 
an intact DMD fragment interposed between a reporter gene and the H19 enhancers, and 
another construct identical except for a 670bp deletion that removed HS2 (see Figure 2b). 
Reporter gene expression in neonatal liver in those lines with the DMD deletion was on 
average 14-fold higher than expression from constructs containing the intact DMD. These 
transgenes were expressed biallelically however, and were largely unmethylated 
suggesting that the necessary sequences for imprinting were not present on the transgene.
In the light of recent work which shows the HS2 region of the DMD to be involved in H I9 
silencing, rather than formation of a boundary element 164} the differences in reporter gene 
expression between the two transgene constructs could equally be interpreted as due to the 
presence or absence of a silencer known to be active in endodermal tissues.
The boundary element properties of the DMD region have also been demonstrated 
in in vitro systems. Reporter constructs containing the DMD region between the promoter 
and enhancer elements have been tested in a variety of stable cell lines 170, 169} ancj
episomal vectors 165. jn these assays, the DMD is able to downregulate reporter gene 
expression in a position-dependent manner. The hypersensitive regions of the DMD, HS1 
and HS2 displayed partial blocking activity, and constructs containing multiple copies of 
each hypersensitive region increased blocking activity in a copy number dependent fashion
169. Regions from the human H19 upstream region were also tested for blocking activity. 
The human H19 5’ region contains several copies of two distinct repeat motifs (the A and B 
repeats), which are differentially methylated 166. a  fragment of this region containing
several copies of the B repeat was found to exhibit enhancer blocking activity 169. The 
mouse hypersensitive regions, and the human B repeat share a 21 bp conserved sequence 
element 166. This motif contains a 14bp consensus binding site for the protein CTCF 169?
170. CTCF has been previously shown to exhibit enhancer blocking activity at the chicken 
P-globin insulator 171. Sequences from within the human and mouse DMD were shown to
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bind CTCF in vitro, and mutation of the core 14bp binding site abolished this interaction. 
Furthermore, methylation of these regions prevents CTCF binding, both in fully 
methylated and in hemi-methylated DNA 1^9, 170
The DMD region clearly contains important regulatory elements for the imprinting 
of both Igf2 and H I9. Igf2 imprinted appears to be mediated, at least in some tissues, by 
the action of a methylation-sensitive boundary element at the DMD. This element, when 
unmethylated, prevents access of downstream enhancers to the Igf2 promoters, hence the 
maternal allele of Igf2 is silent. When methylated, this element cannot bind boundary 
specific proteins, and is therefore unable to prevent the access of the Igf2 promoters to 
enhancer elements and the gene is expressed. H19 silencing appears to be linked to the 
formation of heterochromatin at its promoter, thus leading to an epigenetically stable, silent 
state. The nucleation of this heterochromatin appears to be initiated at the DMD region on 
the maternal allele, and may arise by the recruitment of silencing complexes by methyl- 
binding proteins such as MeCP2, and/or by the action of a methylation-independent 
silencer element.
It is of interest to note that the HS2 region has been implicated in both position- 
independent gene silencing 164 and enhancer blocking 170s 155 at the Igf2/H19 locus.
A DNA element which under different circumstances can act as an insulator and a silencer 
has a precedent in the action of the gypsy insulator in Drosophila 172 The gypsy insulator 
is known to block access to distal enhancers by binding the proteins suppressor of Hairy 
wing [su(Hw)] and mod(mdg4). In wild-type flies, mod(mdg4) is essential for the enhancer 
blocking activity of the insulator DNA. However, reductions in mod(mdg4) activity cause 
the promoter to function as a position-independent silencer. Therefore the accessibility of 
trans- acting factors to boundary element sequences can lead (at least in this case) to a 
change of function from a boundary element to a silencer. A parallel could be drawn to the 
HS2 region at the Igf2/H19 locus, where modulations of trans- factor binding are achieved 
by DNA methylation. In circumstances where there is a high local concentration of bound 
factors such as CTCF (i.e., the unmethylated maternal allele), HS2 would act as a boundary 
element; whereas when these factors were at low concentrations, or absent (such as on the 
methylated paternal allele), HS2 may act as a silencer. Such speculation requires 
experimental verification, such as in an in-vitro system where the levels of HS2 
methylation, and CTCF concentration could be varied.
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Further imprinting control regions
The DMD may not be responsible for the full silencing of maternal Igf2 and paternal H I9, 
as the boundary element experiments utilising transgenics only test the interactions
between the DMD and the H19 enhancers 169? which do not drive gene expression in all
cell types 104. Furthermore, the deletion of the DMD region only resulted in a partial
derepression of the silent Igf2 and H19 alleles 161, 162
When the H19 coding region is replaced by a luciferase reporter gene, in both 
transgenes 39 and its endogenous location 160, full silencing of this locus on the paternal 
allele is rarely observed. Sequences within the H19 coding region may therefore be at least 
partially responsible for its imprinting status.
At the DMD, both mechanisms of allele-specific expression (the H19 silencer and 
the Igf2 boundary) rely on specific interactions with enhancer elements. These 
observations raise the question of whether a common feature of imprinting control 
elements is to limit the access of genes to positive-acting regulatory factors. The action of 
additional candidate imprinting control elements (such as the differentially methylated 
regions at Igf2 (DMRs 0, 1 and 2)) may therefore rely on interactions with undiscovered 
tissue-specific enhancer elements.
In the case of the 7g/2-proximal DMRs, several studies have demonstrated that 
these regions may modulate Igf2 imprinting in a subset of tissues where expression levels 
are not affected by the H19 enhancers. A 30kb transgene in which the Igf2 coding region 
had been replaced with a LacZ reporter construct, as well as ~15kb of upstream sequence 
(including DMR1 and DMRO), displayed imprinted expression in one instance (of eight). 
This effect was not thought to be due to integration of the transgene at an imprinted site
173. In this case, expression of the LacZ reporter was present in the dermomyotomes and 
their derivatives, following paternal transmission of the transgene. Deletion of the Igf2 
upstream region (including DMR1) in a mouse fibroblast cell line resulted in derepression
of the silent alleles of both Igf2 and H I9 174 The f j j g  enhancers have been demonstrated 
to be inactive in mouse fibroblasts 175. in addition, recent work 176 has demonstrated a 
direct role for Igf2 DMR1 in allele-specific silencing of Igf2. Deletion of this region in-cis 
results in tissue-specific activation of the maternal Igf2 allele in mesodermal tissues 
including heart, kidney and lung. In addition, this deletion results in loss of expression of 
the placenta-specific Igf2 transcript from P0. Perhaps as a consequence of this, embryos
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carrying the deletion are 29% smaller than their wild-type littermates at birth, but regain 
weight comparable to their wild-type littermates after birth. The deletion has no effect on 
H I9 expression or imprinting.
The upstream region of Igf2 has also been shown to contain an antisense transcript 
in both mouse 14j 6 ancj man 177> which is expressed from the paternal allele only, and 
shares some genomic regions with the Igf2 gene. While overlapping transcripts have been 
implicated in the regulation of many imprinted genes (see above), in all cases the antisense 
transcript is imprinted in the opposite direction to the sense transcript, and therefore not 
expressed on the same chromosome. The role, if any, of the antisense transcript at the Igf2 
locus in the imprinting mechanism of this gene remains unresolved.
Summary and questions.
The closely linked Igf2 and H I9 genes are expressed in a wide range of embryonic and 
extraembryonic tissues. Expression of these genes is downregulated shortly after birth in 
the majority of tissues, with expression of Igf2 persisting in the exchange tissues of the 
brain and human liver, and H19 expression persisting in skeletal muscle. The expression of 
these genes in the embryonic endoderm and some mesodermal tissues is controlled from a 
shared pair of enhancer elements, which lie approximately 7kb downstream of the H19 
gene. Enhancer elements responsible for gene expression in the remaining tissues have yet 
to be fully characterised.
Igf2 and H I9 are oppositely imprinted, the majority of expression of Igf2 in all 
tissues but the choroid plexus and leptomeninges of the brain arises from the allele 
inherited paternally, and the majority of H19 gene expression arises from the maternal 
allele. Both genes are associated with areas of allele-specific methylation. The active, 
paternal copy of Igf2 is marked by three regions of methylation, two upstream of the 
coding region, and one within the body of the gene. The function of this methylation is 
unclear, but thought not to constitute an epigenetic modification that serves to differentiate 
the two parental alleles, as these regions are not differentially modified throughout all 
stages of development. Instead these regions may contain tissue-specific silencer elements, 
to which the binding of effector proteins is determined by their methylation status. The 
silent allele of H19 is methylated at its promoter, and within the coding region of the gene, 
and the packaging of H19 into a heterochromatic state correlates well with gene silencing 
in most circumstances. A region approximately 2kb upstream of the H19 gene (the DMD) 
has been shown to be responsible for the silencing of both the maternal allele of Igf2, and
52
the paternal allele of H I9. This region is methylated on the paternal allele during the 
majority of development, and also in sperm. This methylation may therefore constitute a 
primary epigenetic mark, which distinguishes the parental alleles and directs subsequent 
events that lead to the activation/silencing of the two genes on the appropriate alleles. The 
continuous presence of the DMD region is required to maintain the imprinting status of 
Igf2. The DMD is also required in early development for the correct methylation of the 
paternal H I9 promoter, and the silencing of the gene. The two activities within the DMD 
region can be separated into (at least) two domains. Firstly, the DMD contains an element 
that can form a boundary between the Igf2 gene and the HI 9 enhancers (and possibly 
additional enhancers which lie beyond the boundary) to block the interaction of Igf2 with 
downstream enhancers, thus leading to its silenced state. When methylated, the DMD loses 
this activity, allowing expression of Igf2 on the paternal allele. Secondly, the H19- 
proximal half of the DMD contains an element that can silence the paternal H19 allele, 
again by preventing the activity of the H I9 enhancers, though not by a boundary activity, 
and possibly by a methylation-independent mechanism.
Many questions remain concerning elucidation of the mechanisms of correct 
expression and imprinting of these genes. The elements demonstrated to play a role in the 
imprinting of Igf2 and H I9 to date have a common feature. All elements (the boundary, the 
H19 silencer, and the Igf2 mesodermal silencer) act in a tissue-specific manner due to their 
interactions with enhancer elements. While the nature of these interactions are not 
understood at present, it is clear that to understand the imprinting mechanisms at this locus, 
the elements which drive tissue-specific expression of lgf2 and H19 must be characterised 
and mapped. Therefore, what is the nature and location of additional elements that drive 
the expression of Igf2 and H I9 in the extraembryonic and mesodermal tissues, as well as in 
the exchange tissues of the brain? In tissues with imprinted expression of Igf2, such 
enhancers may lie either beyond the proposed boundary, or further boundaries may exist. 
How does Igf2 (and not HI9) escape imprinting in the choroid plexus and leptomeninges? 
Again, the location of enhancer elements may be critical if the boundary element model of 
Igf2 imprinting is correct. Thirdly, why is genome context so critical for the correct 
imprinting of these genes, i.e., what additional factors are required to stabilise the 
epigenetic environment that is proposed to be initiated from the DMD region?
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Aims of the project
The CCD
The CCD (for centrally conserved domain, see Figure 1) was initially identified in a study 
that scanned approximately 130kb of the genomic region containing the HI 9 and Igf2 
genes for regions that were sensitive to the nuclease DNasel. A region 32kb upstream of 
the H19 gene was found to display a high level of nuclease sensitivity on both parental 
alleles. This region was also found to be hypomethylated in comparison to surrounding
DNA, and to be conserved in a number of mammalian species 1^1.
The presence of nuclease sensitive sites (indicative of functional chromatin, see 
above), as well as its evolutionary conservation, suggests the CCD as a good candidate for 
an additional regulatory element at this locus. This region could function as a tissue 
specific enhancer or silencer, or a further imprinting element at this locus. The purpose of 
this work is to investigate the role of the CCD in the tissue-specific expression and 
imprinting of the H19 and Igf2 genes.
Experimental set-up
Is the CCD able to direct reporter gene expression in the developing embryo?
This study will utilise luciferase reporter transgenes created by Ward et. al. 108 jn order to 
examine the expression profile conferred on Igf2 as a result of cis regulatory elements (see 
Figure 3). In these experiments 96 transgenic lines were created containing a luciferase 
reporter gene driven from the Igf2 P3 promoter, in combination with additional elements 
from the Igf2/H19 locus. The elements used are depicted in relation to their endogenous 
location in Figure 1 and the reporter constructs derived from these regions are shown in 
Figure 3. Of particular interest is the role of the CCD in the tissue specific-expression of 
these genes. The following questions will be addressed:
i) Does the CCD region harbour mesoderm-specific enhancer activity?
ii) Can the CCD reproducibly drive reporter gene expression from P3 in the brain, 
specifically in the exchange tissues?
iii) Does the CCD interact with the H I9 enhancers, to broaden or limit their range of 
expression, or modulate quantitative levels of expression?
iv) Is the CCD involved in the imprinting mechanism of Igf2/H19, acting either alone 
or in combination with the H19 enhancers?
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These questions will be answered by extending the analysis of Ward et. al. 10^ into a 
broader range of tissues, to assay for luciferase activity in transgenic neonates in a) skeletal 
muscle and tongue (mesodermally-derived tissues); b) brain (specifically the meninges and 
choroid plexus); and c) liver and kidney (predominantly endodermally-derived tissues), 
driven by the A, H  and Q transgenes (see Figure 3). The expression profile of reporter 
genes in additional transgenic lines created during the course of this study are also 
reported.
Use of transgenic mouse models
There are many advantages of using a transgenic system in which to investigate the 
function of elements thought to be required for correct gene expression. Firstly, transgenic 
systems provide an in vivo system, in which the action of elements in a full nuclear context 
can be investigated. The expression and imprinting of Igf2 and H I9 has been primarily 
carried out using mice as a model system, so experiments in transgenic mice are operating 
in a well understood genetic system.
Some of the disadvantages of using a transgenic system to study complex 
regulatory interactions have been highlighted above. The limitations of a transgenic system 
mainly rest upon the danger of such a system being too reductionistic, i.e. that single 
regulatory elements alone may act in a different manner than when in combination with 
their usual neighbours. Additionally, but related is the problem of position effects, i.e. that 
the behaviour of a transgene may not be due to the cis elements present on the 
experimental construct, but due to elements present at the transgene integration site. This 
problem can be overcome by comparison of several transgenic lines, that share the same 
experimental construct, but differ in their sites of integration. However, it should be noted 
that transgene copy number is potentially an additional confounding variable. All 
experiments in this study will rely on the use of at least three transgenic lines bearing the 
same construct in order to control for position effects.
Is the CCD able to direct reporter gene expression in an in vitro system?
Transient transfection experiments can be a useful tool in the determination of activity and 
tissue specificity of putative regulatory elements. The H19 enhancers were initially 
characterised by transient transfections of constructs containing the gene region where 
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Fig.3 Summary o f Igf2/luciferase reporter constructs used in this study. All constructs are 
derived from M , which contains P3 fused to the luciferase reporter gene. Further 
elements (described in Figure 1) are added to M.
In order these elements are: DMR (.Igf2 DMR1, approximately 2.8kb EcoRI- 
BamHI fragment); P3 {Igf2 promoter 3, nucleotides -162 to +74 with respect to 
the
transcription start, which includes part of exon 4); CCD (a nuclease 
hypersensitive region lying midway between Igf2 and H I 9, 2kb EcoRI-EcoRl 
fragment); the H19 promoter, (a 2kb BamHI-Nhel fragment which includes 
part of H19 exon 1); the H19 enhancers (2.7kb Spel-Bglll fragment). The C is 
identical to H  except it contains a LacZ reporter gene (a 3kb Notl fragment) in 
the place of the luciferase reporter gene.
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A number of cell lines are used in this study to investigate whether: i) the CCD can drive 
reporter gene expression in a cell-type specific manner, and ii) the CCD can interact with 
the H19 enhancers, to enhance or suppress gene expression.
Can sequence comparisons between the CCD region in a number of mammalian species 
tell us anything of CCD function?
Evolutionary conservation of the CCD region has been demonstrated by cross 
hybridisation of genomic DNA from a range of species to a mouse CCD probe 151. while 
this study has demonstrated that similar sequences exist in other species, it does not 
identify what these sequences are. By comparing the CCD sequence from several species, 
conserved regions within the region can be identified at the nucleotide level, and this 
information may illustrate the minimal regions required for the function of the CCD.
In summary, the aims of this work are to investigate the function of a conserved, DNasel 
hypersensitive region that lies in the intergenic region between the imprinted Igf2 and HI 9 
genes. A role for directing both tissue-specific, and allele specific expression will be tested, 
utilising both in vivo and in vitro techniques, as well as comparisons of the nucleotide 
sequence between species.
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C hapter 2: Materials and Methods.
P la sm id s
Igf2~luciferase reporter constructs containing candidate regulatory elements from the 
Igf2/H19 region (illustrated in Figure 1) were constructed by Dr A. Ward (as described in,
178108) xhe M  construct contains lgf2 promoter 3 fused to the luciferase reporter gene, 
inserted into the BluescriptSK+ vector. All other constructs were generated by insertion of 
candidate elements (CCD, DMR1, H I9 enhancers, H I9 promoter) into M. A summary of 
these constructs is illustrated in Figure 3, The Igfi-LacZ reporter construct containing the 
CCD region (C lines, Figure 3 , Chapter 1) was constructed by Dr G. Dell, and is identical 
to the H  construct except the LacZ gene replaces the luciferase coding region, 
pi 75a:4, the source of the CCD deletion constructs, is composed of the 2kb EcoRI CCD 
fragment {Figure 1) cloned into BluescriptSK+, and was obtained from Dr A. Ward. This 
plasmid is illustrated in Figure 32, Chapter 8. To create the CCD deletion constructs 
described in Chapter l,p l75a:4  was digested with PstI to produce fragment sizes of 
approximately l.lkb, 0.8kb and 3.0kb. The l.lkb and 0.8kb fragments were then reinserted 
into the PstI cut vector sequence (which contained a residual ~100bp of CCD sequence). 
This created the truncated and deleted versions of the CCD. The deleted and truncated 
CCD fragments were then excised from the vector with Spel and Nhel and these fragments 
inserted into an Nhel site immediately downstream of the luciferase coding region in the 
reporter plasmid P3MM. The deleted (pCCD4a) and truncated (pCCDlla) CCD reporter 
constructs are illustrated in Figure 26, Chapter 7.
T ran sgen ic  m ice
The majority of transgenic mice used in this study are detailed in Ward et. al. 108.
The transgenic mouse lines Quiche, Connie, and Columbo were constructed as 
follows: Linear construct DNA (lpg/ml) was microinjected into one pronucleus of an FI 
zygote that was the product of a cross between a C57BL/6J& and a CBACa 9, using 
standard techniques 179. Injected embryos were transferred into the oviduct of a 
pseudopregnant MF1 foster mother by Dr A. Ward or Dr W. R. Bennett.
Lines were established and maintained by breeding the transgenics with FI 
(C57BL/6J x CBACa) partners. This combination has the advantage of hybrid vigour, as
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well as responding well to superovulation, and has been widely used in the production of
transgenic mice 179; but as a consequence the transgene was transmitted through various 
combinations of the C57BL/6J and CBACa genomes. The first letter of the name of the 
transgenic line corresponds to the transgene construct inserted.
Mice with a targeted insertion of a neomycin resistance cassette at the p53 gene
(creating a functional null allele, as described by Clarke et. al.180) were obtained from Dr 
A. R. Clarke, and maintained on an FI background as described above.
A n tib o d y  s ta in in g  p ro to c o ls
(Adapted from Harlow and Lane, 1988 1&1)
Embryos
Embryos were obtained from crosses of males hemizygous for the transgene against FI 
(C57BL/6Jx CBACa) non-transgenic females. The gestational age was calculated from the 
middle of the dark cycle preceding the observation of a vaginal plug. Embryos were 
dissected from pregnant females on embryonic day 12.5 (el2.5), or day 14.5 (el4.5) of 
gestation. Luciferase assays were performed on the yolk sac of each embryo to determine 
whether the embryo carried the transgene (see the isolation and identification of samples 
section, below).
Paraffin embedding
Transgenic embryos and their wild-type littermates were fixed according to four different 
methods: i) over-night in 4% paraformaldehyde/phosphate buffered saline (PBS); ii) over­
night in MEMFA [0.1M MOPS buffer pH 7.4, 2mM EGTA, 2mM MgCL, 4% 
formaldehyde]; iii) 5 hr in Zambonis’ phosphate buffer [20mM Na2HP0 4 , 70mM 
NaH2P0 4 , 0.85% paraformaldehyde, 0.15% saturated picric acid]; or iv) 5 hr in 20% 
ethanol. Samples were dehydrated in an ethanol series (at least 4hr each in 2 x 70%, 80%, 
90%, 95% and 2x absolute ethanol) and cleared in Histoclear (National Diagnostics). The 
samples were then embedded in paraffin wax (Lamb). Saggital sections were cut at 7pm, 
dewaxed in Histoclear and rehydrated in an ascending ethanol series.
Cryostat embedding
Transgenic embryos and wild-type littermates were rinsed in cold PBS, then embedded in a 
block of O.C.T. compound (BDH Laboratory Supplies) by immersion in a liquid nitrogen/
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isopropanol slurry. Saggital cryosections were cut at 15pm, dried over-night at room 
temperature, then stored at -20°C.
Antibody staining on paraffin sections
Sections were washed twice in PBS. At this stage, in some experiments samples were 
permeablised for 30 min in 0.2% Triton X-100. In all treatments the samples were blocked 
for lhr in one of a number of blocking agents: i) BLOTTO [5% skimmed dried milk in 
PBS]; ii) Bovine Serum Albumin (BSA) + Tween [5% BSA (Sigma), 0.02% Tween 20 
(Sigma) in PBS]; iii) FCS [5% Fetal Calf Serum (Gibco-BRL) in PBS]; iv) Horse Serum + 
BSA [10% heat-inactivated Horse Serum (Gibco-BRL), 5% BSA in PBS].
Primary antibody [rabbit polyclonal anti-luciferase (Promega, Cortex or Sigma) or 
rabbit polyclonal anti-neurofilament 200 (Sigma)], in the same blocking agent used in the 
blocking step, was added for variable amounts of time (usually 1 hr, 2 hr at room 
temperature or over-night at 4°C). After two 10 min washes in PBST (PBS + 0.1% Tween- 
20), sections were incubated with the alkaline phosphatase conjugated secondary antibody, 
anti-rabbit alkaline phosphatase (Vector) for 1 hr or 2 hr. Slides were washed twice for 10 
min in PBST. The substrate for alkaline phosphatase was added [Napthol-AS-MX/ Fast 
Red TR (Sigma)] with lOOmM levamisole to block endogenous alkaline phosphatase 
activity, and allowed to develop for 5 min. In some experiments a peroxidase secondary 
detection system was used. In these cases, prior to the addition of primary antibody, the 
slides were incubated for 5min in 3% hydrogen peroxide (Sigma) in tap water, followed by 
30min in 0.5% hydrogen peroxide in methanol, then washed 3 x lOmin in PBST, in order 
to quench endogenous peroxidase activity. Following incubation with the primary antibody 
(as above), the sections were washed for 3 x lOmin in PBST. A biotinylated anti-rabbit 
IgG (Vector) was applied for lhr, then washed 3 x lOmin in PBST. Slides were incubated 
for 5min at room temperature in ABC kit streptavidin-horseradish peroxidase complex 
(Vector), prepared according to the manufacturer’s instructions. All further steps were 
carried out according to the manufacturer’s instructions for the ABC kit (Vector). In all 
cases, nuclei were counter-stained with Mayer’s haemotoxylin for 5 min. Slides were 
mounted in Mowiol (Calbiochem) and examined using a Leica DMR microscope.
Negative controls were carried out with the addition of blocker instead of primary 
antibody in order to discern any non-specific binding by the secondary antibody, and with 
the addition of blocker in place of the secondary antibody to control for endogenous 
peroxidase or alkaline phosphatase activity.
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Preparation of acetone powder
Mouse acetone powder was prepared by dissection of el2.5 embryos from an FI x FI 
cross. Embryos were homogenised in 0.9% NaCl at 4°C, at ~lg/ml. 8 ml acetone at -20°C 
was added and the mixture incubated on ice for 30 min with occasional vigorous mixing. A 
precipitate was collected by centrifugation at 10,000g for 10 min using a Sorvall RC5B 
centrifuge with SS34 rotor. Supernatant was discarded and the pellet resuspended in fresh 
acetone, spun down and air-dried at room temperature on clean filter paper. Dried powder 
was used at a final concentration of 1%, incubated for lhr with antibody in blocking agent 
at 4°C
Antigen retrieval
In some experiments an antigen retrieval protocol was used prior to the blocking step in 
antibody reactions. Two methods were employed, a high temperature antigen unmasking 
method (obtained from Dr J. Smith, University of Birmingham), and a microwave antigen 
unmasking method as described by Cuevas et. al.1^2
The high temperature unmasking method was performed as follows: Following dewaxing 
and rehydration, slides were pressure cooked for lmin in lOmM citrate buffer pH 6.0 (the 
pressure cooker was filled with sufficient buffer to cover the slides, brought to the boil, 
then the slides were placed within and the lid sealed, timing began once the pressure 
indicator rose to visibility). The slides were then allowed to cool while still immersed in 
buffer, then washed for 3 x lOmin in PBST at room temperature.
Antibody staining of cell culture sam ples
Cells were grown to a confluent monolayer on sterilised coverslips, then washed in PBS 
several times. The cells were then fixed for 30min in 4% paraformaldehyde/PBS at room 
temperature, washed in PBS several times, and permeablised by incubation for 30min in 
0.1% TritonX-100 (Sigma)/PBS. Blocking was carried out by incubation of the coverslips 
in blocking buffer [20% Blocking Reagent (Boehringer Mannheim)/0.1 % Triton X- 
100/PBS] for 3hr at room temperature. Primary antibody (rabbit a-prealbumin 
(transthyretin), DAKO) was added at Vioo in blocking buffer, and the cells incubated 
overnight at 4°C. The coverslips were washed 3x lOmin in PBS in a large volume, then the 
secondary antibody (fluorescein labelled a-rabbit (goat), Vector) was added at V io o o  in 
blocking buffer, and the coverslips incubated at room temperature for 3 hr. The secondary
61
antibody was removed by 3 x lOmin washes in PBS. FITC and bright field images were 
obtained by Dr D. Tosh and X. Shen using a Zeiss 510 Laser Scanning Microscope.
A s s a y  for lu c ifera se  sp e c if ic  a c tiv ity  
Isolation and identification of sam ples
Preliminary experiments
Prior to the antibody staining experiments detailed in Chapter 3, luciferase specific 
activities were determined for the offspring of crosses of transgenic fathers (Alicia, Ost and 
Helga lines) vs. non-transgenic (FI) mothers. Embryos were dissected from the uterus at 
12 days following the appearance of a vaginal plug, crudely dissected, and assayed for 
luciferase activity. Samples collected were; liver, brain, tail, tongue and placenta/yolk sac. 
For identifying transgenic offspring the extraembryonic tissue samples were placed in 100 
pi cell lysis buffer [25mM Tris-phosphate pH7.8, 2mM DTT, 2mM 1,2- 
diaminocyclohexane-N, N, N’, N’ tetracetic acid, 10% glycerol, 1% TritonX-100]. 5pl was 
assayed for luciferase specific activity as described below.
Tissue-specific and parent of origin-specific expression of transgenes a te  14.5 and 
D1
Samples of whole brain, tongue, muscle (upper hind limb), liver bulk and kidneys, at lday 
post-partum (Dl), and head, body, yolk-sac and placenta at e l4.5 were collected on ice and 
stored at -20°C in 1.5ml eppendorf tubes. For specific activity assays of each transgenic 
line, at least 40 samples of each tissue were taken on the day of birth, or at e l4.5. Half of 
these followed paternal transmission of the transgene, the other half from maternal 
transgene transmission. Both sets were handled simultaneously on ice.
For identifying transgenic offspring, tail tips ~0.5cm long were placed in 100pi cell 
lysis buffer and 5pi was assayed for luciferase specific activity as described in in the 
following section.
Specific activity assays
Cell lysis buffer (1ml for brain, liver, head and body samples, 0.5ml for tongue, muscle, 
kidney, placenta and yolk-sac samples) was added to each sample and the tissue 
disaggregated with the 0.1 -5ml dispersing tool of an IKA-Labortechnik Ultra-Turrax T8 
homogeniser (about 10s, medium setting). To prevent cross-contamination, the dispersing
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tool was rinsed several times in water and wiped dry between each sample. The samples 
were spun at 13000rpm for 3min and duplicate 5pi amounts were taken from the clear 
supernatant. These samples were placed in microtitre plates and the enzyme activity 
measured using 100pi Luciferase Assay Reagent (Labtech International) in an Anthos 
Lucy 1 luminometer (in the case of D1 samples), or a E. G. & G. Berthold Microplate 
Luminometer LB96V. Light emission was counted for 10s. For each assay, a standard 
curve was constructed using serial dilutions of purified luciferase (Sigma). The 
relationship of relative light units to amount of luciferase was linear in the lOOng to lxlO"5 
ng range, and all samples assayed fell within this range.
Protein assays
Luciferase activity measurements were normalised for soluble protein concentration. lOpl 
amounts of the homogenised tissue supernatant were diluted 100-fold (tongue, muscle, 
kidney, head and yolk sac) or 200-fold (brain, liver, body and placenta) with water. From 
each of these dilutions a lOpl aliquot was mixed with 200pl BioRad dye reagent, and the 
absorbancy at 590nm measured against dilutions of a BSA standard, as described by
Bradford 183. The specific activity was always expressed as the ng equivalent of the 
luciferase standard per mg soluble protein.
Statistical analysis
For each tissue in each line, the specific activity of the reporter was measured 
independently for paternal and maternal transmission of the transgene, and then the 
differences in the means were compared by using a Student’s r-test 184.
S o u th ern  b lo ttin g  a n d  h yb rid isa tio n  
Genomic DNA preparation
For DNA methylation analyses, genomic DNA was prepared from samples derived from 
the luciferase standard activity experiments (see above). In all other cases, approximately 
500mg tissue sample was placed in 560pl tail buffer (50mM Tris.HCl pH 8.0, lOOmM 
EDTA, lOOmM NaCl, 1% SDS) containing 285pg/ml Protinase K (Boehringer 
Mannheim). This was incubated overnight at 55°C.
For all samples, 500pl homogenised or digested tissue (in lysis or tail buffer, 
respectively) was treated with 0.7pg/ml RNaseA (Sigma) for lhr at 37°C. NaCl was added
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to 1.25M, followed by an equal volume of chloroform/isoamylalcohol 24:1 (vol/vol), and 
this was gently mixed on an orbital shaking platform for 2hr at room temperature. The 
solution was spun in a microcentrifuge at 13000rpm for lOmin, and the upper, aqueous 
layer transferred to a fresh tube. An equal volume of propan-2-ol was added to this 
fraction, and mixed gently to precipitate the DNA. This was spun at 13000rpm for 15min, 
and the supernatant removed. The pellet was washed for lhr in 70% ethanol, then the pellet 
was allowed to dissolve overnight at 4°C in lOOpl TE (lOmM Tris.HCl pH 8.0, ImM 
EDTA).
Southern blotting
~20pg genomic DNA samples were digested overnight with restriction enzymes, run on a 
1 % agarose gel and transferred onto Hybond-N (Amersham) membranes according to 
standard procedures 185.
Probe fragments used in these analyses are detailed in the following section. Fragments 
were gel purified using the Promega gel extraction kit and ~20ng labelled to high specific 
activity with 32P dCTP (Amersham) with the High Prime labelling kit (Boehringer 
Mannheim), according to the manufacturer’s instructions. The blot was prehybridised for 2 
hr in Church’s buffer 186 and approximately 1 Ox 106 c.p.m. of denatured probe added. 
The filters were hybridised for at least 12 hr at 65°C, then washed twice for 15 min and 
once for 1 hr in wash solution containing 1%SDS, 40mM Na2HPC>4, ImM EDTA. All 
washes were done at 65 °C.
For hybridisation to non-identical sequences (as for rat DNA described in Chapter 
8), hybridisation was carried out at 55°C, and washes were identical to those described 
above, except they were performed at 55°C.
The filters were then rinsed in 40mM Na2HPC>4, wrapped in SaranWrap and put 
down for autoradiography with X-ray film (X-OMAT AR, Kodak) at -80°C with 
intensifying screens.
Probes used in Southern blots
Probes used in methylation analysis described in Chapter 5 are illustrated 
diagrammatically in Figure 13 and Figure 14y Chapter 5. The P3-luciferase probe 
specific to the Igf2 P3 promoter, and the 5’ region of the luciferase gene was prepared by 
digestion of the Af-construct containing plasmid (p3MM, see plasmids) with EcoRl. The
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appropriate 984bp band was purified from a 1% agarose gel using the Qiagen gel 
extraction kit (Qiagen), according to the manufacturers instructions. An H19 enhancer 
probe, spanning the mid- to 3’ region of the H I9 enhancer region was cut from an A- 
construct containing plasmid (pl66a:2, obtained from Dr A. Ward) with PstI, and the 
appropriate 949bp band was gel purified as described above. A CCD probe corresponding 
to the entirety of the CCD sequence used in the H  construct was excised from p!75a:4 by 
digestion with EcoRI. The appropriate 1910bp fragment was gel purified as above.
T ransien t e x p re s s io n  a s s a y s  
Cells
The human hepatocarcinoma-derived cell line Hep3B,the monkey kidney cell line Cos7, 
and the mouse fibroblast cell line NIH3T3 were all obtained from Dr. A Ward and cultured 
at 37°C, 5% CO2 in Dulbeco’s Modified Eagles Medium (DMEM, Gibco-BRL) 
supplemented with 5% Fetal Calf Serum, 25pg/ml amphotericin, lOOIU/ml penicillin, 100 
pg/ml streptomycin and 2mM glutamine (all Gibco-BRL).
The murine myoblast cell line C2 were obtained from Dr J. Smith, and cultured as 
above, except Fetal Calf Serum concentration was 10%. C2 cells were induced to 
differentiate into myotubules as described previously 187, 188 Briefly, cells were washed 
three times in sterile PBS, then culture medium (DMEM with antibiotics as above) was 
added, supplemented with 10% Horse Serum (Gibco-BRL). Myotubules were first visible 
at approximately 48hrs following the addition of Horse Serum.
The origin of choroid plexus cells is detailed below.
Transient transfections
Transfections of Hep3B, Cos7, 3T3 and C2 cells were performed using FuGene reagent 
(Boehringer-Mannheim) according to the manufacturer’s instructions for transient 
transfections of adherent cells. These cells were plated in 6-well dishes at least 24hr before 
transfection. In the case of choroid plexus cells, the tissue was prepared as described in 
Section 7.2, and the cells plated into 6-well dishes at a density of ~5xl05 cells/well, and 
cultured as described in that section. 24hr prior to the transfection, the medium was 
replaced with choroid plexus culture medium lacking cytosine arabinoside. All cells (-70% 
confluent) were transfected with 1 fig luciferase reporter plasmids M, H, A and Q, and in 
some cases the CCD deletion constructs pCCD4a andpCCDlla  (see plasmids, and
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Figure 3, Chapter 1 and Figure 27, Chapter 7). The vector pSVj3-galactosidase (1 fag, 
Promega) was co-transfected as an internal standard for transfection efficiency. 
pBluescriptSK+{S\xdXdigtnQ) was used as a negative control. The cells were harvested 48hr 
after transfection and were assayed for luciferase and fi-galactosidase activity (as in 189). 
Protein was measured using the Bradford assay with known quantities of bovine serum 
albumin (BSA) used as a standard 183
L u cifera se  activity a ssays of transfected cells
Cells were rinsed once with PBS then lysed by addition of lOOpl Cell Lysis Reagent 
(Labtech International) for lOmin. Cell lysates were then microcentrifuged (13,000rpm, 1 
min), and lOjul added in duplicate to microtitre plates. The enzyme activity was measured 
as described for tissue samples above.
P repara tion  o f  p r im a ry  cu ltu res  o f  m o u se  c h o ro id  p le x u s
(A modification of Hoffmann et. al. 190)
Preparation of tissue culture v esse ls .
Prior to plating choroid plexus cells, culture vessels were seeded with NIH3T3 cells, and 
the cells allowed to grow to a confluent monolayer (for culture conditions see Section 6.1). 
The cells were then lysed by the addition of 1% TritonX-100 (in large enough quantity to 
cover the cells) for 30min at room temperature. The culture dishes were then washed 3 
times in MilliQ water, and stored at 4°C for up to one month 191
Choroid plexus primary culture
Approximately 10 choroid plexi were removed from the fourth ventricle of FI mice, 7-10 
days post-partum. The tissue was washed in Mg2+- Ca2+-free PBS, then transferred into
5ml Pronase (4mg/ml in PBS, Calbiochem, as described by 192) ancj incubated at room 
temperature for 5 min. Pronase digestion was stopped by addition of serum-containing 
culture medium. After centrifugation of the cell suspension at lOOOrpm the sedimented 
cells were resuspended in minimum essential medium (MEM)-Earle’s medium with non- 
essential amino-acids, 10% fetal calf serum, 25pg/ml amphotericin, lOOIU/ml penicillin, 
100pg/ml streptomycin and 2mM glutamine (all Gibco-BRL). The cells were seeded onto 
35mm tissue culture dishes, which had been prepared as described in the previous section. 
Cells were counted using a haemocytometer, and viability was estimated using exclusion
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of 0.01% trypan blue (Sigma). Approximately l-2xl06 viable cells were seeded per 35mm 
culture dish. 48hrs after seeding the culture was washed with PBS to remove erythrocytes 
and, in order to prevent the growth of cell types other than choroid plexus epithelial cells, 
the medium was supplemented with 2xlO-5M cytosinearabinoside (Sigma, as described by
Hoffmann et. al.190). Epithelial cells reached confluency after 7-10 days in vitro at 37°C 
with 5% CO2.
M olecular c lon in g  te ch n iq u es  
Digests
5pg plasmid DNA was digested in a reaction volume of 10-20pl with 10 units restriction 
enzyme (Promega) over-night, according to the manufacturer’s instructions.
Ligations
Ligations were carried out in a volume of lOpl containing lpg digested plasmid DNA, 10 
units T7 DNA ligase (Promega) and ligation buffer. The reaction was carried out at 13°C 
for 4hr, or over-night. Following incubation, DNA ligase was heat deactivated at 75°C for 
10 min. Reactions were stored at -20°C, or used immediately in a transformation reaction.
Transformation of DH5a cells
lOOpl competent DH5a cells (provided by J. Dutton) were mixed with 2pi ligation 
reaction. The cells were incubated on ice for 10 min, heat-shocked at 42°C for 90 s, then 1 
ml SOC was added, and the mixture incubated at 37°C for 15 min. lOOpl of the 
transformation mix was plated onto LB agar 185 with 50mg/ml ampicillin (Sigma).
Plasmid minipreps
(after Miller and Miller, University o f Oregon)
Single colonies were picked from transformation plates and grown overnight in 3ml LB + 
50mg/ml ampicillin in a shaking incubator at 37°C. 1.5ml culture was transferred to an 
eppendorf tube and centrifuged at 13,000rpm for 3 min. The pellet was resuspended in 400 
pi resuspension buffer [15% Sucrose, 50mM Tris HC1, 50mM EDTA, pH8.5] and 
vortexed. 50pl lysozyme (12mg/ml) was added and incubated at room temperature for 5 
min. 300pl Lysis buffer [70mM Tris HC1, pH8.0, 70mM EDTA, 50mM EGTA, 0.2% 
TritonX-100] was added. Tubes were inverted to mix and placed at 70°C for lOmin. The
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mixture was centrifuged at full speed for 10 min and the lysed cells pelleted were removed, 
lpl DEPC (Diethyl Pyrocarbonate, Sigma) was added, and the mixture was placed at 70°C 
for a further lOmin. Tubes were spun for 2min, the supernatant added to a fresh tube and
DNA precipitated by tha addition of absolute ethanol 1^5 Pellet was resuspended in 55 pi 
TE [lOmM Tris HC1 pH8.0, ImM EDTA] + lOpg/ml RNaseA. 5pl was digested with 
restriction enzymes to confirm plasmid identity.
DNA sequencing
DNA sequencing of plasmids was carried out with, and according to the instructions of the 
T7 Sequenase Kit (Amersham Life Science) using T7 Sequenase version 2.0 DNA 
polymerase. 50pl plasmid DNA derived from minipreps was denatured by addition of 5 pi 
2M NaOH/2mM EDTA, incubation at room temperature for 5 min, then addition of 5pl 
2.5M Ammonium acetate + 150pl 100% ethanol, and stored over-night at -20°C. The 
following day the DNA was precipitated, washed once with 100% ethanol, and allowed to 
air dry.
The template was labelled with 5pCi 35S and annealed to lpM of one of the 
following primers:
-40 M 13 (Amersham): 5 ’ GTTTTCCCAGTCACGAC 3 ’
KS (Perkin Elmer): 5’ TCGAGGTCGACGGTATC 3’
T7 (Gibco-BRL): 3’ CGGGATATCACTCAGCATAATG 5’
SP6 (Gibco-BRL): 5 ’ ATTTAGGTGACACTATAGAATAC 3 ’
Primers used for sequencing of the rat CCD were:
CCDP1: 5 ’ CAGRGCYRGGRCAGAGGAAGA 3 ’ (where R is A/G, Y is C /T )
CCDP4: 5’ CCAACCTTCCTAACAACCTGC 3’ (both Gibco-BRL), 
as well as T7 and SP6
The sequencing gel was created with the use of the Sequagel ‘Ultra Pure’ 
Sequencing system (National Diagnostics) and run on an IBI ‘Baserunner’ sequencing rig 
at 30W for at least 4 hr. The gel was dried and autoradiography performed at room 
temperature with the X-ray film described in Section 5.2.
In some cases sequencing reactions were carried out by Dr P. Jones (Sequencing 
Core Facility, University of Bath).
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R ib o n u c le a se  p ro te c tio n  a n d  N orthern h yb rid isa tio n  a n a ly s is
Isolation of total RNA
Total RNA was isolated according to the manufacturer’s instructions using TRI Reagent 
(acid guanidinium thiocyanate phenol chloroform extraction, Sigma).
50-100mg of tissue (Dl: liver, fourth ventricle choroid plexus, brain depleted for choroid 
plexus, and various embryonic and extra-embryonic tissues as specified in Chapter 8) was 
removed from the animals immediately after sacrifice, placed in 0.5ml TRI Reagent on ice, 
and homogenised immediately with the 0.1-5ml dispersing tool of an Ultra-Turrax T8 
homogeniser (IKA-Labortechnik). Subsequent isolation of RNA from the homogenate was 
carried out according to the manufacturer’s instructions for TRI Reagent. Purified RNA 
was stored at -80°C in DEPC (diethylpyrocarbonate)-treated H2O.
Ribonuclease protection assays
All hybridisations were carried out at 48°C.
RNase protection assays were performed on lOpg of RNA using the method of Isaacs et. al
193. Probes were generated and transcribed as follows: the luciferase probe was derived by 
subcloning a 400bp fragment of P3MM (containing the P3 promoter, a 70bp region of Igf2 
exon 3 and the first 160bp of the luciferase coding region) into BlueScript KS+ 
(Stratagene). This plasmid (pLuxP) was digested with BamHI, and transcribed with T7 
polymerase (Promega), such that the resulting antisense RNA protected 160bp of a 
luciferase transcript in transgenic samples, and 70bp of the Igf2 mRNA in all samples. The 
probe for the ubiquitously expressed control mGAP was made by digestion of an mGAP
containing plasmid (obtained from A. Ward, as described in Rathjen et. al. 194) with AccI, 
and transcribing with T7 polymerase, protecting a 65bp region of the mGAP transcript. The 
CCD probe was generated by subcloning a 313bp Scal/EcoRI fragment of p i 75a: 4 
(containing the CCD open-reading frame) into BlueScript KS+ (Stratagene), This plasmid 
(pCCDP) was digested with EcoRI and transcribed with T3 polymerase (Promega), or 
digested with Hindlll and transcribed with T7 polymerase.
Northern blotting and hybridisation
Northern blots were performed according to standard protocols 185 with modifications. 
RNA samples were separated using standard gel electrophoresis, on 1.2% agarose gels:
4.2g agarose was dissolved in 304ml nuclease free H2O and cooled to 65°C in a water-
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bath. To this was added 35ml lOx MOPS running buffer [lOx buffer = 200mM MOPS (3- 
[N-Morpholino]propanesulphonic acid), (Sigma) pH 7.0; 50mM Na Acetate, lOmM 
EDTA) and 10.5ml 37% formaldehyde (Sigma)] and the gel was immediately poured. 
RNA samples were prepared for loading by mixing up to 11.25 pi RNA solution with 5 pi 
MOPS buffer, 8.75pl formaldehyde, 25pl formamide (Sigma), in a total volume of 50pl. 
This was denatured for 15min at 55°C, 5pl lOx Ficoll loading buffer was added 185 ancj 
the samples loaded onto the gel. The gel was run in lx MOPs buffer for 18hr at 50V. The 
gel was then capillary blotted onto Hybond-N membrane.
Probes used in Northern hybridisation experiments
An mGAP 194 probe for quantitation of mRNA levels during Northern analysis was 
obtained from Dr A. Ward, this probe will hybridise to the 1.5kb mGAP transcript. A 
mouse Igf2 exon 6 probe was obtained from Dr A. Ward, and is predicted to hybridise to 
the 2.5kb Igf2 transcript. To create the transthyretin (TTR) probe, the plasmid pTTR- 
7kbexV3 was obtained from Dr R. Costa (described in Yan et. al.195). This plasmid 
contains 7kb of the genomic region of mouse TTR, as well as exons 1 and 2, and intron 1.
A probe of 980bp covering exon 1, intron 1 and approximately half of exon 2 was obtained 
by digestion of this plasmid with BglH and Stul. This probe would be predicted to 
hybridise to a 0.7kb TTR transcript in liver and choroid plexus tissue, as well as a 1 kb 
choroid plexus-specific TTR transcript. For detection of transcripts from the ORF within 
the CCD, the CCD probe previously utilised for Southern hybridisation was used (see 
above, Section 5.3). Probe labelling and hybridisation of blots was carried out exactly as 
described for Southern blotting (see above).
P o lym e ra se  chain  rea c tio n  (PCR) a n a ly se s  
Amplifying the rat CCD
Primers: CCDP1: 5’ CAGRGCYRGGRCAGAGGAAGA 3’,
CCDP2: 5’ CCTTCTGWCCWGCTSCAAGCT 3’,
CCDP3: 5’ CGTGAGGTCAGYGGKYAGCAT 3’,
(where R is A / G ,  Y is C / T ,  W is A / T ,  S is C /G ,  K is G / T ,  Gibco BRL).
Initial PCR was performed using Reddy-Mix PCR buffer with 1.5mM MgCl2 according to 
the manufacturer’s instructions (Advanced Biosciences), with primers at 1.5pM.
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Subsequent PCRs were carried out using Jeffreys’ Buffer 196? with 1 unit of ABI Taq 
polymerase, and the same primer concentrations as above. PCR reactions were denatured 
for 5 min at 94°C, then cycled at 94°C for 1 min, 62°C for 1 min, 74°C for 1 min for 36 
cycles, followed by a 10 min final extension at 74°C. Completed reactions were run out on 
2% agarose gels, stained with ethidium bromide and examined on an ultraviolet light 
source.
p53 PCR
The primers used to identify p53 null mice described in Section 1.2 are those described in 
Malcomson et. al. 197. p c r  was performed using the Reddy-Mix PCR buffer with 1.5mM 
MgCb according to the manufacturer’s instructions (Advanced Biosciences), with primers 
at 1.5pM. PCR cycles were as described above.
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C h a p te r  3: Is th e  CCD a b le  t o  d rive  r e p o r t e r  g e n e  e x p r e s s io n  in  
v iv o ? Q u a lita tiv e  a ss a y .
In trodu ction
Background
This study will use the resources of a large panel of transgenic mice, which have been
generated by Ward et. al. 108 These transgenics contain different candidate regulatory 
elements of the Igf-2/H19 locus fused to a luciferase reporter gene, under the control of 
Igf2 promoter 3 (P3, depicted in Figure 1 and Figure 3, Chapter 1).
Expression of luciferase from these transgenic constructs reproduced several of the 
characteristics of expression of the endogenous Igf2 gene. The transgene activity followed 
the decline of both Igf2 and H19 mRNA that occurs after birth 95# Assays for luciferase in 
these lines following paternal and maternal transmission demonstrated that the H19 
enhancers regularly imposed imprinted gene expression, as well as confirming that this 
element is a strong enhancer of P3 in the liver. These experiments have also indicated that 
the CCD may be an enhancer of P3 in the brain.
Accurate assays of reporter gene activity in whole organs fall short of the ideal, 
which is measurement of activity in each cell type of every organ. The method of Ward et.
al. allowed the detection of minor but significant changes in expression in a large 
number of samples. Since whole organs were homogenised, it was not possible to 
distinguish between changes in activity due to a change in the amount of luciferase 
produced by a particular cell type, or a change in the range of cell types expressing 
luciferase.
Dissection of organs to give rise to samples of cell subtypes within that organ are 
problematic, as one cannot always be sure that such dissections are clean, and in many 
organs (eg, the kidney), cells of different germ layers are highly intercalated. Far more 
sensitive methods for identifying gene expression at the cellular level are provided by in- 
situ hybridisation techniques.
The aim of the following experiments was to develop a system in which to detect 
luciferase reporter gene activity in vivo by the use of immunocytochemistry.
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Experimental strategy
In this study, embryos derived from crosses of transgenic mice can be treated with an 
antibody raised against the luciferase protein, in an attempt to resolve luciferase 
expression. If successful this technique can provide information of both spatial and 
temporal activities of regions contained in the transgenes. Of most interest is whether any 
expression of luciferase can be resolved in /7-line transgenic embryos (the //-construct 
contains the CCD alone fused to F3-luciferase, see Figure 3, Chapter 1).
Commercial sources of the a-luciferase antibody
Immunohistochemistry using ant\-luciferase antibodies is a technique with few precedents 
in the literature. Two published studies 198, 199^  useci this technique to detect transgene 
expression of luciferase, in transgenic, wax embedded tissues of mice. In both cases the 
antibody used was generated by the workers directly, by raising antibodies in rabbits 
against firefly luciferase, followed by affinity purification. These preparations have not 
been made generally available. Due to time constraints, it was decided to use a commercial 
source of a -luciferase antibodies, rather than go through the lengthy procedure of creating 
and purifying this reagent de-novo.
Several commercial sources exist for this reagent (Sigma, Cortex and Promega).
All three sources raised antibodies in rabbits against purified luciferase protein, and the 
immune sera were then affinity purified on luciferase-codXtd columns.
These anti-luciferase antisera were polyclonal preparations, which potentially 
contain multiple antibodies directed against different epitopes on the luciferase protein. 
The advantage of using a polyclonal antibody preparation is that it is possible for several
antibodies to bind to the same protein target, thus generating a strong signal 181. a  
disadvantage of using such preparations is that there are relatively high concentrations of 
antibodies that can potentially bind to epitopes present on other proteins apart from the 
target (i.e., cross reactivity), generating background signals.
Preliminary experiments
Previous to this work, (C. Mackensie, unpublished data) carried out preliminary studies on 
a variety of commercially available luciferase antibodies, to study the affinity of these 
reagents to luciferase protein. The conclusions of this study were as follows:
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i) Using an enzyme-linked immuno-absorbance assay (ELISA), it was found that the 
Cortex anti-luciferase serum, at a concentration of V500 was able to resolve between 
1 0 -1 0 0pg of purified luciferase protein.
ii) Using Western blotting, purified luciferase protein could be detected at levels of 2- 
lOng in a protein homogenate. A luciferase signal was detected in the homogenised 
livers of transgenic mice (independently assayed quantitatively, and shown to 
contain ~4ng luciferasePNestem blotting sample). A signal could not be detected in 
the lung, skin or brain of the same animal (0 .8 6 , 0 .8 8 , 0 .6 6 ng luciferase, 
respectively), suggesting that the limit of detectability for purified and native 
luciferase protein are similar.
It was decided to assay organs from transgenic mice to be used in immunohistochemistry 
studies, to ascertain if levels of luciferase protein are comparable to those that can be 
detected by Western blotting. It is difficult to translate thresholds of detection by Western 
blotting into the ability to resolve a signal by immunohistochemistry, as the quantitative 
levels do not distinguish between a punctate or diffuse distribution of protein. The former 
would be expected to be readily detected by antibody staining, whereas the latter may be 
problematic to resolve over any background staining. As a first approximation, though, 
levels of luciferase protein in whole organs at greater than 2 ng are assumed to have a good 
chance of detection by immunohistochemical staining with an mti-luciferase antibody.
R e su lts  
D issections of e12.5 embryos and assay  for lu c ife ra se  specific activity.
In order to create a developmental profile of luciferase expression in transgenic lines, it 
was first necessary to ascertain whether luciferase protein was expressed at detectable 
levels in the target embryos. The embryos chosen for this quantitative study were from 
some of the same transgenic lines as those that would be used in subsequent staining 
experiments. The embryonic stage e l2.5 was chosen as it represents the earliest stage at 
which staining would be assayed. Luciferase gene expression from the P3 promoter has
previously been shown to rise from midgestation, reaching a maximum before birth 108 
Consequently, it should be noted that e l2.5 embryos might be expected to contain the 
minimum level of gene expression used in this study.
The offspring of crosses of transgenic fathers {Alicia, Ost and Helga lines) vs. non- 
transgenic (FI) mothers were dissected from the uterus at el2.5 days. Embryos were
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crudely dissected, and the samples were assayed for luciferase activity. Samples collected 
were; liver, brain, tail, tongue (lower jaw) and placenta/yolk sac. The extraembryonic 
tissue sample was assayed for luciferase and used to judge the transgenic status of the 
embryo.
Representative samples are tabulated below, with standardised quantities of 
luciferase protein given in ng/whole organ. Transgenic samples are shown paired with 
non-transgenic littermates (Table 1).
Expression of luciferase protein is in some cases above the threshold of 2ng luciferase 
(Alicia and Ost liver) therefore would at least be detectable by Western blotting.
Antibody titre
Preliminary experiments using e l2.5 and e l4.5 embryos derived from crosses of males 
from four different transgenic lines (Alicia, Helga, Tilly and Ost) against FI females 
produced a luciferase antibody staining pattern in both transgenic embryos and their wild- 
type littermates. As the non-transgenics cannot produce luciferase protein, this pattern 
must be due to background.
The background staining was always observed in the same subset of tissues 
regardless of the transgenic line from which the embryos were derived. These tissues were 
the walls of the heart and the white matter of the presumptive spinal cord.
This staining pattern was also observed in those embryos treated with a positive 
control primary antibody, anti-neurofilament 200 (which reacts with a structural protein of 
the central and peripheral nervous system). Treatment with this antibody (at concentrations 
of Vioo and above) also produced a signal from other areas in the embryo, most notably in 
the dorsal root ganglia. This staining was generally more intense and localised, in contrast 
to the background, and believed to be a true signal. No staining of this kind was observed 
in those sections treated with the anti-luciferase antibody, even at antibody concentrations 
of I /5 0 .
Two problems therefore needed to be overcome, the background staining needed to 
be reduced, and the luciferase epitopes (those fragments of the protein in the sample that 




Liver Brain Tail Tongue
Alicia 20.27 0.85 0.56 0.88
Non-
transgenic
1.99x10'* 2.27x10'* 1.63xl0"4 6.32x10°
Ost 11.09 0.54 0.37 2.46x10'*
Non-
transgenic
1.53x1c4 6.52xl0'4 5.48x10° 1.88x1c4
Helga 1.72x1c4 3.51x10* 1.21X10"4 4.24x10'*
Non-
transgenic
1.72x1c4 1.72x1c4 3.44x10° 3.44x10°
Table 1. Quantitative levels of luciferase protein in representative embryos from the 
transgenic lines Alicia, Ost and Helga.
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Secondary antibody
In most cases a secondary antibody labelled with alkaline-phosphatase was used, which 
was detected with a chromogenic substrate. There is some endogenous alkaline 
phosphatase activity present in mouse tissues (e.g., in liver, bone, kidney, intestine and 
placenta), but the addition of levamisole is sufficient to block this activity in all tissues 
except intestine and placenta. In some experiments, a secondary antibody labelled with 
horseradish peroxidase was used. In these cases endogenous peroxidase activity was
quenched with excess peroxide 181. Controls in which no antibody was applied, and 
detection reagents were added showed no staining (except the expected intestinal 
phosphatase) in both cases, therefore background staining was not due to endogenous 
enzyme activities.
A common cause of background problems is due to the secondary antibody, which 
is raised against rabbit proteins, cross-reacting with mouse proteins present in the sample. 
A control was done in all experiments in which primary antibody was substituted with 
blocking solution, then treated as normal with secondary antibodies. These secondary 
antibody-only controls showed no signal in all cases, showing that the secondary antibody 
has no cross reactivity to mouse proteins.
The secondary antibody was titrated to optimise the amount used in the following 
experiments. The anti-rabbit antibody was able to detect a signal from positive controls 
(anti-neurofilament 2 0 0  at a concentration of V50) at titres of V100 and above. The 
secondary antibody was thus used at concentrations of V100 and incubated for one hour in 
all following experiments.
Primary antibody
Those antibodies in the primary antibody preparation which bind to non-luciferase 
epitopes should necessarily be at lower concentration than those binding to luciferase 
epitopes, against which the antibodies were raised. If the background is due to this 
inappropriate binding it should be possible to minimise it by titration of the primary 
antibody to a level at which there is significant mti-luciferase binding, but very little 
inappropriate binding.
Sections of Tilly e l2.5 embryos and wild-type littermates were treated with anti- 
luciferase at concentrations of Vsoo, V300, Viooand V50 (Table 2). The level of staining was 
judged subjectively as intensity of pink coloration produced by the action of alkaline- 
phosphatase on its chromogenic substrate.
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No signal at all was observed until the anti-luciferase concentration reached Vioo, 
and this signal was the background staining pattern. Similar results were obtained using the 
anti-Neurofilament 200 antibody, though at concentrations of Vioo and above the specific 
signal described previously was also present.
These results strongly suggest that the background is not due to the presence in the 
preparation of antibodies binding non-specific epitopes, as the same subset of non-specific 
antibodies (i.e. those binding heart and spinal cord epitopes) would not be expected to be 
found in independently derived primary antibody preparations against two different 
proteins.
Both primary antibodies are used at concentrations of l/ioo and above in all 
subsequent experiments, unless stated otherwise.
Blocking reagents
Background problems can be caused by ‘non-specific sticking’, i.e. due to either the 
primary or secondary antibody binding to the specimen through interactions which do not 
involve the antigen-combining site. This can be combated by the use of blocking agents, 
solutions with high protein concentrations that by pre-incubation with the antibody can 
pre-absorb this non-specific activity.
A variety of blocking agents were investigated on Tilly embryos and wild-type 
littermates. Sections were incubated for one hour with Bovine Serum Albumin (BSA), 
BLOTTO, Horse Serum or Fetal Calf Serum (FCS) blocking solutions before antibody 
treatments (Table 3). Both the primary and secondary antibodies were applied to the 
specimens in the appropriate blocking agent. Anti-luciferase was applied to specimens at 
Vioo or V50. As high titres of antibody give more background than low (Table 2), the 
blocking power of the reagents tested can be compared by their ability to reduce different 
levels of background. Non-transgenics were also stained to test whether any specific 
staining would be revealed if background levels were reduced.
The most efficient blockers were BLOTTO and Horse Serum, which were able to 
remove all background at antibody titres of Vioo, and reduce background at antibody titres 
of V50 as compared to BSA and FCS. In subsequent experiments, Horse Serum was used as 
a blocking agent.











i/' 500 transgenic - -
1/
'300 transgenic - -
Vioo transgenic - +
Vso transgenic - ++++

















Table 2. Effect of anti-luciferase concentration on levels of specific and non-specific 
(background) staining. Staining levels are indicated by -  (no signal) or number of + (+ low 
/ ++++ high).
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T r e a t m e n t S a m p l e [ a -
luciferase\
L e v e l  o f
s p e c i f i c
s t a i n i n g
L e v e l  o f  
n o n ­
s p e c i f i c  
s t a i n i n g
B S A transgenic V io o - ++
transgenic V 50 - ++++
non-
transgenic
V io o - +
non-
transgenic
V so - ++++
B L O T T O transgenic V io o - -
transgenic V 50 - + + +
non-
transgenic
V io o - -
non-
transgenic
V so - + +
H o r s e
S e r u m
transgenic V io o - +
transgenic V so - + +
non-
transgenic
V io o - -
non-
transgenic
V so - +
F C S transgenic V io o - ++
transgenic ‘/ s o - +++
non-
transgenic
V io o - -
non-
transgenic
V so - +++
Table 3. Effect of different blocking solutions on the level of specific and non-specific 
staining with the anti-luciferase antibody. Levels of staining are indicated as in Table 2.
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Acetone powder
Another method of reducing non-specific sticking is to pre-incubate the antibody with an 
acetone powder made using the control tissue. This method can also be used to remove 
antibodies in the preparation that cross-react with non-specific epitopes.
A dehydrated preparation was made from non-transgenic e l2.5 embryos with the 
same genetic background as transgenics, i.e. an FI x FI cross. Both anti-luciferase and 
anti-neurofilament 2 0 0  antibodies (at a concentration of V50) were pre-incubated with this 
preparation prior to application to the sections. Any protein present in non-transgenic 
embryos which binds the anti-luciferase antibody should be removed by this treatment, 
leaving only those antibodies which react specifically to epitopes present in the transgenic 
but not non-transgenic preparations.
The anti-neurofilament 200 treatment acts as a control for this procedure; 
neurofilament 2 0 0  antigen is present in non-transgenics, therefore no anti-neurofilament 
staining should be observed if the acetone powder treatment is successful.
Results are presented in Table 4. Treatment with acetone powder was able to 
significantly reduce background signals, and to remove anti-neurofilament 2 0 0  specific 
staining.
Again, no specific anti-luciferase patterns were observed in any treatments. 
Fixatives
Background signals can be significantly reduced with the use of appropriate blocking 
agents and treatment with acetone powder. In no treatment so far discussed had any clear 
specific staining been uncovered with anti-luciferase antibodies following the reduction in 
background staining. The method of fixation employed in all treatments had been that of 
paraformaldehyde fixation. It was decided to vary the method of fixation to try to unmask 
any epitopes that might have been hidden by this procedure.
A perfect fixation technique would immobilise the antigen while retaining authentic 
cellular and subcellular architecture, and permitting unhindered access of the antibody to 
all cells and subcellular compartments. No fixation technique reaches this ideal, by cross- 
linking proteins present in the sample many epitopes will be masked or altered by 
fixatives. Three different fixation techniques which were compatible with wax embedding, 
in addition to paraformaldehyde fixation, were employed on sections from Tilly e l2.5 
embryos and their wild-type littermates. These fixatives are MEMFA, 20% ethanol and
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Zambonis' Phosphate Buffer (detailed in the M a t e r i a l s  a n d  M e t h o d s  section), and the 
results are shown in Table 5.
Very little difference was observed between different fixation techniques. None 
showed any specific staining with the anti-luciferase antibody, while all showed some 
degree of specific staining with the positive control (anti-neurofilament 200). The most 
obvious differences were in section quality, the level at which morphological architecture 
was preserved after treatments. Those embryos fixed in 20% ethanol showing very poor 
quality, while those fixed in Zambonis Phosphate buffer showed superior quality.
Cryostat fixation
All fixation techniques employing paraffin embedding have failed to unmask any specific 
anti-luciferase staining. Consequently cryostat embedding, a technique with less harsh 
treatment of tissue was examined. Using this method, no fixation is employed and instead 
the embryo is snap frozen in the polymeric matrix O.C.T. then sectioned. Any proteins 
present are assumed to adopt a more physiological conformation as compared to a 
technique that employs chemical cross-linking 181.
Anti-luciferase specific staining was not uncovered by this procedure (in embryos 
of crosses Ann x FI and Holly x FI). However, positive controls have shown anti­
neurofilament staining at a level significantly above background, at lower antibody 
concentrations, suggesting that cryostat embedding techniques are more sensitive than 
those previously employed, at least for this antibody.
Antigen retrieval
Cuevas et.al. (182) made a study of the effect of microwave irradiation on the staining of a 
range of commonly used primary antibodies in formalin-fixed, wax embedded material. 
They found that microwave irradiation permitted successful immunostaining with 20 
antibodies that otherwise stained only frozen tissues. The staining characteristics of 21 
antibodies that were already known to stain formalin fixed, wax embedded material were 
improved. Another 39 antibodies did not show enhanced staining with this technique.
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- transgenic a -luciferase - ++++
+acetone
powder
transgenic a-luciferase - +
- transgenic a-neurofilament ++ +++
+acetone
powder
transgenic a-neurofilament - +
- non-
transgenic














Table 4. Effect of acetone powder on the specific and non-specific staining of embryos 
treated with anti-luciferase and anti-neurofilament 200 antibodies. Level of staining is 
indicated as in Table2.
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Table 5. The effects of four different fixation techniques on the level of specific staining 
with anti-luciferase and anti-neurofilament antibodies, and on section quality. Levels of 
staining are scored as in Table 2.
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The mechanism of antigen retrieval achieved by microwave irradiation remains obscure, 
though it has been suggested that microwaves disrupt the cross-linking of proteins.
A further method of antigen retrieval is by a high temperature technique, in which 
specimens are heated at high pressure. This method has also brought favourable results 
with a number of antibodies that do not normally stain fixed, wax embedded tissues (J. 
Smith, pers. comm.).
Both methods of antigen retrieval were attempted on a number of wax embedded 
sections fixed in Zambonis’ phosphate buffer, and stained with a-luciferase and a- 
neurofilament, at antibody concentrations of V500, V200, Vioo, Vso-
Sections treated with the a-neurofilament antibody had a stronger specific staining 
pattern after antigen retrieval, at antibody concentrations of Vioo or higher. Background 
staining was unchanged.
a-luciferase staining was not revealed by either antigen retrieval technique. 
Microwave irradiation substantially increased the level of background staining, especially 
when the antibody concentration was high.
Different brands of antibody
All of the techniques described above were carried out using the a-luciferase antiserum 
from Cortex, for which the initial ELISA and Western blot characterisations were done.
Subsequently, several of these trials were repeated with antibodies from Promega 
and Sigma. These antibodies have been used in combination with paraformaldehyde and 
Zambonis’-fixed wax embedded sections, with the best of the blocking reagents (Horse- 
Serum). Cryostat embedded tissue was stained with Sigma a-luciferase, but not the 
Promega reagent, as by this point it had been withdrawn from sale. In all cases the 
background staining at high antibody concentrations was identical to that observed with the 
Cortex antibody, and no specific staining was ever observed.
C o n c lu s io n s
Immunohistochemistry is a powerful technique for discovering information about the 
spatial and temporal expression of protein encoding genes.
It has been found that transgenic mice with a variety of regulatory regions of the 
Igf2/H19 locus fused in-cis to a luciferase reporter construct can demonstrate readily 
detectable levels of gene expression when measured by a photometric enzyme assay (Ward 
et.al. 108, an(i this study). Knowledge of specific domains of expression driven from
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luciferase transgenes was limited by the ability to dissect particular tissues in sufficient 
quantity and purity for the photometric assay.
Immunohistochemical staining of transgenic samples for luciferase protein seemed 
to be the ideal method by which to discover the fine distribution patterns of gene 
expression from transgene constructs. In this investigation it was attempted to discover the 
sub-organ distribution of luciferase protein in-vivo. Unfortunately all attempts to resolve 
reporter gene expression by antibody staining have failed.
Embryos at e l2.5 and el4.5, from transgenic lines known to express abundant 
levels of luciferase protein in a subset of tissues were treated with a-luciferase antibodies 
from a variety of sources, and with an a-neurofilament-200 positive control. While the 
positive control antibody gave a consistent, neuron-specific pattern of staining under a 
number of conditions, staining with a-luciferase exhibited a general, non-specific 
background staining pattern, which was identical in both transgenic embryos and their 
wild-type littermates. Variation in conditions, by use of several fixation, blocking and 
embedding protocols was able to reduce this background, but never able to reveal a 
consistent pattern of luciferase staining, even when antigen unmasking protocols were 
employed.
Previous workers have reported a-luciferase staining of transgenic, wax embedded, 
paraformaldehyde/formalin-fixed transgenic tissue 198, 199. Lee et. al. 2 0 0  created a rat 
cardiac myosin light chain (MLC) 2 promoter-luciferase fusion gene, which was 
introduced by microinjection into 1-cell embryos to create transgenic mice. Luciferase was 
detected by immunostaining in these animals, exclusively in the ventricular compartment 
of the heart. Another group created transgenic mice using an construct consisting of 
luciferase fused to the murine preproendothelin-1 promoter, and reported luciferase 
staining in the endothelial cells of both large and small arteries, as well as low levels of 
staining in veins and capillaries 198.
Both groups used antisera preparations that were not from commercial sources 198,
199, 2 0 0 } groups having raised the antibodies against luciferase in rodents, and purified 
them using affinity chromatography. It is possible that here lies the difference between the 
two published studies, and the work presented above. In the literature accompanying the 
commercial antibodies used in this study, there is no mention of their use on fixed tissues. 
A possible reason for the failure of this technique lies in the use of commercially available 
antibodies, preparations which are not sufficiently sensitive to resolve luciferase epitopes
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in sectioned tissues. A further explanation is that the fixation techniques employed led to 
the modification of luciferase epitopes beyond the recognition of these antibody 
preparations. This explanation seems less likely as even unfixed cryosections did not give a 
specific luciferase signal.
The two studies cited above also detailed quantitative measurements of luciferase 
enzyme activity, following expression of the reporter constructs in target tissues. 
Unfortunately in both cases enzyme activity was expressed as relative light units 
generated/mg protein. As luminometer equipment varies it is not possible to compare these 
non-standardised measurements with the luciferase specific activities measured from 
Igf2/H19 reporter constructs. Despite this, it could be suggested that the level of protein 
produced from preproendothelin-1 promoter -luciferase constructs and MLC-2 promoter- 
luciferase constructs is much higher that that produced by any of the transgenic lines 
assayed here. In this case it may be that luciferase protein levels from Igf2IH19 transgenic 
lines in this study are too low to be detected by an immunohistochemical method.
Further work
Information about the elements directing the tissue-specific distribution of Igf2 and H I9 
gene expression at single cell resolution will be invaluable in the investigation of the 
mechanism of imprinting of these genes. The purpose of this study was to investigate 
whether several elements, which lie in-cis to the Igf2 and H19 genes, could confer tissue- 
specific expression upon a luciferase reporter gene, by the use of a immunohistochemical 
strategy. Unfortunately, the detection of luciferase protein was unsuccessful in the hands of 
this investigator, despite extensive optimisation of the protocol. The failure of this 
technique could be due to several possible causes, and these causes must dictate how to 
proceed with the investigation of the role of cis-acting elements (particularly the CCD) in 
the regulation of Igf2 and H19. One possible cause is that the commercially obtained 
luciferase antisera was unable to detect luciferase protein in tissue sections. This failure 
could either be due to poor sensitivity, or due to the fact that these antisera had been raised 
against purified protein, which may display different epitopes than luciferase protein 
produced by mammalian cells. In the transgenic lines discussed in this study, levels of 
luciferase gene expression could be very low, or the gene products too unstable to allow 
detection by an immunohistochemical method.
These problems could be overcome by the use of one of a variety of techniques. 
Firstly, an anti-luciferase preparation could be generated de-novo. Previous investigations
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of luciferase gene expression in-situ have been accomplished by the use of antisera 
generated by the investigators themselves 200} 198 However, commitment to 
generating a new anti-luciferase antibody would have to be considered carefully, for 
considerable time and resources would be involved in creating such a reagent.
Furthermore, the use of such a reagent has no guarantee of success, especially if the cause 
of failure lies elsewhere. Secondly, the search for luciferase protein could be abandoned in 
favour of an assay for luciferase mRNA in-situ. The use of this technique would dispense 
with the need for unreliable reagents, and overcome the problem of mammalian cell- 
specific luciferase epitopes. However, in-situ hybridisation for mRNA in mouse tissues is 
another technique that may require extensive optimisation, complicated by the possibility 
that if the level of luciferase protein is limiting, this could be reflected in the abundance of 
the mRNA. Protein levels are not linear with respect to mRNA levels, as one mRNA 
molecule is thought to be processed by many ribosomes. A small amount of protein in 
these samples may therefore reflect an even smaller amount of mRNA, which could be 
below the threshold of detection of this technique. A third strategy is the creation of new 
transgenic lines bearing a different reporter gene. p-galactosidase has been used 
successfully as a reporter gene in several studies of gene activity conferred by elements at 
the Igf2/H19 locus. In particular this reporter was used to demonstrate the tissue specificity
conferred by the H19 enhancers 106, 109 p-galactosidase is a very stable protein, and its 
enzyme activity can be measured both quantitatively (by a photometric assay which 
measures enzyme hydrolysis of the substrate ONGP (o-nitrophenyl J3-D- 
galactopyranoside)), or histochemically (by cleavage of the substrate X-Gal (5-bromo-4- 
chloro-3-inodyl P-D-galactosidase, which creates an indigo blue derivative). A 
disadvantage of the use of this reporter is that some mammalian cells possess endogenous 
P-galactosidase activity, but this variant is lysosomal and active only at low pH. 
Endogenous p-galactosidase activity can therefore be blocked by performing the assays at 
a pH greater than 7.5 (reviewed in 201).
In order to circumvent the problems of visualising luciferase gene activity, it was decided 
to embark upon the creation of new transgenic lines bearing the P-galactosidase gene as a 
reporter, in place of luciferase. To date, over 500 embryos have been microinjected with 
the C construct (which is identical to the H  construct, excepting the replacement of 
luciferase with p-galactosidase), and transplanted into the uterus of pseudopregnant foster 
mothers. Of these embryos, more than 10% (61) were recovered at Dl, and two individuals
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have been recovered with successful integration of the transgene (the transgenics Connie 
and Columbo, data not shown). Unfortunately time constraints have prevented any further 
analysis of C transgenics, so it is not yet known whether these individuals will transmit the 
transgene to their offspring, or the resulting pattern of p-galactosidase activity generated in 
the presence of the CCD. Ultimately several C-construct transgenic lines will be needed to 
assess the role of the CCD in directing gene expression to specific tissues.
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C h a p te r  4: Is th e  CCD a b le  t o  d rive  r e p o r t e r  g e n e  e x p r e ss io n  in  
v i v o ?  Q u a n tita tiv e  a ssa y .
In troduction
As was previously discussed in the Introduction, the only enhancers at the Igf2IH19 locus 
fully characterised to date are those that lie approximately lOkb downstream of the H I9 
gene (the H19 enhancers). These enhancers certainly confer high levels of expression to 
both genes in endodermally-derived tissues (namely liver and gut epithelium), and may 
play a role, perhaps in concert with other elements, in driving tissue-specific expression in 
the yolk-sac and the exchange tissues of the brain.
The following experiments seek to determine whether the CCD has the ability to 
drive tissue-specific expression of Igf2 and H I9, either alone, or in combination with the 
H19 enhancers.
Transgenic mice with luciferase reporter constructs (detailed in Figure 3, Chapter 
1) were used in an in vivo assay to ascertain the quantitative level of gene expression from 
Igf-2 promoter 3 (P3) when other Igf-2 control elements were present. Previous 
experiments have shown that a construct containing P3-luciferase alone (the M-construct, 
see Figure 3) cannot drive reporter gene expression above the background levels of this 
assay 108 Elements of interest in this study are the H19 enhancers and the CCD. To this 
effect, expression levels were measured in tissues derived from transgenic mice bearing the 
A construct (?3-luciferase-H19 enhancers), in the lines Alicia, Archy, Ayah', the H  
construct (P3-luciferase-CCD), in Harold, Holly, Hamish lines; and the Q construct (P3- 
luciferase-CCD-H19 enhancers), Quasar, Quark, Quiche lines. Expression levels were 
examined in three transgenic lines representing each construct in an attempt to distinguish 
real effects on P3 due to the element of interest, from position effects caused by transgene 
integration. Any effects observed across the majority of lines bearing a particular element 
will be regarded as real.
All tissues were collected from one-day post-partum (Dl) offspring of crosses of 
females or males hemizygous for the transgene vs. FI (the background strain, see 
Materials and Methods) partners. Offspring therefore inherited the transgene from one
parent only. Previous experiments 108 have shown that transgene expression levels from
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the P3 promoter are usually maximal from embryonic day 17.5 to 3 days post-partum, after 
which expression levels decline sharply. At least 20 individuals were collected and assayed 
from each parental cross to enable comparison of parent-of-origin specific expression 
within each line by a student’s t test (see next chapter).
R e su lts  
Tissue-specific expression at D1
The first question posed by this experiment was; what tissue-specificity is conferred by the 
H19 enhancers and the CCD when linked to the reporter gene-P3?
Previous studies 108 have shown that the H I9 enhancers are able to drive high 
levels of reporter gene expression from P3 in liver, and moderate levels in heart and 
kidney. The CCD has been shown to drive expression from P3 in the brain, particularly in 
the exchange tissues.
The purpose of this study is to extend this previous analysis into a wider range of 
tissues. The CCD is a candidate for the yet undescribed mesoderm specific enhancers. 
Reporter gene expression was therefore examined in muscle and tongue, as well as brain, 
liver and kidney.
A second question within this category is; do the two elements interact to modulate 
expression levels or create new patterns of expression? This question is examined using 
transgenic mice bearing the Q construct, which contains both the H19 enhancers and the 
CCD, and has not previously been analysed for tissue-specific reporter gene expression. 
The Quiche transgenic line was created during the course of this study in order to allow 
examination of three independent Q lines.
Figure 4 shows tissue-specific reporter gene activity across the lines. It should be 
noted that expression levels from Quark and Hamish are extremely low in all tissues, and 
may represent position effects. Expression following male transmission and female 
transmission of the transgene are shown separately for each transgenic line, as in some 
cases the means are significantly different (see Chapter 5).
Mesoderm-specific expression
In tongue and skeletal muscle samples the reporter gene is expressed at low levels in lines 
containing both elements (see Figure 4a and 4b). There appears to be little difference in
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levels of reporter gene activity driven by the H19 enhancers, the CCD or with both 
elements together.
Endoderm-specific expression
In liver and kidney samples, significant levels of reporter gene expression are only found 
in those lines that contain the H19 enhancers {Ayah, Archy, Alicia, Quark, Quasar, Quiche; 
Figures 4c and 4d). Levels of luciferase expression in the liver are extremely high in 
comparison to expression levels from other tissues.
Brain-specific expression
In brain samples significant levels of reporter gene expression are only seen in those lines 
containing the CCD {Quasar, Quiche, Harold, Holly; Figure 4e), though a low level of 
gene expression can be detected in all three A  lines.
To summarise; the H19 enhancers are able to drive expression of luciferase from P3 in 
tongue, muscle, kidney, and to very high levels in liver. The CCD is able to drive gene 
expression from P3 in tongue, muscle, and with the greatest upregulation in the brain. The 
large variation in expression levels between the lines bearing each construct (particularly 
the Q lines), has prevented the observation of any interaction between the two elements to 
alter levels of expression. However, no new patterns of expression were observed when 
both elements were present in the same construct.
is the brain expression confined to the exchange tissues?
It was of interest to discover whether the brain-specific expression of luciferase was 
reflective of endogenous Igf2 expression, or merely the product of ectopic gene expression. 
Igf2 expression in the brain is largely confined to the exchange tissues (i.e., the choroid 
plexus and leptomeninges, see the Introduction). Luciferase gene expression from 
transgenic lines would therefore be expected to be concentrated in these tissues, and 
depleted in the remainder of brain tissues. To test this assertion, brains and livers were 
removed from Holly, Alicia and Quasar neonates. The brain sample was further dissected 
into a sample containing the majority of the exchange tissues (labelled CP), and the 
remainder of the brain tissue (labelled brain). RNA was extracted from these samples, and 
gene expression was examined using the ribonuclease protection technique. Sample RNA
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was hybridised with a luciferase probe (to measure transgene expression) and an mGAP 
probe to control for loading. The results of this analysis are shown in Figure 5.
Figure 5a shows luciferase expression in Alicia neonates. Reporter gene 
expression is very abundant in liver samples, as might be expected from the analysis of 
luciferase enzyme activity described above. Furthermore, luciferase mRNA can be 
detected in exchange tissue samples, but not in the remainder of the brain. Alicia neonates 
are known to express the reporter gene in the brain (see Figure 4e). The reporter gene 
expression pattern closely resembles that of the endogenous Igf2 gene, suggesting that the 
H I9 enhancers are able to upregulate gene expression in the exchange tissues of the brain. 
Figure 5b shows an identical pattern of gene expression for Quasar samples as that 
described for Alicia samples. Figure 5c demonstrates that the gene activity observed in the 
brains of //-construct bearing transgenic lines is a consequence (for Holly at least) of gene 
expression in the exchange tissues. CCD-bearing lines therefore demonstrate a pattern of 
reporter gene expression that resembles endogenous Igf2 expression. It appears that both 
the CCD and H19 enhancers are able to drive gene expression in the exchange tissues of 
the brain, though the two elements may be responsible for gene expression in different cell 
types (e.g., meningial cells vs. choroid plexus epithelium). Unfortunately, a quantitative 
comparison could not be made of expression levels between the three transgenic lines, as 
reporter gene expression levels varied a great deal between different individuals of the 
same line (e.g., the two Alicia samples in Figure 5a).
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Figure 4. Tissue-specific expression across the transgenic lines at D1
Figure 4a. Matched expression levels of mean reporter gene activity in tongue samples 
across the lines, following male (M) and female (F) transmission of the transgene. Reporter 
gene expression is seen in lines that are representative of all three reporter constructs (A, Q 
and H). Error bars show the standard error of the mean.
Figure 4b. Matched expression levels of mean reporter gene activity in skeletal muscle 
samples across the lines, following male (M) and female (F) transmission of the transgene. 
Reporter gene expression is seen in lines that are representative of all three reporter 
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Figure 4 (cont.) Tissue-specific expression across the transgenic lines at D1.
Figure 4c. Matched expression levels of mean reporter gene activity in liver samples 
across the lines, following male (M) and female (F) transmission of the transgene. Reporter 
gene expression is only seen in those lines that contain the H I9 enhancers, i.e., Ayah,
Archy, Alicia, Quark, Quasar, Quiche. Error bars show the standard error of the mean.
Figure 4d. Matched expression levels of mean reporter gene activity in kidney samples 
across the lines, following male (M) and female (F) transmission of the transgene. Reporter 
gene expression is only seen in those lines that contain the H19 enhancers, i.e., Ayah,
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Figure 4 (cont.). Tissue-specific expression across transgenic lines at Dl.
Figure 4e. Matched expression levels of mean reporter gene activity in brain samples 
across the lines, following male (M) and female (F) transmission of the transgene. The 
highest levels of reporter gene expression are seen in those lines that contain the CCD, i.e. 
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Figure 5. Transgene expression in the brain is confined to the exchange tissues.
Figure 5a. Ribonuclease protection analysis on RNA derived from two Alicia neonates 
(A), and a non-transgenic littermate {NTG). Samples collected were liver, brain with 
exchange tissue removed {brain), and the exchange tissues of the brain, including the 
choroid plexus (CP). RNA derived from these samples was hybridised with a luciferase 
probe and an mGAP probe, and protected fragments are visualised by autoradiography (see 
Materials and Methods). The two Alicia individuals assayed display a large variation in 
the level of luciferase expression in both liver and CP samples, but the reporter gene is 
expressed in these two tissues. Luciferase transcripts could not be detected in the depleted 
brain samples, or in samples derived from the non-transgenic littermate.
Figure 5b. Ribonuclease protection analysis on RNA derived from a single Quasar 
neonate {Q), and a non-transgenic littermate {NTG). The origin of the samples, and details 
of the assay are identical to those described in Figure 5a. Luciferase mRNA can be 
detected in both liver and CP samples, but not in depleted brain samples from the 
transgenic individual. Luciferase message could not be detected in non-transgenic samples, 
or in a tRNA control.
Figure 5c. Ribonuclease protection analysis on RNA derived from two Holly neonates 
(H), and a non-transgenic littermate {NTG). The origin of the samples, and details of the 
assay are identical to those described in Figure 5a. Luciferase mRNA can be detected in 
CP samples only, not in liver or depleted brain samples from the transgenic individual. 
Luciferase message could not be detected in non-transgenic samples, or in a tRNA control.
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Figure 5c
Tissue-specific expression at e14.5
The data collected from D1 neonates has revealed tissue-specific expression patterns of the 
P3-luciferase transgenes, when in-cis to either the H19 enhancers or the CCD. The H19 
enhancers drive expression in endodermally derived tissues, as well as in the brain, and the 
CCD drives reporter gene expression in the exchange tissues of the brain. Neither element 
could drive reporter gene expression to high levels in mesodermally derived tissues.
It next seemed appropriate to ask whether this expression was recapitulated at an 
earlier stage of development, in particular to corroborate the expression from CCD- 
containing transgenes in the brain. This brain expression has been shown to be confined to 
the choroid plexus and leptomeninges.
The choroid plexus first appears in the fourth ventricle of the developing mouse brain at 
e l2, having arisen from the ependymal layer of the myelencephalon 202  ^203 By e l3 the 
anterior choroid plexus has expanded laterally into the first two ventricles. By el5 there is 
a choroid plexus in the third ventricle. At the time point of embryonic day 14.5 the anterior 
and fourth ventricle choroid plexi should be fully formed, and the third ventricle choroid 
plexus in the process of forming. To allow the analysis of a large number of samples, a 
crude dissection was performed on e l4.5 embryos, with the head taken to assess the level 
of reporter gene expression in the exchange tissues of the brain. It has been shown above 
that at D1 the exchange tissues constitute the majority of head expression driven by the 
CCD. There is very little expression from H  transgenes in the remainder of the brain, or in 
tongue and skeletal muscle. It cannot be ruled out, however, that there may be other tissues 
in the head that can utilise the CCD to drive reporter gene expression above background 
levels.
The question of whether either the H19 enhancers or the CCD can drive expression in 
extraembryonic tissues could not be tackled by the D1 analysis, as these tissues cannot be 
recovered post-partum. As discussed in the introduction, the mesodermal components of 
the chorioallantoic placenta and the yolk sac are both major sites of Igf2 expression in mid­
gestation mouse embryos (Lee, 1990). There is some evidence that the H19 enhancers 
drive the expression of Igf2 in the yolk sac 105, but not in the placenta 104 
Luciferase reporter gene activity has not previously been assayed in the extraembryonic 
tissues. The following experiments will test the contribution of the H19 enhancers (A- 
lines), the CCD (//-lines) and both elements together (0-lines) on the expression of 
luciferase from P3 in these tissues.
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A further question in this section is do the two elements interact to modulate expression 
levels? At the D1 time-point, expression levels between lines with a particular construct 
were highly variable, preventing any comparison between constructs. Expression from the 
P3 promoter has been shown to decline shortly after birth both at its endogenous location 
204, and jn the transgenes utilised by this study 108 Transgenic lines could vary slightly in 
the timing at which they begin to downregulate expression from the P3 promoter, resulting 
in large quantitative differences in expression levels between the lines. At mid-gestation, 
expression is predicted to be maximal, and therefore it follows that expression levels 
between lines might be more comparable. Body samples (whole embryo minus head) were 
collected primarily to test for quantitative differences in reporter gene expression levels 
arising from an association between the H19 enhancers and the CCD.
As in the D1 analysis, tissues (head, body, yolk sac, and placenta) were collected from the 
offspring of crosses of females or males hemizygous for the transgene vs. FI partners (the 
background strain, see Materials and Methods). Embryos were collected 14 days 
following the appearance of a copulation plug. Reporter gene expression levels were 
measured in tissues derived from transgenic mice bearing the A  construct (V3-luciferase- 
H19 enhancers), the lines Alicia, Axe and Ayah; the H  construct (P3-luciferase-CCD), 
Harold, Holly and Hamish lines; and the Q construct (P3-luciferase-CCD-H19 enhancers), 
Quasar, Quark and Quiche lines. A single line bearing P3-luciferase with no additional 
elements (the M  construct, Marcus) was included, as levels of reporter gene expression 
from P3 alone have not previously been assayed at this stage. Figure 6 shows tissue- 
specific reporter gene activity across the lines. Expression following male transmission and 
female transmission of the transgene are shown separately for each transgenic line, as in 
some cases the means are significantly different (see Chapter 5).
In all tissues examined, expression of the luciferase gene could not be detected above 
background levels in the Marcus line. The mean luciferase specific activity from Marcus 
samples is included below to represent the background specific activity in this assay.
Head expression (Figure 6a).
In head samples reporter gene activity is seen in samples representative of all three reporter 
constructs. The highest levels of gene activity were observed in those lines containing the 
CCD (Quark, Quasar and Harold).
Body expression (Figure 6b).
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High levels of reporter gene expression in the bodies of transgenic mice were observed 
only when the H19 enhancers were present. H  lines all expressed the transgene at levels 
comparable to Marcus. Q lines expressed the transgene at ~5 fold greater levels than A 
lines (based on median figures for each construct).
Yolk-sac expression (Figure 6c).
In yolk sac, those lines containing the H I9 enhancers expressed the reporter gene above 
background levels, but at very low levels. A and Q lines expressed the transgene at 
approximately equal levels.
Placental expression (Figure 6d).
All of the transgenic lines assayed displayed reporter gene activity in the placenta that was 
very close to background levels.
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Figure 6. Tissue-specific expression across the lines, at embryonic day 14.5.
Figure 6a. Mean reporter gene activity in head samples across the lines, following male 
(M) and female (F) transmission of the transgene. The highest levels of reporter gene 
activity are seen in Q and H  lines, both of which contain the CCD. Error bars show the 
standard error of the mean.
Figure 6b. Mean reporter gene activity in body samples across the lines, following male 
(M) and female (F) transmission of the transgene. Reporter gene activity is seen in A and Q 
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Figure 6 (cont.). Tissue-specific expression across the lines, at embryonic day 14.5.
Figure 6c. Mean reporter gene activity in yolk-sac samples across the lines, following 
male (M) and female (F) transmission of the transgene. Reporter gene activity is seen in 
those lines that contain the H19 enhancers. Error bars show the standard error of the mean
Figure 6d. Mean reporter gene activity in yolk-sac samples across the lines, following 
male (M) and female (F) transmission of the transgene. Extremely low expression levels 

















































The first question posed by this analysis was; what tissue specificity is conferred by the 
H I9 enhancers/CCD when linked to luciferase-P3? The CCD provided a good candidate 
for the yet undiscovered mesodermal enhancers at the Igf2IH19 locus. A previous analysis 
has shown that the CCD cannot drive reporter gene expression above basal levels in 
cardiac mesoderm 108 This result is unsurprising in the light of a study in which a YAC 
transgene containing ~130kb of genomic sequences including the Igf2 and H I9 genes was 
shown not to express either H19 or an /g/2-linked JJ-galactosidase reporter gene in heart
tissue 36. The YAC transgene did, however, recapitulate other mesoderm-specific 
expression patterns of these genes, demonstrating that some of the necessary regulatory 
elements do lie within the 130kb region. The experiments described in this chapter 
demonstrate that the CCD is unable to drive reporter gene expression in the mesodermally- 
derived tongue and skeletal muscle, and do not act on the H19 enhancers to broaden their 
range of tissue-specificity to these tissues.
Extremely low levels of reporter gene expression were detected in the liver and 
kidney when P3-luciferase was in-cis to the CCD, confirming that it does not act as an 
enhancer in these tissues. Conversely, when the H19 enhancers were present in the 
transgenic constructs, very high levels of luciferase specific activity was detected in liver, 
and moderate levels were detected in kidney (perhaps reflecting a smaller endodermal 
component to this organ). The H19 enhancers are known to drive expression in endodermal 
tissues, so this result is expected 103, 104, 108, 109
In brain samples, significant levels of reporter gene expression were observed in 
those transgenic lines containing the CCD. Analysis of luciferase mRNA expression by 
ribonuclease protection analysis confirmed that this expression was confined mainly to the
exchange tissues, consistent with the known gene expression of Igf2 97. Luciferase mRNA 
was detected in the exchange tissues of the brains of A-construct-bearing transgenic mice 
too, suggesting that the //79-enhancers are also able to drive gene expression in these 
tissues. Leptomeningial expression from transgenes containing a placental alkaline
phosphatase reporter gene in-cis to the H19 enhancers was reported recently 109. These 
results are interesting in the context of a study of Igf2 expression in the exchange tissues of
the rat 102 Choroid plexus expression was shown to be monoallelic from el3.5 to el5.5,
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with a subsequent switch to biallelic expression from e l8.5, after which expression of Igf2 
remained biallelic. Such a switch could imply that more than one element is responsible for 
Igf2 expression in the exchange tissues of the brain.
It was of interest to discover whether the H  transgenes were expressed 
concomitantly with the development of the choroid plexus. Luciferase specific activity 
assays were performed on transgenic mice at embryonic day 14.5. At this stage the anterior 
and fourth ventricle choroid plexi have been formed, and the third ventricle choroid plexus
is beginning to delaminate from the ependymal layer of the pia mater 202, 203
Two out of three of H  transgenic lines {Holly, Hamish) expressed luciferase at 
above-basal levels in head samples at el4.5. This suggests that the CCD is active in the 
brain at developmental stages concomitant with the development of the choroid plexus. 
However, as whole head was assayed in order to allow the collection of a large number of 
samples, this is not the only conclusion that can be taken from this data. The CCD may 
well drive gene expression in other head tissues at this developmental stage. A  lines also 
exhibit above-basal levels of reporter gene expression in the head. As with the H  
transgenes, gene expression from the H19 enhancers cannot be localised to the exchange 
tissues of the brain, as these elements are likely to drive gene expression in other head 
tissues. Only in-situ expression data will be able to resolve expression patterns in the head 
driven by the CCD and the H19 enhancers.
The analysis at el4.5 tested the possibility that the CCD or the H I9 enhancers 
might be responsible for the expression of Igf2 in extraembryonic tissues. Both the 
allantoic component of the placenta, and the yolk sac 70, 87? 88 are major sites of Igf2 
gene expression at mid-gestation in the mouse. Transgenic mice carrying a construct 
composed of a H19 minigene in-cis to the H19 enhancers displayed transgene expression
in yolk-sac in some lines, but not others *05 Paternal deletion of the H19 enhancers results 
in the reduction of Igf2 expression in the yolk sac by 30% compared to wild-type levels
104# in this study the H19 enhancers in concert with P3-luciferase demonstrated above­
background levels of reporter gene expression in yolk sac at el4.5. The luciferase mean 
specific activities were at ~10 times lower levels than found in the embryonic tissues, 
suggesting that these enhancers may not account for the totality of expression in this tissue 
where the Igf2 gene is expressed abundantly 88. In-situ studies could elucidate whether the 
expression from the H19 enhancers is distributed to all, or a subset of cells within this 
tissue. The CCD made no contribution to expression of the reporter gene in the yolk sac.
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In the placenta there was no significant upregulation of luciferase gene expression 
from P3 in any transgenic line. It must be concluded that neither the HI 9 enhancers nor the 
CCD can drive reporter gene expression in this organ at el4.5. This result is unsurprising, 
since a 130kb YAC extending from promoter 1 of Igf2 to 35kb downstream of H I9 does 
not express the H19 gene, or an /g/2-linked Lac-Z reporter gene in placenta (J. Ainscough, 
pers. comm.). There is accumulating evidence that the enhancers for Igf2 (and possibly 
H19) in this tissue lie upstream of lgf2. P3-luciferase transgenes containing a 2kb region 
including DMR1 (T  lines, Figures 1 and 3) express the reporter gene above background 
levels in the placenta at el4.5 (G. Dell and M. Charalambous, unpublished). The upstream 
region is also implicated in the production of a placental-specific transcript, and placental- 
specific methylation 6, 14.
A second question within this analysis was; do the H I9 enhancers and the CCD 
interact to create new patterns of gene expression, or modulate expression levels? In 
transgenic mice at Dl, no new patterns of gene expression were revealed in Q construct 
bearing transgenic mice, as compared with A lines or H  lines, at least in the limited number 
of tissues analysed. It was impossible to compare quantitative expression levels resulting 
from construct type, due to the variability of expression between lines bearing the same 
construct (e.g., Quark vs. Quasar). This variability may be due to one or more of the 
transgenes being subject to position effects, i.e., the low-expressing Quark and Hamish 
lines could have the transgene inserted into a heterochromatic region of the genome, thus 
silencing the luciferase gene. For Quark, this explanation seems unlikely, as liver 
expression is still very high, and the transgene has been shown to be unmethylated in liver, 
brain and tongue (see next chapter). Another explanation for discrepancies between 
quantitative gene expression levels for transgenic lines with the same construct comes from
the observation that both in-vitro 204 ancj in-vivo 108} expression from the P3 promoter 
has been shown to decline shortly after birth. Transgenic lines could vary slightly in the 
timing at which they begin to downregulate expression from the P3 promoter, resulting in 
large quantitative differences in expression levels between the lines. At an earlier 
developmental stage, when such a shift in promoter activity is not expected, transgene 
expression levels might be more uniform. Indeed, luciferase specific activities at el4.5 
were found to be more uniform for lines derived from a particular transgene construct, 
within each set of tissues assayed.
I l l
Comparisons of quantitative expression levels of A lines vs. Q lines in body 
samples revealed that Q lines show an ~5-fold greater level of luciferase specific activity 
than A  lines. H  lines are not expressed above background levels in the body.
In some cases (205, 206 ancj reviewed in 207) transgene expression levels can be directly 
correlated to copy number, but only in the presence of a locus control region (LCR). When 
the LCR is deleted from these transgenes, this correlation is lost. Other groups report no 
correspondence between transgene copy number and expression levels 208 As shown in 
Appendix 7, there is no correlation between transgene copy number and levels of reporter 
gene expression in this case.
It is possible that transgene size may play a role in the level of gene expression, perhaps 
larger transgenes insulate their reporter genes more effectively from flanking genomic 
DNA, or stabilise the reporter gene in an ‘open’ chromatin conformation. The E  transgene 
(Figure 3, Chapter 1) is of approximately equal size to the Q transgene, containing a ~2kb 
DMR1 region instead of the CCD. Mice bearing transgenes express luciferase at 
comparable levels to A in the body at el4.5 (not shown), suggesting that transgene size 
alone is not a factor here. The DMR1, however, is not a ‘neutral’ region of DNA, and its 
effect here may be misleading.
Without in-situ data it is impossible to distinguish whether this synergistic effect between 
the two elements seen in Q lines is due to expression of luciferase in a broader range of 
tissues, or to increased enhancer activity within the same tissues.
Quantitative assays of luciferase reporter gene expression in transgenic mice bearing the A 
construct (H19 enhancers), the H  construct (CCD) and the Q construct (both elements), at 
two developmental stages, D1 and el4.5 have revealed:
Neither the CCD nor the H I9 enhancers can drive reporter gene expression to high levels 
in the mesodermally derived tissues skeletal muscle and tongue, or in the placenta.
The H19 enhancers in P3-luciferase transgenics act in the expected manner, by driving 
gene expression in the endodermally derived liver and kidney. These enhancers were also 
shown to drive gene expression in the yolk sac of the el4.5 embryo.
The CCD can drive reporter gene activity in brain at D l, specifically in the exchange 
tissues, and may be contributing to expression in the head at el4.5.
At el4.5 the two elements manifest a synergistic effect, with expression levels from Q 
lines exceeding expression levels from A lines by approximately 5-fold, in the embryonic
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tissues. The significance of this small effect awaits verification by the study of in-situ 
patterns of transgene expression.
113
C h a p te r 5: P a re n ta l orig in -specific  e f fe c ts  o f  P3-luciferase
TRANSGENES.
Introduction
There is increasing evidence that the H19 enhancers play a minor role in the imprinting 
mechanism of Igf2 and HI 9. Transgenes containing a H19 mini-gene with 5kb upstream 
sequence and lOkb downstream sequence, including these enhancers were found to be 
reproducibly silenced when inherited paternally, and expressed the mini-gene when
inherited maternally, at ectopic locations in the mouse genome 37. These transgenes also 
exhibited methylation patterns in the 5’ flanking region and within the gene itself, which 
were very similar to those observed at the endogenous locus. Transgenes derived from 
these, that did not contain the H19 enhancers were found not to be expressed, and 
furthermore, the parent-of-origin-specific methylation patterns of the transgene were lost. 
Two conclusions could be drawn from this work; i) expression of a gene is required for its 
correct methylation/imprinting, or ii) sequences are present in the enhancer region that 
stabilise the imprinting process. The second explanation is supported by the work of Ward
et. al. in which P3-luciferase reporter transgenes containing the H19 enhancers 
regularly displayed higher levels of luciferase activity when the transgene was inherited 
maternally, than when it was paternally inherited. Though this was a minor effect (2-3-fold
in most cases), this, and the observation that only very large 36, or very high copy number 
(38, 39^  37} 156) transgenes are imprinted, suggests that imprinting at this region could be 
a result of multiple factors, some with minor activities.
Choroid plexus and meningial expression of Igf2 is biallelic in several mammalian 
species including mouse 98 and rat 97. Elements that drive expression in these tissues must 
somehow overcome or bypass the imprinting mechanism. As a candidate for an enhancer 
element in these tissues, the CCD may have properties that allow it to moderate imprinting 
effects. No such parent-of-origin-specific differences have yet been observed in transgenic 
mice carrying the CCD, so the possibility exists that this element can induce loss of 
imprinting in transgenes.
Can either the H19 enhancers or the CCD confer parent-of-origin specific 
differences in gene expression? As discussed above, this question has been answered in
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part by a previous study in which parent-of-origin effects were observed in the livers 
of those lines bearing the A construct. In this case, a 2-3-fold increase in expression was 
observed when the transgene was inherited maternally above levels of expression from 
paternal transgene transmission. Patterns of H  construct expression appeared to be 
consistent with Igf-2 expression, i.e., when expressed in the brain the reporter gene showed 
no parental bias in gene expression.
This study extends the previous analysis into additional tissues, and examines if the 
two elements combined increase or diminish parent-of-origin specific effects.
R esu lts  
Parental origin specific effects at D1
As described in Chapter 4, tissue samples for the D1 analysis of transgene expression 
were collected from the offspring of both male and female hemizygotes. This allowed a 
test for expression differences when the transgene was transmitted through the male or 
female germline. At least 20 individuals of each transgenic line, following male or female 
transmission of the transgene, were collected to allow comparisons of mean luciferase 
specific activity by a Student’s t test. Expression levels were measured in tissues derived 
from transgenic mice bearing the A construct (P3-luciferase-H19 enhancers), Alicia, Archy 
and Ayah lines; the H  construct (P3-luciferase-CCD), the Harold, Holly and Hamish lines; 
and the Q construct (P3-luciferase-CCD-H19 enhancers), the Quasar, Quark and Quiche 
lines (all shown in Figure 3 , Chapter 1). Expression levels were examined in three 
transgenic lines representing each construct in an attempt to distinguish real effects on P3 
due to the element of interest from position effects caused by transgene integration. Any 
effects observed across a majority of lines bearing a particular element will be regarded as 
real.
Of particular interest will be any test that shows a p- value of less that 0.01, when 
there is a >2-fold difference between the means. These conditions are imposed arbitrarily, 
with the aim of distinguishing true parental origin specific effects from Type I errors. This 




ng lux/m g 
protein
Quark Quasar Quiche Archy Alicia Ayah Holly Hamish Harold
Brain M 1.69x1 O'2 0.72 3.16x10 '’ 1.52x10'2 1.21 xlO '2 2.36x1 O'3 0.29 2.39x10* 0.14
F 1 .8 1 x l0 '2 0.85 3 .1 5 x 1 0 ' 1.35x1 O'2 5.93x10* 1 .5 8 x l0 '3 0.32 1.74x1 O'2 0.15
p-value: 0.049 0.124 0.987 0.500 0.299 0.019 0.408 0.0007 0.637
TongueM 2.10x10"* 8.84x10'* 6.58x10 '2 4.72x1 O'2 1.82xlO 'z 6 .5 4 x l0 '2 6.80x1 O'3 3.20x10"1 9.86x1 O'2
F 4.58x10"* 0.12 1.60x10* 8 .4 3 x l0 '3 4.6  l x l  0 '2 1.07x10 '' 1.16x10* 3.61x10"* 9.63x1 O'2
p-value: 4.1 lx l0 ‘3 3.82x10 0.027 0.126 0.049 0.073 0.298 0.635 0.912
Muscle M 4 4 9 x T ( r 2 8 2 x 1 0 - 1.03x10 '1 7 .2 1 x l0 'z 4 .40x10 '3 8.33x1 O'2 4 .12x10* 1.10x10"* 3 .3 9 x l0 '2
F 5.44x10"* 2.49x1 O'2 1.82x1 O'2 8.15x1 O'3 5.99x10'* 5.03x1 O'2 2 .7 1 x l0 '2 1.61x10"* 1.75x1 O'2
p-value: 0.629 0.754 0.340 815xl0‘3 0.671 0.383 0.613 0.276 0.016
Liver M 2.68 10.41 14.12 n ® ... 4.74 7.52 4.00x1 O'4 5 .1 0 x 1 c 6 3.00x1 O'3
F 5.69 15.21 18.49 6.47 54.40 1.84 6.21x10"* 7 .1 4 x 1 c 6 3.44x10"*
p-value: 3.31xi0"3 0.108 0.182 3.7°xlO« 6.38x103 0.013 0.087 0.348 0.009
KidneyM 2.69x10 s 2 .8 0 x l0 '2 2.50x10 '2 8.76x10 2.26x10 '5 8.70x1 O'2 2.40x1 O'3 1.79x1 O'5 1.00x10"*
F 4.95x1 O'3 4 .9 1 x l0 '2 2 .2 6 x l0 '2 7 .67x10 '3 6.22x1 O'2 7.76x1 O'2 1.56x1 O'3 2 .53xlO '5 2.03x10"*
p-value: 0.149 0.135 0.848 7.83x10*3 0.088 0.694 0.063 0.111 0.121
Table 6. Summary of expression data of the luciferase reporter constructs across the 
transgenic lines, at D l. Levels of expression following male (M) and female (F) 
transmission of the transgene are shown as mean luciferase specific activity (ng 
luciferase/mg soluble protein. Differences in the means of each tissue in each line 
following paternal or maternal transmission are compared using a Student's r-test, with the 
null hypothesis; ‘there is no difference between the means following maternal or paternal 
transmission of the transgene’. The /7-value for each comparison is shown, and highlighted 
in light grey if a significant difference between the means is observed, i.e. if p is in the 
range 0.01 -0.05, or the difference between the means is <2-fold at a high level of 
significance p < 0.01. Darker grey boxes represent those tests where a highly significant 
difference was found (i.e. /?<0.01) between the means, with a greater than 2-fold 
difference. The tests highlighted in dark grey represent those tests that conform to the 
conditions in which the null hypothesis will be rejected.
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Figure 7. Parent of origin-specific effects at D l, the A construct.
Figure 7a, Ayah matched male and female transmission. Mean reporter gene expression 
levels (ng luciferase/mg protein) are shown for each tissue following male (M) and female 
(F) transmission of the transgene. Liver expression is shown on a separate axis due to a 
large difference in scale. Liver samples show a low, but significant difference in 
expression levels following maternal vs. paternal transmission of the transgene (p=0.13), 
paternal highest. Error bars show the standard error of the mean in each case.
Figure 7b. Archy matched male and female transmission. Mean reporter gene expression 
levels (ng luciferase/mg protein) are shown for each tissue following male (M) and female 
(F) transmission of the transgene. Liver expression is shown on a separate axis due to a 
large difference in scale. Muscle (p=8.2xl0'3), kidney (p~7.8 xlO'3) and liver (p=8.2x!0'3) 
samples all show a significant difference in expression levels following maternal vs. 
paternal transmission of the transgene, paternal highest. Error bars show the standard error 
of the mean in each case.
Figure 7c. Alicia matched male and female transmission. Mean reporter gene expression 
levels (ng luciferase/mg protein) are shown for each tissue following male (M) and female 
(F) transmission of the transgene. Liver expression is shown on a separate axis due to a 
large difference in scale. Tongue (p=0.049) and liver (p=6.38 xlO'4) samples show a 
significant difference in expression levels following maternal vs. paternal transmission of 
the transgene, maternal highest. Error bars show the standard error of the mean in each 
case.
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Figure 8. Parent of origin-specific effects at D l, the Q construct.
Figure 8a. Quark matched male and female transmission. Mean reporter gene expression 
levels (ng luciferase!mg protein) are shown for each tissue following male (M) and female 
(F) transmission of the transgene. Liver expression is shown on a separate axis due to a 
large difference in scale. Tongue (p=4.1xl0's) and liver (p=3.3x!0'4) samples show a 
significant difference in expression levels following maternal vs. paternal transmission of 
the transgene, maternal highest. Error bars show the standard error of the mean in each 
case.
Figure 8b. Quasar matched male and female transmission. Mean reporter gene expression 
levels (ng luciferase!mg protein) are shown for each tissue following male (M) and female 
(F) transmission of the transgene. Liver expression is shown on a separate axis due to a 
large difference in scale. Liver (p=3.8xl06) samples show a significant difference in 
expression levels following maternal vs. paternal transmission of the transgene, maternal 
highest. Error bars show the standard error of the mean in each case.
Figure 8c. Quiche matched male and female transmission. Mean reporter gene expression 
levels (ng luciferase!mg protein) are shown for each tissue following male (M) and female 
(F) transmission of the transgene. Liver expression is shown on a separate axis due to a 
large difference in scale. Tongue (p=0.027) samples show a significant difference in 
expression levels following maternal vs. paternal transmission of the transgene, maternal 
highest. Error bars show the standard error of the mean in each case.
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Figure 9. Parent of origin-specific effects at D l, the H construct.
Figure 9a. Hamish matched male and female transmission. Mean reporter gene expression 
levels (ng luciferase/mg protein) are shown for each tissue following male (M) and female 
(F) transmission of the transgene. Brain samples show a significant difference in 
expression levels following maternal vs. paternal transmission of the transgene, paternal 
highest, but the difference is less than two-fold (p=7.0xl0'4). Error bars show the standard 
error of the mean in each case.
Figure 9b. Harold matched male and female transmission. Mean reporter gene expression 
levels (ng luciferase!mg protein) are shown for each tissue following male (M) and female 
(F) transmission of the transgene. Muscle (p=0.016) and liver (p=9.2x!0's) samples show a 
significant difference in expression levels following maternal vs. paternal transmission of 
the transgene, paternal highest. Error bars show the standard error of the mean in each 
case.
Figure 9c. Holly matched male and female transmission. Mean reporter gene expression 
levels (ng luciferase!mg protein) are shown for each tissue following male (M) and female 
(F) transmission of the transgene. Error bars show the standard error of the mean in each 
case. There are no significant differences in expression between reporter genes inherited 
maternally compared to reporter genes inherited paternally.
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A lines (Figure 7)
Samples derived from the Ayah line show parent-of-origin effects in the liver at a low level 
of significance (p=0.013), where reporter gene expression is ~4-fold higher following 
paternal transmission of the transgene.
Samples derived from the Archy line show parent-of-origin specific effects in muscle, liver 
and kidney. All reporter gene expression is higher following paternal transmission of the 
transgene. In muscle reporter gene expression is ~9-fold higher (p=8.2xl0's), in liver
Q
reporter gene expression is ~4-fold higher (p=3.7x10' ) and in kidney reporter gene 
expression is ~11-fold higher (p=7.8 xlO'3).
Samples derived from the Alicia line show parent-of-origin specific effects in the tongue 
and the liver. In tongue reporter gene expression is ~2.5-fold higher following maternal 
transmission of the transgene, at a low level of significance {p-0.049). In liver reporter 
gene expression is ~11-fold higher following maternal transmission of the transgene 
(p=6.38 xlO4).
Q lines (Figure 8)
Samples derived from the Quark line show an increase in expression levels following 
maternal transmission of the transgene in tongue and liver. In tongue maternal reporter 
gene expression is ~2-fold higher (p=4.1xl0's) and in liver maternal reporter gene 
expression is also ~2-fold higher (p=3.3xl0'4) than paternal reporter gene expression. In 
the Quasar line the only parent-of-origin specific differences are observed in tongue where 
expression levels following maternal transmission are ~ 14-fold higher than paternal 
reporter gene expression {p-3.8xl0'6). The Quiche line also displays a parental origin- 
specific effect in the tongue, where expression levels following maternal transmission of 
the transgene are ~2-fold higher {p-0.027) than paternal gene expression levels.
H lines {Figure 9)
In all three H  lines examined, only one parent-of-origin specific difference was observed in 
which gene expression following transmission from one parent was more than 2-fold 
greater than expression following transmission from the other parent. The single parental 
origin specific effect was seen in Harold liver, where despite very low expression levels 
paternal expression of the transgene is ~ 10-fold higher than maternal expression levels 
(p=0.009).
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To summarise; the H19 enhancers in concert with P3 appear to be able to confer parent-of- 
origin specific differences in luciferase gene expression in a subset of tissues. Quark, 
Quasar, Quiche and Alicia lines all show higher levels of reporter gene expression when 
the transgene is inherited maternally. In contrast, the Archy and Ayah lines show higher 
levels of expression when the transgene is inherited paternally. This result is contradictory 
to the previous analysis where all expression differences were higher following 
maternal transmission of the transgene. The CCD is never able to create a parental bias in 
expression greater that 2-fold, and is unlikely to be an imprinting control element, unless it 
exerts an influence via other elements not tested in this study. As all three Q lines 
presented here show parent-of-origin-specific effects, the CCD does not appear to be 
overriding the imprinting signal, at least in the tissues assayed.
Parental origin specific effects at e14.5
Are the parental origin specific effects observed at D1 also present at earlier developmental 
stages? It was observed in the previous chapter that expression from the P3 promoter in 
luciferase transgenes is downregulated around the time of birth, to a variable degree 
between transgenic lines, making comparisons between lines problematic. This variable 
downregulation of P3 may complicate the analysis of parental origin specific effects.
Samples for the spatial analysis of transgene expression at el4.5 were collected 
from the offspring of both male and female hemizygotes. As with the D1 study, at least 20 
individuals were collected to represent each parental cross, for each transgenic line, to 
allow comparison of mean luciferase expression in each tissue by a Student’s Mest. The 
lines analysed were A lines (Axe, Alicia and Ayah), Q lines (Quark, Quasar and Quiche), 
and H  lines (Harold, Hamish and Holly). At least 2 lines bearing each construct have also 
been analysed at D1 (see above).
As before, of interest are those lines that show at least a 2-fold difference between 
the means when the transgene is maternally vs. paternally inherited, at a significance of 
p<0.01. Mean luciferase specific activity following each parental transmission, and the p- 
value obtained from a Student’s f-test are tabulated for each line in Table 7, and 






Quark Quasar Quiche Axe Alicia Ayah Holly Hamish Harold
Head M 1.470 5.17x10'' 2.47x10'' 5.58x10'' 1.23x10* 2.04x10'' 1.36x10' 1.73x1 O'2 1.163
F 2.576 1.180 2.61x10'' 2.86x10'' 5.46x10' 2.15x10'' 1.84x10'' 4.01x1 O'2 2.176
p-value. 0.065 3.32x104 0.651 0.027 0.054 0.889 0.074 9.37x10* 0.013
Body M 1.842 2.425 1.92x10'' 6.39x10'' 1.07x1 O'2 3.77x10'' 5.90x10* 2.36x1 O'3 1.44x1 O'2
F 6.304 5.258 2.09x10' 3.61x10' 6.59x10'' 9.67x10'' 4.32x10'2 2.22x1 O'3 4.43x1 O'2
p-value: 0.557 0.006 7.13x10* 6.82x10'4 0.074 0.432 5.01XW4
Placenta M 7.14x10* 4.72x10'* 9.60x10'3 1.13xlO'3 5.44x10'3 1.06x10'1 9.72x10U 1.94x1 O'3 3.95x10"*
F 9.40x10'3 5.56x10'3 1.09x1 O'2 1.34x10'3 2.09x10'2 1.25x1 O'2 3.96x10"* 1.66x10* 1.74x1 O'3
p-value: 0.374 0.654 0.559 0.569 0.054 0.742 0.001 0.042 0.033
Yolk sac M 5.09x1 O'2 1.01x10'' 8.97x1 O'2 1.51xlO'2 8.08x10'2 3.59x10'2 6.83xl0'3 2.99x1 O'3 5.89x10"*
F 1.40x10'* 9.93x1 O'2 1.09x10' 3.38xl0'2 1.69x10'' 1.75x10'' 4.66x103 2.07x1 O'3 1.57x10"*
p-value: 0.034 0.980 0.275 0.013 0.395 7.31 x 
--- --------
0.237 0.015 3.60x1 O'3
Table 7. Summary of expression data of the luciferase reporter constructs across the 
transgenic lines, at el4.5. Levels of expression following male (M) and female (F) 
transmission of the transgene are shown as mean luciferase specific activity (ng 
luciferase!mg soluble protein). Differences in the means of each tissue in each line 
following paternal or maternal transmission are compared using a Student's f-test, with the 
null hypothesis; ‘there is no difference between the means following maternal or paternal 
transmission of the transgene’. The p-value for each comparison is shown, and highlighted 
in light grey if a significant difference between the means is observed, p is in the range 
0.01-0.05, or the difference between the means is less than 2-fold at a high level of 
significance (i.e., p<0.01). Darker grey boxes represent those tests where a highly 
significant difference (i.e. p is less than 0.01) was found between the means that was 
greater than 2-fold. The tests highlighted in dark grey represent those tests that conform to 
the conditions in which the null hypothesis will be rejected.
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Figure 10. Parental origin-specific effects at el4.5, A construct
Figure 10a. Alicia matched male and female transmission. Mean reporter gene expression 
levels (ng luciferase/mg protein) are shown for each tissue following male (M) and female 
(F) transmission of the transgene. Body samples show a significant difference in 
expression levels following maternal vs. paternal transmission of the transgene, maternal 
highest (p=7.13xl0'4). Error bars show the standard error of the mean in each case.
Figure 10b. Axe matched male and female transmission. Mean reporter gene expression 
levels (ng luciferase/mg protein) are shown for each tissue following male (M) and female 
(F) transmission of the transgene. Head (p=0.027), body (p=0.006) and yolk sac (p=0.013) 
samples show a significant difference in expression levels following maternal vs. paternal 
transmission of the transgene, paternal highest, but with a less than two-fold difference 
between the means in head and body samples. Error bars show the standard error of the 
means.
Figure 10c. Ayah matched male and female transmission. Mean reporter gene expression 
levels (ng luciferase!mg protein) are shown for each tissue following male (M) and female 
(F) transmission of the transgene. Body (p=6.82xl0'4) and yolk sac (p=7.32xl0'3) samples 
show a significant difference in expression levels following maternal vs. paternal 
transmission of the transgene, maternal highest. Error bars show the standard error of the 
mean in each case.
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Figure 11. Parental origin-specific effects at el4.5, the Q construct.
Figure 11a. Quark matched male and female transmission. Mean reporter gene expression 
levels (ng luciferase!mg protein) are shown for each tissue following male (M) and female 
(F) transmission of the transgene. Body (p=9.1 4 x 1 0 and yolk sac (p=0.034) samples 
show a significant difference in expression levels following maternal vs. paternal 
transmission of the transgene, maternal highest. Error bars show the standard error of the 
mean in each case.
Figure lib . Quasar matched male and female transmission. Mean reporter gene 
expression levels (ng luciferase/mg protein) are shown for each tissue following male (M) 
and female (F) transmission of the transgene. Head {p-3.32x10’4) and body (p=5.79x10'5) 
samples show a significant difference in expression levels following maternal vs. paternal 
transmission of the transgene, maternal highest. Error bars show the standard error of the 
mean in each case.
Figure 11c. Quiche matched male and female transmission. Mean reporter gene expression 
levels (ng luciferase!mg protein) are shown for each tissue following male (M) and female 
(F) transmission of the transgene. There are no significant differences in expression 
between reporter genes inherited maternally compared to reporter genes inherited 
paternally. Error bars show the standard error of the mean in each case.
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Figure 12. Parental origin-specific effects at el4.5, the H  construct.
Figure 12a. Holly matched male and female transmission. Mean reporter gene expression 
levels (ng luciferase/mg protein) are shown for each tissue following male (M) and female 
(F) transmission of the transgene. Placenta samples show a significant difference in 
expression levels following maternal vs. paternal transmission of the transgene (p=0.01), 
maternal highest, but expression levels are generally very low. Error bars show the 
standard error of the mean in each case.
Figure 12b. Hamish matched male and female transmission. Mean reporter gene 
expression levels (ng luciferase/mg protein) are shown for each tissue following male (M) 
and female (F) transmission of the transgene. Head samples show a significant difference 
in expression levels following maternal vs. paternal transmission of the transgene 
(p=9.37x10'4), maternal highest, but expression levels are generally very low. Error bars 
show the standard error of the mean in each case.
Figure 12c. Harold matched male and female transmission. Mean reporter gene expression 
levels (ng luciferase/mg protein) are shown for each tissue following male (M) and female 
(F) transmission of the transgene. Samples from head (p=0.013), body (p=5.01x!0~4) and 
yolk sac (p=3.60xl0's) show significant differences in expression levels following 
maternal vs. paternal transmission of the transgene, but expression levels are extremely 
low in the latter two tissues. Error bars show the standard error of the mean in each case.
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A lines {Figure 10)
In Alicia lines, a significant difference between means is seen in the body, where the mean 
luciferase specific activity following maternal transmission of the transgene is 60-fold 
higher than the mean specific activity following paternal transmission of the transgene 
(p = 7 .1 3 x l0 \
In Axe lines, a significant difference between the means following maternal or paternal 
transmission of the transgene is seen in head, body and yolk sac; in all cases the mean 
luciferase specific activity is higher following paternal transmission of the transgene. In 
head (p=0.037) and body (p=0.006), the difference between the parental means is less than 
2-fold. In yolk sac, the ~2-fold difference between the means is at a low level of 
significance (p=0.013).
Samples from Ayah lines show increased luciferase specific activity following maternal 
transmission of the transgene in body and yolk sac. In the body, the level of maternally 
derived reporter gene expression is ~3 times that of paternally derived transgene 
expression (p=6.82xl0“*), in yolk sac the difference is 5-fold (p=7.32x10 s).
Q lines {Figure 11)
In Quark, significant differences are observed between mean maternal- and paternal-allelic 
expression of the transgene in the body {p=9.14xl0~4) and yolk sac {p=0.034, only just 
significant). In both cases the mean luciferase specific activity was 3-fold higher following 
maternal transmission of the transgene.
Samples from Quasar lines show a significant difference between the means in head 
(p=3.32x10“*), and body {p=5.79xl0~5). In both cases the mean luciferase specific activity 
was 2-fold higher following maternal transmission of the transgene.
No significant differences in mean reporter gene expression levels between parental 
samples were found in Quiche lines.
H lines {Figure 12)
Parental origin specific effects were seen in many samples from H  lines where transgene 
expression was at basal levels, i.e., in Harold body {p=5.01xl0'4) and yolk sac {p=3.60xl0~ 
3), Hamish yolk sac {p=0.015) and in the placentae of all three lines (at a low level of 
significance). In these cases differences between the means actually represent very small 
differences in gene expression, and the difference between the means was frequently less 
than 2-fold. Significant differences between parental means were observed in Hamish head
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(p=9.37xl0'4) where the mean luciferase specific activity was ~2-fold higher following 
maternal transmission of the transgene; and Harold head (at a low level of significance, 
p -0.013), where the mean luciferase specific activity was less than 2-fold higher following 
maternal transmission of the transgene.
At e l4.5 parental origin-specific effects are seen in the majority of transgenic lines 
containing both the H19 enhancers and the CCD. These effects in H  lines are weak in the 
majority of cases, being present in samples where expression levels are very low (see 
Chapter 4), or at a low level of significance. The most robust parental origin specific 
effects (i.e. those where there is a greater than 2-fold difference between the means, at a 
level of significance p<0.01) are seen in Alicia, Ayah, Quark and Quasar lines, all of 
which demonstrate higher mean reporter gene activity following maternal transmission of 
the transgene.
Parental origin specific effects are most frequently observed in body (Quark, 
Quasar, Axe, Alicia, Ayah and Harold) and in yolk sac {Quark, Axe, Ayah, Hamish and 
Harold).
Table 8 summarises parental origin specific effects observed at D1 and el4.5. The rows 
highlighted show where D1 and el4.5 data agrees, i.e., where there is a bias in gene 
expression following differential parental transmission of the transgene, which is 
consistent in direction at both stages. Alicia, Quark and Quasar show consistent parental 
origin specific expression at the developmental stages assayed. All three lines demonstrate 
higher reporter gene expression levels when the transgene is maternally transmitted. H  
lines never show consistent parental origin specific effects, and in many cases there is 
either very little difference between parental means, or the differences between the means 
are only significant at the 5% level.
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1 line Parental origin specific effects observed in:
D1 el4.5
tissue bias tissue bias
Archy liver paternal nd
muscle
kidney
Alicia (tongue) maternal body maternal
liver
Ayah (brain) paternal body maternal
(liver) yolk sac
Axe nd (head) paternal
(body)
(yolk sac)
Quark (brain) maternal body maternal
tongue .
liver . yolk sac
Quasar tongue maternal head maternal
body
Quiche (tongue) maternal no differences
Holly no differences (placenta) maternal
Hamish (brain) paternal head maternal
(placenta) paternal
(yolk sac)




Table 8. Summary of parental origin specific effects at D1 and e l4.5.
Parental effects are categorised for each line according to the tissues in which they occur, 
and the parental bias, i.e., ‘maternal’ bias denotes a higher mean luciferase specific activity 
following maternal transmission of the transgene vs. the mean specific activity following 
paternal transmission of the transgene, ‘nd’ indicates analyses not done. Rows highlighted 
indicate those lines where a parental bias is present, and consistent at both developmental 
stages. Brackets indicate a low level of significance from the Student’s t-test, i.e. 
0.01<p<0.05, or where there is a less than 2-fold difference between the means.
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Are parental origin-specific effects a consequence of transgene 
methylation?
The luciferase specific activity assays detailed above have shown a difference in levels of 
transgene expression dependent upon their parent of origin. Can these differences in gene 
expression be explained by differences in patterns of transgene DNA methylation? CpG 
methylation has been associated with both differences in expression of alleles at imprinted 
loci (as discussed in the Introduction), and in silencing of multi-copy transgenes inserted 
into the mouse genome (38, 39} 37^  156)
To examine differences in methylation patterns associated with differences in 
reporter gene expression levels; genomic DNA samples were isolated from those 
individuals that show the highest or lowest levels of reporter gene activity. Samples were 
chosen from the livers and brains of A lines, and the livers, tongues and brains of Q lines.
In liver, all three A lines, and one Q line displayed parental-allele-specific differences in 
gene expression. In tongue, all three Q lines showed parent-of-origin-specific effects. In 
brain, no such effects were seen in any line, and these samples serve as a control. DNA 
derived from all samples was digested with enzymes which, in combination with a specific 
probe, provided a diagnostic restriction pattern (see Figure 14) and either Hpall or Mspl. 
Both of these enzymes cut at the same sites (CCGG), Hpall is methyl-sensitive whereas 
Mspl is methyl-insensitive. Hpall/MspI is predicted to cut the transgene once within the P3 
promoter, ten times within the coding region of the luciferase gene, and once within the 
H19 enhancers (Figures 13 and 14). Southern blots of digested genomic DNA were probed 
with a P3-luciferase specific probe, and in some cases a HI 9 enhancer specific probe, 
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Figure 13a. 25kb genomic region including the Ig/2 gene and upstream sequences. 
Features include: repeat region; differentially methylated regions (DMRs) 0, 1 and 2; 
u 1, u2 are upstream exons 1 and 2. E1-E6 are exons 1-6. Restriction sites relevent to 
methylation analysis are as follows: S, Spel\ E, EcoRV\ K, Kpnl\ X, Xmal. The P3 
probe used for methylation analysis corresponds to 300bp immediately 5' to exon 3. 
Complete digestion with Xmal/Kpnl will yield a 3.2kb fragment. Complete digestion 
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Figure 13b. 28kb genomic region encompassing the HI9 gene and the H19 enhancers. 
Restriction sites relevent to methylation analysis are marked. S, Spel\ E, EcoRV.
The H I9 enhancer probe used in this analysis is indicated by an arrow below the 
line. Complete digestion with Spel/EcoR V will yield a 12.5kb fragment that hybridises 
to the H19E probe.
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Figure 14a. The Q construct, comprised of the luciferase reporter gene with SV40 
poly-A sequences driven from the Igf2 P3 promoter, fused in cis to the CCD region 
and the H19 enhancers. The crossed line shows Hpall/MspI sites within the transgene. 
Restriction sites relevent to methylation analysis are marked; X, Xmal; K, KpnL 
The P3-luciferase probe used in this analysis is indicated as an arrow below the 
construct. Complete digestion with Xmal/Kpnl should yield a 2.3kb fragment that 
will hybridise to the P3-luciferase probe.
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Figure 14b. The A construct, comprised of the luciferase reporter gene with SV40 
poly-A sequences driven from the Igf2 P3 promoter, fused in cis to the H I9 enhancers. 
The crossed line shows Hpall/MspI sites within the transgene. Restriction sites 
relevent to methylation analysis are marked;S, Spel\ E, EcoRV. The P3-luciferase 
probe and the H19 enhancer probe used in this analysis are indicated as arrows 
below the construct. Complete digestion with Spel/EcoRVshould yield a 1.8kb 
fragment that will hybridise to the P3-luciferase probe, and a 3.8kb fragment that 
will hybridise to the H19E probe.
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Figure 15. Methylation analysis on maternally and paternally derived Ayah brains and 
livers. The origin of the samples is detailed in the table below (Table 9). Samples were 
digested with Spel/EcoRV (E/S), Spel/EcoRV/Hpall (E/S/H) or Spel/EcoRV/MspI 
(E/S/M). Digested DNA was subjected to Southern blotting, and hybridised to probes P3- 
luciferase (15a) and H19E (15b). The expected fragment sizes from these digests are 
represented in Figures 13 and 14b.
The transgene appears to be highly methylated in both tissues, when inherited from 
either parent. This methylation is present both at sites within the promoter/gene region, and 
at the single restriction site within the enhancer region. This methylation is not complete, 
as two bands at ~1.4kb and -  lkb are present in E/S/H lanes, but not in E/S lanes of Figure 
15a. These band appear irrespective of tissue-type or parental origin; compare brain vs. 
liver (52B vs. 50L) and maternal transmission vs. paternal transmission (42L vs. 50L).
Sample Parental origin of 
the transgene
Tissue Specific activity
(ng luciferase/ mg 
protein)
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Figure 16. Methylation analysis on maternally- and paternally-derived Archy brains and 
livers. The origin of the samples is detailed in the table below (Table 10). Samples were 
digested with Spel/EcoRV (E/S), Spel/EcoRV/Hpall (.E/S/H) or Spel/EcoRV/MspI 
(E/S/M). Digested DNA was subjected to Southern blotting, and hybridised to the P3- 
luciferase probe. The expected fragment sizes from these digests are represented in 
Figures 13 and 14b.
The transgene appears to be under-methylated in both tissues, when inherited from 
either parent. Faint bands are visible at ~4kb (representing a partial transgene digest) and 
1.8kb (representing a complete transgene digest) in E/S/H digests of samples L36 and L37, 
which may represent protection of the transgene by methylation in a portion of the sample. 
The appearance of this band does not seem to be a product of differences in loading 
(compare samples L24, B37 and L36). Samples L36 and L37 are both from livers where 
the transgene was maternally inherited.
Sample Parental origin of 
the transgene
Tissue Specific activity
(ng luciferase/ mg 
protein)
22L paternal liver 45.07 1
24L 42.14
36L maternal 2.15 1
37L 1.05
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Figure 16. Pi-luciferase probe.





















Figure 17. Methylation analysis on maternally and paternally derived Alicia brains and 
livers. The origin of the samples is detailed in the table below (Table 11). Samples were 
digested with Spel/EcoRV (E/S), Spel/EcoRV/Hpall (E/S/H) or Spel/EcoRV/MspI 
(E/S/M). Digested DNA was subjected to Southern blotting, and hybridised to probes P3- 
luciferase (17a) and H19E (17b). The expected fragment sizes from these digests are 
represented in Figures 13 and 14b.
The transgene appears to be highly methylated in both tissues, when inherited from 
either parent. This methylation is present both at sites within the promoter/gene region, and 
at the single restriction site within the enhancer region. As with Ayah (see Figure 15a), 
this methylation is not complete, as two bands at ~1.4kb and -  lkb are present in E/S/H 
lanes, but not in E/S lanes of Figure 17a. These bands appear irrespective of parental 
origin and tissue. No differences are observed at the H I9 enhancers (see Figure 17b), 
where the transgene is highly methylated in all samples.
II Sample Tissue Parental origin of the 
transgene
Specific activity
(ng luciferase/mg protein) 1
8 1 2 brain paternal 7.15xl0_:i
B13 9.92 xlO'3
B56 maternal 9.97 x lO3
B57 9.51 xlO'3
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Figure 18. Methylation analysis on maternally- and paternally-derived Quark brains, 
tongues and livers. The origin of the samples is detailed in the table below (Table 12). 
Samples were digested with Xmal/Kpnl {X/K), Xmal/KpnI/MspI (X/K/M) or 
Xmal/KpnI/Hpall (.XJKJH). Digested DNA was subjected to Southern blotting, and 
hybridised to the P3-luciferase probe. The expected fragment sizes from these digests are 
represented in Figures 13 and 14a. NTG refers to a DNA sample derived from a non- 
transgenic littermate.
The transgene appears to be under-methylated in all tissues, when inherited from 
either parent, though unequivalent loading of brain samples complicates the analysis. The 
samples appear to be completely digested by Hpall in most cases, though in 3L, the 2.3kb 
transgene band is protected. This must be treated with caution, as no such band appears in 
the adjacent 5L samples, where the DNA loading is of equivalent quantity.
Sample Parental origin of 
the transgene
Tissue Specific activity
(ng luciferase! mg 
protein)
3B paternal brain 2.70xl0'i
39B maternal 1.73xl0‘z
40B 3.00xl0';i
3L paternal liver 1.73





2T paternal tongue 1.67X10-4
3T 1.52xl0'4
4T 1.22xl0'4
39T maternal 9.04x1 O'4
40T 8.06x1 O'4
41T 6.96x1 O'4
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Figure 19. Methylation analysis on maternally and paternally derived Quasar brains, 
tongues and livers. The origin of the samples is detailed in the table below (Table 13). 
Samples were digested with Xmal/Kpnl (X/K), Xmal/Kpnl/MspI (X/K/M) or 
Xmal/KpnI/Hpall (X/K/H). Digested DNA was subjected to Southern blotting, and 
hybridised to the V3-luciferase probe. The expected fragment sizes from these digests are 
represented in Figures 13 and 14a. NTG refers to DNA samples derived from non- 
transgenic littermates.
The transgene appears to be under-methylated in all tissues, when inherited from 
either parent.
Sample Parental origin of 
the transgene
Tissue Specific activity
(ng luciferasel mg 
protein)
13B maternal brain 0.75
23B paternal 0.68






53T paternal tongue 2.34xl0'3
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Summary of methylation analysis 
A lines
In Ayah lines {Figure 15), DNA from brain and liver exhibits almost complete methylation 
of the transgene, both at P3-luciferase and at a single site at the H19 enhancers. Partial 
methylation of the transgene is exhibited by fragments of 1.4kb and Ikb that hybridise to 
the P3-luciferase probe. The Hpall sites giving rise to these fragments must be within the 
coding region of the luciferase gene, as opposed to the promoter, as the promoter region is 
only ~0.3kb long, giving a minimum fragment size of 1.5kb (see Figure 14b). Despite 
differences in DNA loading the methylation patterns of the transgene appear to be identical 
in brain and liver, following male and female transmission of the transgene.
In Archy lines {Figure 16) the A transgene appears to be undermethylated in both 
brain and liver. Faint bands corresponding to the full length 1.8kb transgene are present in 
liver samples derived from maternal transmission of the transgene, which are known to 
display luciferase specific activities 20-40-fold lower than their paternally derived 
counterparts {Table 10). The differences between mean luciferase specific activity 
following male vs. female transmission of the transgene in Archy liver is highly significant 
(p=3.70x10'8). These partial digests are absent from other brain and liver samples, and 
represent a minority of the total transgene DNA.
In Alicia lines {Figure 17), the transgene exhibits almost complete methylation, 
both at P3-luciferase and at the H19 enhancers. Partial methylation of the transgene is 
identical to that exhibited by the A transgene in Archy lines.
Q lines
Quark samples from liver, brain and tongue generally exhibited a pattern of methylation 
where the transgene was entirely unmethylated {Figure 18). Unequivalent loading prevents 
detailed examination of brain samples, but they appear to be largely unmethylated. An 
exception lies in a single liver sample, where a full-sized transgene fragment is present in 
//pa/Z-digested DNA, representing protection of transgene digestion by methylation. This 
band is unique amongst the liver samples, so hypermethylation is not taken to be a general 
feature of the transgene in Quark liver.
The transgene methylation patterns observed in Quasar livers, brains and tongues 
are identical to those of Quark, i.e., the transgene was found to be fully unmethylated in all 
tissues, regardless of the parental origin of the transgene {Figure 19).
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To summarise, samples with luciferase specific activities ranging from -lx lO '4 to -lxlO 2 
were assayed for levels of transgene methylation, and no correlation was found between 
reporter gene activity and transgene methylation. The methylation status seemed to be 
reliant upon the particular line examined (i.e., in the Quasar line the transgene is 
unmethylated, in the Alicia line the transgene is almost fully methylated), and all samples 
within, regardless of tissue or parental origin of the transgene, displayed the same 
methylation pattern.
C o n c lu s io n s
Can either the H19 enhancers or the CCD confer parental origin-specific differences in
expression on the reporter gene? As seen in a previous study 108, the H I9 enhancers 
reproducibly confer parental-origin-specific differences in luciferase expression from P3. 
In the experiments described above, at D1 all transgenic lines studied containing this 
element demonstrated significantly higher luciferase specific activities when the transgene 
was inherited either maternally {Quark, Quasar, Quiche, Alicia), or paternally {Archy, 
Ayah). In one case, the ratio of parental transmission was as high as 14:1 {Quasar tongue). 
These imprinting-like effects were most commonly observed in liver and tongue, and 
interestingly, were never observed to a high level of significance in brain, where Igf2 is
known to be expressed biallelically 70. The maternal allele of Igf2 must bypass the 
imprinting mechanism in the choroid plexus and leptomeninges of the brain, either by 
escaping inactivation during early development, or by being reactivated at a later 
developmental stage. Support for the second of these mechanisms comes from a study of
Igf2 expression in the rat choroid plexus *02, where monoallelic expression from the 
paternal allele is seen on days 13.5 and 15.5 of gestation, and a subsequent switch to 
biallelic expression is observed by e l8.5. Thereafter approximately equivalent expression 
from both alleles is observed until at least 3 months of age. The absence of parental allele- 
specific effects in brains in this study may be due to an absence in these tissues of a trans- 
‘imprinting factor’ required to silence the maternal allele. The presence of parental origin- 
specific effects in 0-lines demonstrates that the CCD is not able to override the effect of 
the H19 enhancers.
At el4.5, parental origin-specific effects were again observed in the majority of 
lines, but the effects were most robust in those lines that contained the H19 enhancers 
{Alicia, Ayah, Quark and Quasar). In all cases these lines demonstrated greater reporter
150
gene activity following maternal transmission of the transgene. Consistent parental origin- 
specific effects were never observed in H  lines, and in many cases there was either very 
little difference between parental means, or the differences between the means only were 
significant at the 5% level.
The investigation of the tissue-specificity of these effects was limited, as the dissections 
were very crude. Despite this, some tissue specificity was apparent as if parental origin 
specific effects were observed; they were always manifested in the bodies of transgenic 
embryos, and often observed in the yolk sac {Ayah, Quark and Quasar). None of the 
transgenic lines tested expressed luciferase above background levels in the placenta, so no 
genuine parental origin specific effects could be observed in these samples.
A comparison of the data from the D1 study and the el4.5 study reveals that Alicia, Quark 
and Quasar lines consistently demonstrated a higher level of luciferase specific activity 
following maternal transmission of the transgene. The magnitude of the expression level 
following maternal vs. paternal transmission ranged from ~2-fold {Quasar) to 60-fold 
{Alicia, el4.5). A maternal bias conferred on luciferase gene activity by the H I9 enhancers
was also reported in a previous analysis of some of the transgenic lines discussed here 108 
It cannot be concluded, however, that the only ‘real’ parental origin-specific effects were 
those where expression levels were highest following maternal transmission of the 
transgene, as one of the most significant effects was observed in Archy liver (p=3.70xl0'8), 
where expression levels were ~4-fold higher following paternal transmission of the 
transgene. In this case, the comparison at el4.5 was not performed.
It is difficult to compare these results to other studies in transgene imprinting, as in most 
cases the levels of expression from individuals bearing transgenes following maternal or
paternal inheritance are not quantitated 38, 39} 37 jn addition the variation in expression 
levels between individuals of a particular parental cross are not reported. In this study, 
large differences in gene expression were often observed between individuals that had 
inherited the transgene from one-or-other parent (e.g. see Table 13), which were 
reminiscent of the ‘high/low’ levels of expression observed at endogenous imprinted loci. 
However, the differences in reporter gene specific activity were often observed against the 
background of individuals expressing the reporter gene at intermediate levels. In one study 
109 transgenic mice were created with constructs bearing LacZ or placental alkaline- 
phosphatase (PLAP) reporter genes in-cis to the HI 9 enhancers and a portion of the H19 
upstream region. When the transgene construct contained at least 3.8kb of the H I9 5’
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region, the transgenic embryos demonstrated repression of the reporter gene upon paternal 
transmission, and activation upon maternal transmission. The degree of repression upon 
paternal inheritance was variable between littermates, and in a minority of cases the 
embryos escaped inactivation altogether. At the level of the tissue, partial imprinting 
effects can be observed, with genomic elements biasing the contribution of gene 
expression from one-or-other of the parental alleles. It would be interesting to discover 
whether expression differences between parental alleles in a given tissue are due to 
changes in quantitative expression levels in each cell, or a change in the number of cells 
expressing the gene.
Expression from the maternal allele of the Igf2 gene has been reported to occur in 8.3% of
hepatocytes at e l3.5 111, and maternal Igfi mRNA is estimated at 2-4% of paternal levels
in MatDi7 and parthenogenetic embryos 8. Similarly, paternal HJ9 transcripts have been
estimated to represent up to 5% of late-embryonic and neonatal H19 mRNA 86, 27? ancj
expression from this allele was reported in 13.4% of hepatocytes at e l3.5 111. Ratios of 
mean reporter gene expression following differential parental inheritance of 14:1 (Quark 
tongue at Dl) and 60:1 {Alicia body at e l4.5) compares favourably with the reports of 
expression from the ‘silent’ allele of imprinted genes at a level of ~5-10%. An assumption 
of this comparison is that luciferase specific activity can be taken as a direct indicator of 
gene expression, (i.e., that the amount of luciferase protein measured in the above assays is 
directly proportional to the level of luciferase mRNA), which may not be the case. The 
majority of parental origin-specific effects reported here show a 2-3-fold difference in 
mean luciferase specific activity following differential parental transmission of the
transgene, in line with a previous study of these transgenes Taken together, these 
results lead to the conclusion that the H19 enhancers are playing a minor role in biasing 
gene expression levels in a parent of origin-specific manner.
The link between cytosine methylation and imprinting is well documented, and discussed 
at length in the Introduction. Studies of transgenes constructed from parts of the H I9
locus 38? 39? 37 have reported hypermethylation of the silenced transgene both at the 
promoter and within the structural gene (which are differentially methylated at their
endogenous location). A H  19 gene deletion was constructed 160, jn which almost the 
entire transcription unit was replaced with the luciferase gene. When this modified H I9 
locus is maternally inherited luciferase is expressed to high levels in liver and skeletal 
muscle. There is an appropriate lack of methylation at the H19 promoter, and of the
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upstream region on the maternal allele. When paternally inherited the luciferase gene 
shows a large variability in expression levels, from 5-55% the level of maternal luciferase 
expression. The level of luciferase expression from the paternal allele is inversely 
correlated to the degree of methylation of the promoter and the gene. An individual 
expressing the paternal allele at 9% of the maternal expression level displayed low levels 
of gene methylation. In an individual expressing the paternal allele at 24% of maternal 
levels, the fractions of methylated to unmethylated DNA were approximately equal. This 
study shows that the luciferase gene can be silenced by methylation, at least when driven 
from the H I9 promoter, and that detectable differences in gene methylation can be 
correlated to expression levels.
With this in mind, it seemed reasonable to ask whether the parental-origin specific 
differences in gene expression observed in H19 enhancer-bearing P3-luciferase constructs 
could be correlated to differences in transgene methylation following maternal or paternal 
transmission. It was found that differences in the methylation status of the transgene 
following differential parental transmission generally do not appear to exist, even where 
luciferase gene expression levels between individuals vary by ~2000-fold (Alicia liver, 
samples L36 vs. L63, Figure 17). One exception to this is in Archy liver, where samples 
are generally undermethylated; in samples deriving the transgene maternally, a faint band 
is present in the //pa//-digested lane {Figure 16), corresponding to a small proportion of 
completely methylated transgenes. It is worth noting that Archy livers displayed the most 
significant difference between mean reporter gene activities following maternal vs. 
paternal transmission of the transgene. Despite this, gross changes in DNA methylation at 
the transgene do not reproducibly correspond to differences in reporter gene expression 
level. It is possible that these experiments lack the sensitivity required to detect the 
changes in methylation status responsible for the gene expression differences. As all the 
lines examined above may contain the transgenes in multi-copy arrays (see Appendix 1), 
the analysis is complicated further, as e.g. demethylation of a single site within the 
promoter of a highly methylated transgene array may be swamped by the hypermethylated 
signal. In addition, only a single potentially methylated restriction site was examined in the 
H19 enhancer region of the transgene. If transgene methylation is involved in the 
differential silencing of this locus, the pattern of methylation does not resemble that of the
luciferase gene ‘knock-in’ study cited above 160, where expression levels correlated to 
large changes in CpG methylation over several sites, including sites within the luciferase
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reporter gene sequences. Instead, silencing of -luciferase reporter constructs would have 
to be reliant on the methylation status of very few crucial CpG residues.
A surprising result of the methylation analysis was that samples in which the luciferase 
specific activity measurements were very high could still be very highly methylated. Some 
studies of methylation at transgenic loci 209} 210 211 report a strong correlation between 
transgene expression levels and methylation. An RSVmyc transgene was found to be 
expressed, when paternally inherited, in the myocardium of the heart 209, ancj silent when 
maternally inherited. The active expression state corresponded to a hypomethylated (but 
not unmethylated) transgene, and the silent state to a hypermethylated transgene, at several
different genomic insertion sites 211. Conversely, a group studying expression of a CAT 
reporter gene from the promoter of the HMGCR (3-hydroxy-3-methylglutarylCoA- 
reductase) gene found no correlation between CAT gene expression and methylation of the
transgene 208 At its endogenous locus, the Igf2 gene has been found to be highly
methylated both in the upstream region 128 an£j jn the body of the gene 8, 7 0n the 
expressed paternal allele.
Genetic background effects have been shown to play a strong role in the expression and 
methylation status of transgenes 210? 211 a  HSVtk-promoter-LacZ fusion gene was used
to create a transgenic founder on a complex genetic background 210. when this founder 
was backcrossed onto a parental strain, the FI generation displayed a characteristic 
bimodal pattern of gene expression, in which the foetuses expressed p-galactosidase at 
high, or low levels, in equal proportions. The F2 generation displayed four expression level 
phenotypes, from ‘very low’ to ‘very high’. LacZexpression varied in every cell more or 
less equally, and with little cell to cell variation in the intensity of fi-galactosidase staining, 
so the differences in individual expression profiles were not due to position-effect- 
variegation. The same transgene was bred onto a variety of pure-breeding genetic 
backgrounds, many of which affected the expression of the transgene following a 
Mendelian pattern of inheritance. The investigators concluded that unlinked modifier genes 
were present in some mouse strains which could effect the expression (and methylation 
status) of the transgene. The RSVmyc transgene mentioned above also is sensitive to 
genetic background effects 211. RSVmyc transgenes are expressed following paternal 
transmission in the heart, and silent following maternal transmission, (as discussed above)
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in the original complex founder strain, and on an inbred FVB/N background. However, on 
a C57BL/6J background, the transgene is always silent.
The transgenic parents used to generate offspring whose tissues were analysed in this 
study were the result of at least 3 generations of intercrosses of (C57Bl/6xCBA) FI mice, 
and so reflect a complex genetic background. Though male and female sibs were chosen to 
normalise for parental age and generation differences, the parents nor the offspring would 
be predicted to be genetically identical. The gene expression differences apparently due to 
parental origin of the transgene could therefore be due to the action of modifier genes 
present in some parents, but not others, and could therefore be independent of parental sex. 
This argument is weakened by the fact that more than one parent of a particular sex was 
used to generate offspring, at two different developmental stages. However, the action of 
modifiers can only be ruled out by examination of progeny that are genetically 
homogeneous, differing only in the parental origin of the transgene.
A tissue-specific, parental allele-specific effect has been demonstrated with P3-luciferase 
transgenic lines that contain the H19 enhancers. Alicia, Quark and Quasar lines all 
demonstrate higher levels of reporter gene expression following maternal expression of the 
transgene, at both D1 and at el4.5. Addition of the CCD into reporter constructs does not 
prevent these parental origin specific effects, unless it does so in combination with other 
elements not examined by this study, or in further tissues that were not studied. These 
parental-origin-specific differences in gene expression are not correlated to gross changes 
in the level of transgene methylation.
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C h a p te r  6, Is th e  CCD a b le  t o  d ir e c t  r e p o r t e r  g e n e  e x p r e ss io n  in
AN IN-VITRO SYSTEM? PART 1, IMMORTAL CELL LINES.
In troduction
In parallel to the study of expression of P3-luciferase reporter constructs in vivo (see 
Chapter 4), expression of the reporter constructs {Figure 3, Chapter 1) in tissue specific 
cell lines was examined by transient transfection experiments.
Transient transfection systems provide a sensitive method by which to examine and 
delineate potential tissue-specific regulatory elements. Transient transfection of the 
hepatocarcinoma cell line Hep3B with DNA encoding the HI 9 gene and surrounding 
regions led to the localisation and characterisation of the H I9 enhancers 103 By the 
creation of a series of overlapping subfragments of an original 22.5kb parent construct 
(containing the H I9 gene, 1 Ikb of the 5’ flanking region and 8kb of the 3’ flanking 
region), liver-specific enhancer activity was localised initially to a 2.4kb region 
approximately lOkb 3’ to the start site of the H19 gene. By more detailed mapping, this 
activity was confined to two separable elements, each approximately 270-300bp in length, 
which were each able to enhance transcription of the H19 gene ~30-fold in hepatoma cells. 
Together these elements acted additively to give a ~70-fold enhancement of gene 
expression from the H I9 promoter in an orientation-independent manner.
The main question posed in the following experiments is; can the CCD drive 
reporter gene expression in and in vitro cell culture system? The eventual aim being to 
isolate subregions within this domain that contain regulatory activity. A necessary 
preliminary to this investigation was to determine if P3-luciferase reporter constructs 
demonstrated the same tissue specific gene activity as described for the H I9 reporter 
constructs described above. To this end, Hep3B cells were transiently transfected with the 
M  construct, and the A  construct {Figure 3) in order to determine whether luciferase gene 
expression driven from the P3 promoter was upregulated when the HI 9 enhancers were in 
cis.
The H I9 enhancers provide the majority, if not the entirety of liver expression of 
Igf2 and H19 104, so it is unlikely that the CCD acts as an enhancer in this tissue, and 
therefore in Hep3 cells. The H  construct {Figure 3) was transiently transfected into these
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cells to provide confirmation of this, and to test the possibility that the CCD acts in a 
tissue-independent manner. The CCD may however, act to modulate activity from the 
known enhancers, rather than acting autonomously. The Q construct {Figure 6) was 
transfected into this cell line to test this possibility.
The C2 cell line, originally isolated from murine primary myoblasts 1 87 provides a 
model system in which to study the expression of Igf2 in muscle development.
Igf2 has been shown to be expressed in the mesoderm of the embryo from the 
earliest stages of its development 87. Jgf2 expression persists to high levels in all three 
regions of the somites (sclerotome, dermatome, and myotome) and in their derivatives in 
later development. The expression in myotome increases as development proceeds, and the
levels of Igf2 remains high in myoblasts as they differentiate into myotubules 95.
C2 cells can be induced to differentiate into myotubules upon serum withdrawal, or 
addition of Horse Serum 187, 188 This change is detectable both by morphological 
changes in the cells, and the expression of muscle-specific proteins. Among these proteins 
are many of the factors required for IGF signalling, including Igfl, IgflR  and an Igf 
binding protein 212, ^  wep ^  Igf2.
Igf2 is expressed at low levels in undifferentiated C2 cells, as might be expected if 
these cells resemble native myoblasts 95, 213 upon induction of differentiation of C2 
cells, Igf2 mRNA levels begin to rise; after 16 hours, a 2-fold upregulation over basal 
levels can be detected, this level rises to reach a 15-fold upregulation by 48 hours, and a 
peak of a 25-fold upregulation by 96 hours. The upregulation of Igf2 expression roughly 
follows the morphological changes that occur in the cells, as by 48 hours following 
induction of differentiation, cell fusion and the formation of myotubules is well underway.
By 96 hours, giant myotubules have developed 212.
The transcription of the Igf2 gene in embryonic tissues has been found to be 
initiated predominantly from P3 214, though a very small percentage of transcripts are 
synthesised from promoter 2. A luciferase reporter gene driven from P3 has been shown to 
be expressed at high levels when transiently transfected into undifferentiated C2 cells, but 
the promoter sequences alone were not sufficient to mediate the upregulation of this gene 
upon differentiation by serum withdrawal. Investigation of 25kb of the Igf2 proximal 
region by this method did not isolate any sequences which were able to enhance gene 
expression in cis to P3 upon myoblast differentiation.
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The H I9 enhancers have been reported to drive the expression of reporter genes in
some mesodermal lineages (sclerotome, tongue muscle 106) However, it is doubtful 
that these enhancers drive skeletal muscle-specific expression of Igf2 or HI 9, as a germ 
line deletion of the region containing the enhancers did not significantly reduce the
expression of either of these genes in this tissue 104
The CCD provides a candidate region for a mesoderm-specific enhancer of lgf2 
and/or H19. If this element does drive expression in mesodermal tissues, specifically in 
skeletal muscle, the H  reporter constructs might be expected to express luciferase when 
transiently transfected into the C2 cell line, and to be upregulated upon their differentiation 
into myotubules.
R esults
Construct DNA (depicted in Figure 3) was transiently transfected into a number of cell 
lines, to allow examination of luciferase activity when P3 is in cis to the H19 enhancers (A 
construct), the CCD (the H  construct), and both elements together (the Q construct). Levels 
of expression from P3 alone (M construct) was measured in all experiments, and provided 
a baseline to which other construct activity was compared. In all cases a construct 
containing the LacZ gene driven from the SV40 promoter was co-transfected with test 
constructs to control for transfection efficiency, and levels of total protein were measured 
to control for cell number. All figures of reporter construct activity are calculated as ng 
luciferase!mg total protein/level of fi-galactosidase activity. When no luciferase constructs 
were present, expression was never detected over background levels for the luciferase 
assay.
Expression levels from test constructs was compared to expression from the M  
construct by the non-parametric Wilcoxon’s matched pairs test. As sample sizes were 
small a normal distribution of the data could not be assumed. A paired test was used due to 
variation in basal activity between experiments. The null hypothesis in each case was; 
‘There is no difference in reporter gene expression following transient transfection of the 
basal construct vs. the test construct’. All tests were conducted at a 5% significance level.
Hep3B cells
Luciferase expression levels following transient transfection of construct DNA into Hep3B 
cells are tabulated below, and ratios of test construct to basal level are noted (Table 14).
158
The ratios of mean test construct expression over basal expression are also presented in 
graphical form {Figure 20).
Following transient transfection into Hep3B cells the H  construct exhibited no 
significant upregulation of reporter gene activity over basal levels. Conversely, the A 
construct enhanced transcription of luciferase from P3 by approximately 20-fold, and the 
Q construct enhanced transcription of luciferase by approximately 10-fold. There is a 
significant difference between the expression levels from A and Q constructs at the 5% 
level, suggesting that the CCD is reducing expression from the H19 enhancers by a factor 
of ~2-fold.
C2 cells
Following transient transfection into undifferentiated C2 cells, none of the test constructs 
exhibited increased reporter gene expression over basal levels, see Table 15 and Figure 
21 .
Transfected C2 cells were induced to differentiation by the addition of horse serum, 
and expression from reporter constructs was measured 48 hours following this induction. 
At 48 hours post-induction the cells had visibly differentiated, as judged by the observation 
of myotubules.
The expression of reporter constructs in differentiated C2 cells does not appear to 
differ greatly in magnitude between test constructs and basal levels. Test constructs 
express the reporter gene at between 50% and 75% the levels of basal expression see Table 
16 and Figure 22. The sample size was too small (n=4) to determine whether the 
differences between basal levels and test construct levels of expression were significant. 
Instead, a Mann-Whitney-U test was performed to compare expression level differences 
between differentiated and undifferentiated cells. Comparisons were made between the 
expression levels from the M  construct when the cells were undifferentiated vs. 
differentiated (n=12). This test was repeated with the A construct and with the Q construct. 
In each case, no significant differences were found in expression of the luciferase reporter 
gene between differentiated and undifferentiated C2 cells, when transfected with a 
particular construct.
Further cell lines
Preliminary experiments were performed on two further cell lines, Cos7 cells and NIH 3T3 
cells.
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In each cell line no enhancement over basal levels of expression were apparent with 
any test construct (data not shown). Sample sizes were small in both cases, so these results 
remain speculative, though it seemed clear that in no case was reporter gene activity 
greatly enhanced over basal levels of expression.
160
Table 14. Summary of transient transfection data for Hep3B cells. The M  construct is 
treated as providing the basal level of expression in this experiment, to which all other 
constructs are compared. A normalised value of test construct expression is presented as 
the ratio of test construct expression vs. basal (M) expression. The mean, variance and 
standard error of the mean (s.e.) were calculated for each construct, and each normalised 
construct, where n-7.
There was a significant difference at the 5% level between M  and A, between M  and Q, 
and between A and Q.
Figure 20. Expression levels of each test construct (H, A and Q) following transient 
transfection into Hep3B cells. All test constructs was normalised by dividing by the level 
of basal expression, which is judged as expression levels following transfection of the M  
construct (see Table 14). Error bars show the standard error of the mean in each case.
161j
replicate expression level (arbitrary units) normalised expression 
level: ratio/M
M H A Q urn A/M Q/M
a 1.30 2.19 24.45 14.15 1.68 18.77 10.86
b 0.46 2.25 24.39 19.64 4.93 53.60 43.17
c 9.29 6.53 64.23 38.70 0.70 6.91 4.17
d 3.87 3.60 35.65 30.89 0.93 9.20 7.97
e 10.19 6.65 55.60 60.19 0.65 5.46 5.91
f 4.36 10.94 172.34 21.06 2.51 39.52 4.83
g 17.12 30.76 388.48 173.45 1.80 22.70 10.13
mean 6.66 8.99 109.31 51.16 1.89 22.31 12.43
variance 34.83 101.66 1.78xl04 3.15xl03 2.26 330.16 190.19








Table 15. Summary of transient transfection data for undifferentiated C2 cells. The M  
construct was treated as providing the basal level of expression in this experiment, to 
which all other constructs were compared. A normalised value of test construct expression 
was calculated as above (Table 14). The mean, variance and standard error of the mean 
(s.e.) were calculated for each construct, and each normalised construct, where n=8.
There was no significant upregulation of gene expression from any construct over basal 
levels.
Figure 21. Expression levels of each test construct (H, A and Q) following transient 
transfection into undifferentiated C2 cells. All test constructs were normalised by dividing 
by the level of basal expression, which is judged as expression levels following 
transfection of the M  construct (see Table 15). Error bars show the standard error of the 
mean in each case.
163
replicate expression level (arbitrary units) normalised expression 
level: ratio/M
M H A Q H/M A/M Q/M
a 2.84 0.19 4.49 3.88 0.07 1.58 1.36
b 16.82 41.72 42.65 44.31 2.48 2.54 2.63
c 76.56 72.13 67.55 92.86 0.94 0.88 1.21
d 28.42 29.98 27.55 16.27 1.05 0.97 0.57
e 0.37 0.65 1.09 1.06 1.75 2.93 2.86
f 0.79 0.81 2.00 0.70 0.96 2.54 0.91
g 26.06 49.70 40.17 22.25 1.91 1.54 0.85
h 13.03 26.32 25.38 2.47 1.98 1.91 0.19
mean 20.64 27.69 26.36 22.98 1.40 1.86 1.32
variance 629.59 696.30 552.21 1020.95 0.59 0.57 0.91
1 "
8.87 9.33 8.31 11.30 0.27 0.27 0.34
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Table 16. Summary of transient transfection data for differentiated C2 cells. The M  
construct is treated as providing the basal level of expression in this experiment, to which 
all other constructs are compared. A normalised value of test construct expression was 
calculated as above (Table 14). The mean, variance and standard error of the mean (s.e.) 
were calculated for each construct, and each normalised construct, where n=4, except in 
the case of a single H  sample (sample d, nd) which was not recovered.
Figure 22. Expression levels of each test construct (H, A  and Q) following transient 
transfection into differentiated C2 cells. All test constructs were normalised by dividing by 
the level of basal expression, which is judged as expression levels following transfection of 
the M  construct (see Table 14). Error bars show the standard error of the mean in each 
case.
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replicate expression level (arbitrary units) normalised expression 
level: ratio/M
M H A Q urn A/M Q/M
a 112.23 79 .95 6 0 .8 6 87 .28 0.71 0 .54 0 .78
b 22 .79 14.08 16.05 9 .25 0 .62 0 .7 0 0.41
c 5 .58 5.33 2.98 4 .57 0 .96 0 .5 4 0 .8 2
d 1.61 nd 0 .60 0 .49 nd 0 .37 0 .3 0
mean 3 5 .5 4 33 .12 20 .12 2 5 .4 0 0 .76 0 .54 0 .58
variance 2 .7 0 x 1 0 3 1 .6 6 x l0 3 783 .59 1 .7 2 x l0 3 0 .03 0 .02 0 .07

















P3-luciferase reporter constructs were transiently transfected into four cell lines derived 
from different tissues; Hep3B, the human hepatocarcinoma cell line, C2 a murine myoblast 
cell line, Cos7 a monkey kidney cell line and NIH 3T3, a mouse fibroblast cell line.
In Hep3B cells, the H  construct did not display any upregulation of gene activity 
over the M  construct, which suggests that the CCD is unable to act as an enhancer in liver. 
This result is unsurprising, since the H19 enhancers are thought to be the major enhancers
for the Igf2 and H I9 genes in endodermally-derived tissues 104. Consistent with this is the 
enhancement of luciferase expression over basal levels observed with the A  construct. In 
this case the expression of luciferase was increased approximately 20-fold over the basal 
expression from P3 alone when the H19 enhancers were present. This figure compares 
favourably to the study of the activity of the H19 enhancers in Hep3B cells performed 
previously 103, which reported an approximately 70-fold enhancement of gene expression 
from the H19 promoter when these enhancers were in cis. The difference between a -20- 
fold enhancement compared to a -70-fold enhancement may be a result of a number of 
factors, including a difference in RNA stability between the H19 reporter and luciferase, in 
the relative affinity of the two promoters for interaction with the enhancer elements; or 
could merely be a result of different experimental conditions.
When the CCD and the H I9 enhancers were present in the same reporter construct 
(g), reporter gene levels were reduced approximately 2-fold with respect to the H19 
enhancers alone. The downregulation of the H19 enhancers in the presence of the CCD 
could be the consequence of a less optimal spacing between the enhancers and the 
promoter, rather than due to CCD-specific sequences. This possibility can only be ruled 
out by examining expression levels from a control construct comprising of P3-luciferase, 
the H19 enhancers and an additional 2kb of non-coding DNA in place of the CCD. In vivo 
(Chapter 4) the CCD appeared to upregulate reporter gene expression in embryonic body 
tissues when in cis to the H19 enhancers. This contradiction cannot be resolved without 
further experiments examining the effect of spacing on H19 enhancer function, both in vivo 
and in vitro.
The CCD provided a candidate for the mesodermal-specific enhancers of Igf2 
and/or H19. With this in mind, reporter constructs were transiently transfected into the 
myoblast cell line C2. No upregulation of gene expression over basal levels was observed
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with any of the reporter constructs, even when the cells were induced to undergo 
differentiation, a process known to lead to abundant expression of Igf2 in this cell line.
This result correlates very well to the parallel studies of in vivo expression of P3- 
luciferase reporter constructs presented in Chapter 4. A, H  and Q transgene-bearing mice 
expressed luciferase at low levels in skeletal muscle at D l, with no apparent differences in 
expression levels between constructs.
Preliminary experiments were conducted to establish whether the reporter 
constructs were expressed in further cell lines. In both Cos7 cells and in NIH 3T3 cells, no 
upregulation of reporter gene activity over basal levels was observed following transient 
transfection of any of the test constructs. Despite small sample sizes, it was concluded that 
neither the H I9 enhancers, nor the CCD could drive reporter gene expression in these cell 
lines.
In conclusion, P3-luciferase constructs containing the H19 enhancers, in Hep3B
cells, behave in a manner expected from previous transient transfection experiments 103,
in vivo studies 104, and ^  discussed in this report (Chapter 4). The apparent down- 
regulation of these enhancers in the presence of the CCD cannot be verified without further 
experiments to confirm that CCD-specific sequences, rather than a generalised spacing 
effect is responsible.
In a cell line derived from embryonic muscle cell precursors, the H I9 enhancers do 
not drive luciferase expression from the P3 promoter, suggesting that these enhancers are 
not responsible for the abundant expression of Igf2 and H19 in skeletal muscle. This 
conclusion is supported both by in vivo studies of enhancer function in this work, and 
others 104.
The CCD does not drive reporter gene activity in any cell line examined, 
suggesting that it does not act as an enhancer of Igf2 or H19 in the mesoderm (C2, NIH 
3T3), in liver (Hep3B) or in kidney (Cos7). This result is supported by the in vivo study of 
reporter gene activity presented in Chapter 4.
In order to dissect the function of the CCD further by a transient transfection 
method, a cell line expressing reporter constructs with the CCD in cis must be found. The 
major site of luciferase expression from CCD-containing transgenes was in the exchange 
tissues of the brain, so CCD function must be examined in a cell line derived from these 
tissues. The study of CCD function in a cultured cells derived from the choroid plexus is 
discussed in the next chapter.
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C h a p te r  7 , Is th e  CCD a b le  t o  d ir e c t  r e p o r t e r  g e n e  e x p r e ss io n  in
AN IN-VITRO SYSTEM? PART 2, PRIMARY CULTURE.
In troduction
Experiments utilising a transgenic approach (see Chapter 4) have demonstrated that gene 
expression in the choroid plexus can be conferred on a reporter gene when in cis to the 
CCD (previously defined by a ~2kb DNA fragment, in Chapter 1). In order to further 
delineate activity in this region, in terms of discovering the specific sequences necessary 
for choroid plexus expression and the trans- acting factors that bind to these sequences 
within the CCD, an in vitro approach has been attempted. In vitro systems have previously
been used successfully to isolate both enhancer sequences 103, an(j imprinting control 
regions 169, 1705 155 at the Igf2/H19 locus. These studies made use of previously 
characterised stable cell lines in which to measure changes in reporter gene activity in the 
presence of candidate control elements. The CCD does not appear to drive reporter gene 
expression in a variety of stable cell lines (see Chapter 6), suggesting that it does not act 
promiscuously cis a control element, and instead its activity could be limited to a small 
subset of tissues. The transgenic mouse studies presented in Chapter 4 strongly suggest 
that the CCD can drive reporter gene expression in the exchange tissues of the brain, 
within which the choroid plexus is included.
A single stable cell line exists which originates from choroid plexus tissue, the SCP
cell line 215, This cell line was not used in this study for a number of reasons. Firstly, the 
cell line is infected with the Maedi-Visna virus 216? providing problems for containment, 
and raising doubt upon possible extrapolations from this highly unphysiological culture 
system to any function in vivo. Secondly, the SCP cells are fibroblastic in morphology, not 
epithelial, as would be expected from cells of the choroid plexus, suggesting that they may 
be derived from the mesenchyme underlying the choroid plexus, or that the cells may have 
transformed in culture. Thirdly, the CCD region under study is derived from the mouse, 
whereas SCP cells are ovine in origin. While the CCD has been shown to be conserved in a
number of mammalian species 15 l s this conservation has not been demonstrated in sheep. 
The poor resemblance of SCP cells to the physiological structure from which they were
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derived was judged to render SCP cells an inadequate model in which to study CCD 
function in vitro.
Instead, a strategy has been adopted to derive primary cultures of choroid plexus 
epithelium in which to test reporter gene expression in the presence of the CCD. Primary 
cultures of choroid plexus epithelium have been derived successfully from a number of 
mammalian species 192^  217}218}219? 190s 220f including the mouse 221. a  novel 
method of primary culture of choroid plexus cells in the mouse, and characterisation of 
these cells is described below.
R e su lts
Culture of CP cells
Dissection and cell dispersal
The method of mouse choroid plexus primary culture described by Thomas et. al. 221 
differed from those protocols described for other mammalian species in that embryonic 
(el2.5) choroid plexuses were isolated for culture rather than post-partum samples. Due to 
this, more than 40 embryos were required to achieve a reasonable density of cells for 
culture. As primary cultures from 4-6 week old rat choroid plexuses (with 10 animals 
required per culture) are successful 220? it was decided to attempt to culture post-partum 
mouse choroid plexus. This would allow both the minimisation of the number of animals 
required for these experiments, and reduction of the length of the dissection protocol. The 
age of 7-10 days post-partum (D7-10) was used, as mouse choroid plexus is known to stop 
proliferating by 2-weeks after birth 222? and the success of primary culture from rat cells 
decreased when animals were older than weaning age 220 (approximately 21 days in the 
mouse).
The choroid plexus was dissected from the lateral and fourth ventricles of 
approximately ten (usually one litter) D7-10 mice. The dissected tissue was treated with 
the protease trypsin to release the cells from surrounding connective tissue (as described in 
several previous works 217? 190^  219). Approximately lxlO6 cells were liberated per
experiment, but the number of viable cells was very low. Crook et. al. 192 tested several 
proteolytic enzymes for their ability to release viable cells from bovine choroid plexus 
tissue. A comparison of collagenase, dispase, pronase and the combination of collagenase
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and dispase revealed that treatment with pronase generated the highest number of viable 
cells, and also the most effective cell attachment. The dissection was repeated using 
pronase to disperse the choroid plexus cells in favour of trypsin. Pronase digestion of 
mouse tissue effectively released the cells, and gave a good level of cell viability (an 
average of 5.4 xlO6 viable cells per experiment/ -80% of the cells dispersed, n=13). 
Pronase treatment must be well controlled, since prolonged digestion significantly reduced 
cell viability (not quantitated).
Culture Conditions
As previously reported, choroid plexus epithelial cells do not attach, or grow well on a 
plastic substrate 221. Attempts to grow the dispersed cells on untreated culture vessels 
confirmed this report. Previous investigators have successfully cultured choroid plexus 
epithelium on a variety of substrates (Matrigel and collagen 1221 ^ laminin 219218y j n 
vivo, the choroid plexus epithelium overlies, and is supported by a basement membrane 
provided by fibroblastic mesenchymal tissue 223 a  basement membrane provided by 
fibroblasts grown in culture might then be a good approximation of the extracellular matrix 
(ECM) that the choroid plexus epithelium contacts in vivo. This ECM was obtained by the 
method of Freshney 191. The murine fibroblast cell line NIH3T3 was grown to a confluent 
monolayer, and then the cells lysed by the addition of a detergent. The contents of the cells 
was then washed away, leaving a residue of the ECM laid down by the fibroblasts on the 
base of the culture dish. The dispersed cells were plated onto culture dishes treated in this 
manner, and the majority of cells attached (not quantitated) within 48hrs. The cells were 
then washed to remove unattached cells and debris.
Several days after plating the cells were predominantly of two morphological types: 
flat, polygonal closely opposed cells that formed islands; and fibroblastic cells that were 
dispersed among the islands. The morphology of the polygonal cells was similar to that of
several epithelial cell lines in culture (see below, and Freshney, (1987) 191). Fibroblasts 
initially comprised only a small proportion of the cultured cell population, but they rapidly 
proliferated to occupy the space among the polygonal cell islands. The aggressive growth 
of the fibroblastic cells thus prevented further growth of the epithelial cells. In order to 
prevent the growth of the fibroblast population, the culture medium was supplemented 
with cytosine arabinoside. The addition of this reagent at an early stage in the culture 
(48hrs) was sufficient to prevent the fibroblasts from proliferating, and has been reported
171
to have no influence on the growth of epithelial cells 190 with this treatment, the 
epithelial cells continued to grow and divide until confluency was reached, usually within 
10 days.
Characterisation of primary culture cells
In order to verify that the cells grown in culture are in fact derived from the choroid plexus, 
two criteria were specified: Firstly, do the cells isolated in primary culture display the 
morphological characteristics of epithelial cells? Secondly, do the cells express choroid 
plexus-specific marker genes?
Morphology
The cells grown in primary culture display several characteristics of epithelium as can be 
visualised by light microscopy. As shown in Figure 23a the cells display a ‘cobblestone’ 
morphology of polygonal cells that is a characteristic of epithelial cells grown in a 
monolayer. At higher magnification (Figure 23b), the cells appear to be have a rough 
texture, which is indicative of the presence of villi on the apical surface of the cells, 
another characteristic of epithelium.
Gene expression
Two genes were chosen to act as markers for choroid plexus epithelium in this study, the 
transthyretin gene (777?) and Igf2. As has been discussed at length in the Introduction, the 
Igf2 gene product is absent from all brain tissues, excepting the choroid plexus and
leptomeninges 97? and may therefore serve as a marker for these tissues. In addition, as the 
purpose of this study is in the elucidation of regulatory factors for Igfl in the choroid 
plexus, it is of obvious interest to establish that this gene is expressed in the culture system.
TTR, or prealbumin plays an important role in the plasma transport of vitamin A 
and is also involved in the transport of thyroid hormone. Its major sites of expression in 
rodents and man is in the liver, visceral yolk sac and the choroid plexus 224? 225 ^  the 
developing rodent brain, TTR is expressed from the earliest stages of choroid plexus 
development. Transcripts can be detected in the choroid plexus primordium, a layer of 
epithelial cells associated with two distinct areas of thickened mesenchyme which overlie
the neural tube at the midline 226 y TR is thus an early marker for choroid plexus 
epithelium.
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Figure 23a. Low power view (xlOO) of choroid plexus 
primary cultures. The cells display a 
cobblestone morphology characteristic of 
epithelial cells.
Figure 23b. High power view (x400) of choroid plexus 
primary cultures. The granulated appearance 
of the surface of the cells is due to the presence 
of villi.
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Primary culture cells were fixed and stained with an anti-777? primary antibody, 
and the staining pattern visualised by the use of a fluorescein-labelled secondary antibody. 
The resulting staining pattern is shown in Figure 24. The TTR protein is present at high 
levels in the cultured cells, and shows a cytoplasmic distribution.
To verify that both TTR and Igf2 genes are expressed in the primary cultures, RNA 
was isolated from these cells, and from cells of the human hepatocyte cell line HepG2. 
HepG2 cells would also be expected to express both markers, so this sample serves as a 
positive control. The RNA was subjected to Northern blotting, and hybridised with probes 
to exons 1 and 2 of the TTR gene, and exon 6 of Igf2 (see Materials and Methods).
Figure 25 shows that both the 3kb Igf2 transcript, and TTR transcripts are present in the 
RNA samples derived from choroid plexus primary cultures. TTR mRNA can be visualised 
as two transcripts, one at 0.7kb, which is the expected transcript size as reported by
previous work 227 The second fragment at approximately lkb is compatible with the
report of a choroid plexus-specific TTR transcript reported in mouse by Kita et. al. 228 
HepG2 cells express only the 0.7kb TTR transcript. These cells did not show hybridisation 
to the Igf2 probe. This may be due to the failure of the Igf2 probe derived the mouse to 
label to the human transcript under the stringent hybridisation conditions.
The primary cultures derived from mouse choroid plexi thus appear to have 
retained their identity, both in terms of their morphology, and by the expression of the 
choroid plexus-specific marker genes TTR and Igf2.
Transient transfection of choroid plexus primary cultures
CCD deletion constructs
Three of the constructs that were transiently transfected into choroid plexus primary 
cultures (M, H  and A, described in Figure 3 , Chapter 1) have previously been assayed for 
expression in cultured cells, and the results of this analysis are discussed in Chapter 6. 
Two additional expression constructs (pCCDlla and pCCD4a) were created and 
transiently transfected. These constructs were derivatives of the H  construct, and are 
depicted in Figure 26. The constructs were created in order to assess the role of the 
DNasel hypersensitive sites at the CCD in the activity of this region. As will be discussed 
in Chapter 8, the DNasel hypersensitive sites, which initially characterised the CCD
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Figure 24a.
Fixed primary culture cells treated with an anti-TTR 
preparation followed by a fluorescein-labelled secondary 
antibody. Cells are viewed under FITC, and the image 
overlaid with a bright field image of the cells. Cytoplasmic 
staining for TTR can be clearly seen.
Figure 24b.
Fixed primary culture cells treated with the secondary 
antibody only, and viewed under the same conditions 
as the cells in Figure 24a. There is no background 
staining in the absence of the primary antibody.
mGAP
Figure 25.
Northern blot analysis of transthyretin and Igf2 gene expression 
from cultured cells. RNA was extracted from choroid plexus primary 
cultures (CP) and the hepatocyte cell line HepG2, and analysed with 
probes for TTR and Igf2. The TTR probe hybridises to a transcript of 
0.7kb in both CP and HepG2 samples, in addition to a lkb transcript 
in the CP sample. A 3kb fragment that corresponds to the Igf2 
transcript is visible in the CP, but not the HepG2 sample. Hybridisation 
to the mGAP probe reveals that abundant RNA is present in both 
samples.
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151, have been mapped to the 5’ end of this region 229 jt was of interest to compare the 
activity of the CCD when the hypersensitive sites were present, to when they were deleted. 
pCCDlla  (Figure 26b) is comprised of the l.lkb region containing the hypersensitive 
sites, fused to the most 3’ ~100bp of the CCD. A 0.8kb fragment is deleted from the 
middle of this region. pCCD4a (Figure 26c) contains the 3’ 0.9kb of the CCD. A l.lkb 
region containing the hypersensitive sites has been deleted. These two deletion constructs 
are of a similar size (0.9kb and 1.2kb, respectively), so any differences between them are 
likely to be a result in differences in DNA sequence, rather than the length of the 
transfected plasmid.
Transfections
Construct DNA was transiently transfected into a choroid plexus primary culture cells, to 
allow examination of luciferase activity when P3 is in cis to the H19 enhancers (A 
construct), the CCD (the H  construct), and the truncated CCD in the presence (pCCDlla) 
and absence (pCCD4a) of a l.lkb region containing DNasel hypersensitive sites. Levels of 
expression from P3 alone (M construct) was measured in all experiments, and provided a 
baseline to which other construct activity was compared. In all cases a construct containing 
the LacZ gene driven from the SV40 promoter was co-transfected with test constructs to 
control for transfection efficiency, and levels of total protein were measured to control for 
cell number. All figures of reporter construct activity are calculated as ng luciferaseimg 
total protein/level of p-galactosidase activity. When no luciferase constructs were present, 
expression was never detected over background levels for the luciferase assay.
Luciferase expression levels following transient transfection of construct DNA into 
choroid plexus primary cultures are tabulated below, and presented as ratios of test 
construct to the basal expression level (Table 17). The ratios of mean test construct 
expression over basal expression are also presented in graphical form (Figure 27). The 
transfection experiments were performed at least four times for each expression construct. 
It should be noted that in all cases the transfection efficiency (as assayed by the level of fi- 
galactosidase activity) was very low, and that this may contribute to the variation in 
expression levels observed between experiments, as well as increasing the possibility of 
artefactual results.
The expression levels in choroid plexus cells do not differ in magnitude between 
the test constructs H  and A, and basal levels (M). In the cells expressing the reporter 
constructs, the addition of the CCD or the H19 enhancers has no effect on reporter gene
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Figure 26. Cloning o f  CCD deletion constructs
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a) Restriction map of the H construct showing the CCD divided into three 
regions delineated by EcoRI/PstI restriction sites.
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b) pCCDl la: a CCD deletion construct containing the most 5' 1.lkb of 
the CCD (which includes the DNasel hypersensitive sites) fused to the 









c) pCCD4a: a CCD deletion construct containing the 3' 0.9kb of the 
CCD. The 1 lkb 5' region containing the DNasel hypersensitive 
sites has been deleted.
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expression. In the case of the CCD deletion constructs, pCCDlla  does not appear to differ 
significantly from the parent construct H  in the level of reporter activity from P3.
However, when the DNasel hypersensitive sites are removed from the CCD region, the 
element appears to act as a silencer, depressing reporter gene expression to a level below 
that of the basal M  construct. The small number of replicates make it impossible to assign 
a statistical significance to this result, however.
Creation of a cell line
The primary cultures of choroid plexus cell produced in this study generally 
achieved confluency as a monolayer and were unable to proliferate further. In order to 
establish a cell line from these primary cultures it was necessary for the cells to survive 
passage once they had reached confluency, in order for the culture to be split and 
repropagated. To this end, the cells were dissociated from their attachment to the culture 
flask by treatment with trypsin, and replated into new culture dishes (prepared as described 
previously with an ECM from dissaggregated NIH 3T3 cells). The number of viable cells 
was counted following trypsinisation, and the ratio of cell survival calculated by division 
of this number by the number of cells originally plated. Following trypsinisation, the 
number of surviving cells decreased considerably, and the majority of cells did not reattach 
to the new culture vessel. Those cells that did reattach within a few days displayed the 
‘rounded up’ morphology of apoptotic cells, and did not subsequently proliferate. Much of 
the loss of cell viability could be accounted for by the harsh treatment of trypsinisation. 
However, the fact that viable cells were recovered after this treatment, but then failed to 
proliferate further, suggests that these cells had reached the limit of their proliferative 
potential. Cells derived from the choroid plexus of normal mice did not retain their 
proliferative potential beyond passage.
In an attempt to increase the proliferative potential of the choroid plexus cells, with 
the aim of establishing immortal cell cultures, the experiments were repeated with the 
choroid plexi of mice which lacked the tumour suppressor gene p53. Two lines of evidence 
suggested that cells lacking the p53 gene might be competent to produce an immortal 
choroid plexus cell line. Firstly, primary embryonic fibroblasts (PMEFs) derived from p53
null mice are immortal 230  ^an(j can be maintained indefinitely in culture. Secondly, a 
strain of transgenic mice have been generated that express the immortalising SV40 T -
antigen in choroid plexus epithelium (the T121 strain 231). The variant of SV40 T-antigen
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0.699 0.397 0.130 1.129
0.096 1.807
1.585 0.807 0.108 0.922
0.467 0.604 0.129 0.387
0.81 1.08 0.12 1.06mean
0.48 1.03 0.02 0.587variance
0.28 0.41 0.06 0.383s.e.
Table 17. Summary of transient transfection data for choroid plexus cells. Constructs were 
transiently transfected into the cultured cells. The M  construct is treated as providing the basal level 
of expression in this experiment, to which all other constructs are compared. A normalised value of 
test construct expression is presented as the ratio of test construct expression vs. basal (M) 
expression. The mean, variance and standard error of the mean (s.e.) are calculated for each 
normalised construct (where n=6 for H/M  and A/M  and n=4 for pCCD4a/M and pCCDlla/M). nd 















Figure 27. Expression levels of each test construct (H, A,pCCD4a (4a) and pC CD lla (11a)) 
following transient transfection into choroid plexus (CP) cells. All test constructs are normalised 
by dividing by the level of basal expression, which is judged as expression levels following 
transfection of the M  construct (see Table 17). Error bars show the standard error of the mean in 
each case.
180
expressed by T121 mice is truncated, so that it inactivates the retinoblastoma family 
proteins, but not p53. Choroid plexus epithelium usually withdraws from the cell cycle 
within two weeks after birth and remains in a quiescent state. In T121 mice the cells are 
induced to proliferate aberrantly, and the animals develop choroid plexus tumours within 
30-40 weeks of life. However, tumour growth in T121 choroid plexus is suppressed by the 
induction of /?55-dependent apoptosis. If T121 mice are crossed onto a p53 null background,
choroid plexus tumours develop within 4-5 weeks of life 222 p53 loss of function is thus a 
prerequisite for the immortalisation of choroid plexus cells.
Mice with a null allele of p53 (described by Clarke et. al. 180) were brecj to 
homozygosity, and the offspring of homozygous null parents used in the creation of 
choroid plexus primary cultures. The resultant morphology was identical to that of primary 
cultures derived from wild type mice, and the rate of growth was not obviously different, 
though no quantitative comparison was made. On reaching confluency the cells were 
passaged, and the survival ratio calculated. One week later the cells were passaged for a 
second time, and the survival ratio calculated again. The results of these experiments, for 
three independent preparations of choroid plexus cells, are shown in Figure 28. The small 
number of data points makes this work preliminary, but a clear trend can be seen. After the 
first passage the cells had in two out of three instances reduced in number to less than 50% 
of their plating number. By the second passage, the number of surviving cells was very low 
in all three experiments, and in all cases by a week following the second passage the cells 
had rounded up and ceased proliferating. While a direct comparison between wild type and 
p53 null cells was not attempted, it appears that p53 null cells have some survival 
advantage over their wild type counterparts. Despite this, the lack of p53 alone was not 
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Figure 28. Survival of p53 null choroid plexus cells following passage. Three independent 
preparations of choroid plexus cells (a, b and c), were counted prior to plating into the 
culture flask (plated cells), disaggregated when the cells reached confluency (#1), and the 
cells subsequently replated. The third count (#2) was taken 7 days following this passage, 
and the cells again replated. Within a week of the third count, all three preparations 
consisted exclusively of rounded up, non-proliferative cells.
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Conclusions
When placed in-cis to Igf2 promoter 3, the CCD can drive reporter gene expression in the 
brains of transgenic mice (Ward et. al. 108, and Chapter 4). This activity is limited to the 
exchange tissues of the brain, i.e., the choroid plexus and leptomeninges, sites of
endogenous Igf2 gene expression 70, 97. In order to identify the sequences within the CCD 
that are responsible for this enhancer activity, an in-vitro approach has been attempted. The 
CCD is unable to upregulate reporter gene activity in a range of immortal cell lines that are 
representative of tissues other than choroid plexus (see Chapter 6). This element does not 
therefore act to confer a tissue-independent upregulation of P3. As the CCD drives reporter 
gene activity in the exchange tissues of the brain, an in-vitro system was sought that is 
representative of this tissue. No such cell line was available at the time this study was 
undertaken, so instead a strategy was adopted to derive primary cultures from choroid 
plexus tissue.
Choroid plexus primary cultures have been successfully derived from a number of 
mammalian species including pig 190, rat 217? 218} 220  ^rabbit 219, cow 192 and mouse 
221. in this study a novel method of primary culture of murine choroid plexus cells was
developed. Previously reported primary culture methods for mouse cells 221 utilised 
embryonic tissue, which necessitated the use of a large number of animals per experiment 
(>40). The cell culture protocol developed here is the modification of a method used for
the culture of porcine cells 190. Three important modifications to this basic protocol 
allowed successful primary culture of mouse choroid plexus tissue. Firstly, the dissected 
tissue was dissaggregated with the protease pronase, which improved both cell viability, 
and increased the number of cells that attached successfully to the culture dish. Secondly, 
the cells were grown on a basement substratum that had previously been laid down by a 
confluent layer of fibroblasts. This modification greatly increased the plating efficiency of 
the dispersed cells, and has not previously been reported in a choroid plexus primary 
culture protocol. Thirdly, the nucleotide analogue, cytosine arabinoside, was added to the 
culture medium to prevent the growth of contaminating fibroblasts. These three 
modifications provide a robust protocol for the isolation and culture of choroid plexus 
epithelium.
The identity of the cultured cells was verified by examination of cell morphology, 
and by the study of gene expression. The cultured cells display a flattened polygonal
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morphology characteristic of epithelium. At high magnification the surface of the cells 
appears rough, which can be indicative of the presence of villi. However, this assumption 
could only be verified by examination of the cells by electron microscopy. The expression 
of two genes, transthyretin and Igf2 was detected in the cultured cells. Transthyretin is a 
highly specific marker for choroid plexus epithelium, as this is its only site of expression in
the mammalian brain 226 jgf2 expression is also localised in the mammalian brain to the
choroid plexus and leptomeninges 97. The detection of transcripts from both genes in the 
cultured cells confirms their identity as choroid plexus epithelium.
Once the identity of the cultured cells as choroid plexus epithelium had been 
confirmed, the cultures were then utilised for the study of CCD function. The experimental 
method employed was transient transfection of luciferase reporter constructs into the cells, 
and subsequent assays for reporter gene activity in the presence of the test constructs. 
Unfortunately, the cells were largely refractory to transient transfection by the standard 
method used in this study (see Materials and Methods), as judged by the level of enzyme 
activity following the introduction of a LacZ-bearing reporter construct. As the resultant 
transfection efficiency of the test constructs was low, the data obtained for the expression 
of luciferase reporter constructs should be treated with caution, for they may be 
representative of only a small number of transfected cells in each experiment. The 
preliminary data did suggest, however, that neither the CCD nor the H19 enhancers could 
drive gene expression above the level of expression obtained from the P3 promoter alone. 
This is a surprising result, as the assays on expression from these constructs in-vivo (see 
Chapter 4) indicated that both elements were capable of enhancing gene expression from 
P3 in this tissue. To test the possibility that multiple activities were present within the CCD 
region, which may complicate the analysis, luciferase reporter constructs were constructed 
that were internally deleted for the DNasel hypersensitive sites, or for a deletion of 0.9kb 
at the /779-proximal end. When the 0.9kb fragment was deleted, reporter gene expression 
levels did not differ from levels of expression from P3 alone. However, deletion of the 
hypersensitive sites brought about gene expression at a level approximately 10-fold lower 
than from the promoter alone. As this experiment was only repeated 4 times, too much 
significance should not be attached to this result, but it may indicate that more than one 
activity is present within the CCD region, one which includes the hypersensitive sites, and 
a second region that can act as a silencer. If this result should prove repeatable, it would
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indicate that when the region containing the hypersensitive sites is removed, the silencer is 
able to downregulate reporter gene activity.
In order to effectively test CCD action in choroid plexus cultured cells, it will be 
necessary to optimise the transient transfection protocol, possibly by utilising reagents 
designed for transient transfection of primary cultures, or by the creation of stable cell 
lines. Optimisation of this protocol will require a large number of cells, and therefore 
would be more sensibly conducted in a cell line, rather than in primary cultures. Trial 
experiments were conducted to obtain immortalised cells in culture, by creating cultures 
from choroid plexus tissue derived from p53 null mice. Fibroblasts obtained from such
animals are immortal 230  ^ancj ioss 0f js known to play a role in tumourigenesis of the 
choroid plexus in a mouse model 222 However, loss of p53 alone was not sufficient to 
immortalise choroid plexus cells in this culture system. Inactivation of p53 and the 
retinoblastoma family proteins by the expression of SV40 large T-antigen in the choroid 
plexus of transgenic mice leads these animals to develop choroid plexus tumours within 5 
weeks of life 231. Choroid plexus tissue derived from these mice would provide a good 
source material for the formation of an immortal choroid plexus cell line. Future work in 
the laboratory will seek to establish a mouse choroid plexus epithelial cell line from T- 
n\!p53 null choroid plexus, utilising the primary culture protocol developed in this study. 
The development of such a cell line will be valuable not only in the study of the mode of 
action of the CCD, but also in the study of Igf2 gene regulation in the choroid plexus. 
Choroid plexus cells could be grown in-vitro which are derived from mice that are a 
product of an FI cross between mouse strains polymorphic for a marker in the Igf2 gene. 
The parental origin of the two Igf2 alleles could thus be distinguished in this system. Igf2 
expression would be expected to be biallelic in cells derived from choroid plexus tissue, 
and in the system described above, this supposition can be tested. It is not known at present 
how the Igf2 gene escapes imprinting in the choroid plexus, and the small size of this organ 
in the mouse makes investigations in this tissue problematic. An in-vitro culture of choroid 
plexus tissue (either primary cultures, or an immortal cell line) could be utilised to study 
the allele-specific expression of Igf2 in the presence of e.g. histone acetylating agents or 
DNA demethylating agents, or in cells derived from different developmental stages.
In summary, primary cultures have been derived from murine choroid plexus 
tissue, and the cells resemble their source tissue both in morphology and in the expression 
of marker genes. Technical problems prevented a rigorous examination of CCD function in
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these cells, but transiently transfected expression constructs containing the CCD do not 
appear to express the reporter gene at levels above that from P3 alone. An immortal cell 
line established from these cultures would be a valuable resource in examination of the 
mode of biallelic expression of lgf2. While this study indicates that loss of p53 is not 
sufficient for immortalisation of these cells, the loss of the retinoblastoma family protein 
function, as well as p53 function by the expression of SV40 T-antigen in the choroid 
plexus may well provide starting material with which to establish a cell line.
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C h a p t e r  8, S e q u e n c e  c o m p a r i s o n s  b e t w e e n  t h e  CCD r e g i o n  in  a
NUMBER OF DIFFERENT MAMMALIAN SPECIES
Introduction
Cross hybridisation analysis of genomic DNA from a range of mammalian species 
(including human, cow and rat) to a mouse CCD probe demonstrated that sequences exist 
in each of these organisms that share a high degree of evolutionary conservation with the
mouse CCD region 151. while demonstrating that such sequences exist, this analysis does 
not identify if homologous CCD sequences are present in the context of the Igf2 and H19 
genes in other organisms. Furthermore, the analysis does not identify which sequences 
within the 2kb CCD probe used are conserved among these organisms.
As discussed in the introduction, comparisons between the mouse and human H19 
DMD region at the sequence level revealed several short conserved sequences, which were 
subsequently found to bind the boundary element protein CTCF (156} 169} 170) Cross- 
species analysis of the nucleotide sequence of potential regulatory regions can therefore 
identify good candidates for protein binding factors, and thus indicate the function of such 
regions.
The aim of the work discussed in this chapter was to answer the following 
questions: i) Does the Igf2/H19 loci in species other than the mouse contain a region 
homologous to the CCD? ii) Are specific sequence motifs within the CCD region common 
across a range of species, and if so, what can the nature of these sequences tell us of CCD 
function?
R esults  
Sequencing of the 3’ m ouse CCD
The original CCD clone described by Koide et. al. 151) was a 2kb EcoRI fragment. 
Approximately lkb of this clone had been sequenced, and the DNasel hypersensitive sites 
mapped. An initial step in the analysis of this region was to obtain the full sequence of the 
CCD clone. The portion of the CCD with no sequence data (approximately 900bp) was 
subcloned into a plasmid vector (see Materials and Methods), and sequenced from
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flanking primers in the vector sequence in both orientations. The resulting sequence 
information was assembled using the GELASSEMBLE algorithm of GCG (the Wisconsin 
Package Version 8.0). The complete sequence of the CCD clone used in this study was 
thus obtained, and is shown in Appendix 2.
Evolutionary conservation between mouse and human
Comparison of the complete CCD sequence with previously published sequences was 
carried out using the National Centre for Biotechnology Information’s (NCBI) sequence 
similarity search tool, BLAST. A significant match was found to a PAC (PI Artificial 
Chromosome) genomic clone of human chromosome 1 lpl5.5 (accession number 
AC004556), approximately 30kb upstream of the H19 promoter. This match demonstrated 
that homologous sequences to the CCD exist in the human, at a comparable location, i.e., 
between the Igf2 and H19 genes.
The alignment of the mouse and human CCD as performed by BLAST is shown in 
Figure 29. Over the entire CCD region, approximately 55% sequence identity is observed, 
however the majority of this similarity resides in two domains, indicated here as Region 1 
and Region 2.
Region 1 extends from 425-542bp of the mouse sequence, and shows 
approximately 83% sequence identity between mouse and human, with no gaps. The 
DNasel hypersensitive sites (by which the CCD was first characterised, 151) have 
previously been mapped to this region in the mouse (Dr J. F-X. Ainscough, pers. comm.), 
and their position is noted in Figure 29.
Region 2 extends from 1629-1879bp of the mouse CCD, and shows 87% sequence 
identity between the two species. Two gaps are required in the human sequence to give an 
optimal alignment. Such extensive sequence identity appeared unusual for a regulatory 
region, where sequences are conserved for short blocks. A further possible role for this 
region is that it encodes a gene, or part of a gene. In both the mouse and the human Region 
2 of the CCD contains an extended region encoding no stop codons. In addition, the most 
extended open reading frame (ORF) in the mouse could initiate at the ATG at position 
1617. This start codon is not conserved in the human sequence however. If Region 2 
encodes only part of a gene, the sequence need not initiate at an ATG codon, as it may be 
spliced onto an initiating exon. If this is the case, a splice acceptor consensus sequence 
would be predicted to lie at the CCD-internal end of the conserved sequence. The entire 
2kb mouse sequence was submitted to the Splice Site Prediction by Neural Network
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software package at the Berkeley Drosophila Genome Project. This software predicted the 
existence of several splice acceptor consensus sequences within the CCD region. Of 
interest was a 41 bp sequence at position 1613-1653 that demonstrated a high level of 
conservation to optimal mammalian splice acceptor sites (82% sequence identity). 
Repeating the procedure with sequence from the human CCD region revealed that the 
corresponding 41 nucleotides (according to the alignment in Figure 29) would also be 
predicted to function as a splice acceptor site, though this sequence was less optimal (55% 
identity with the optimal splice acceptor sequence). The position of this putative splice 
junction is illustrated in Appendix 2.
Cloning the rat CCD
The discovery of a long open reading frame in Region 2 in both mouse and human raised
the possibility that a gene may reside at the CCD. Koide et. al. 151 investigated this 
possibility by performing hybridisation analysis to mouse RNA from a variety of 
developmental stages with a CCD probe, and found no evidence of a transcript. It is 
possible however that such a transcript is present at different developmental stages than 
those analysed, or expressed at levels below the limits of detection of their analysis.
Analysis of the nucleotide sequence of a candidate coding region can provide 
indirect evidence that such a region encodes a protein. Due to the redundancy of the 
genetic code, the third position of a codon specifying a given amino acid can vary. The 
first two nucleotide positions of a codon would therefore be expected to be more highly 
conserved than the third position, i.e., the rate of non-synonymous substitution (Ka) of a 
nucleotide sequence specifying an amino acid would be expected to be lower than the rate 
of silent, or synonymous substitutions (Ks). How much, then, would sequences be expected 
to vary between two organisms, both at neutral sites, and at functional sequences? McVean
and Hurst 68 have compiled a database of the rates of synonymous and non-synonymous 
substitutions between 422 orthologous genes in the rat and mouse. From this, the 
distribution of the rate of protein evolution between the two species has been calculated. If 
the CCD contains a gene, the calculated Ka/Ks value for the predicted protein would be 
expected to lie within this distribution. In order to carry out such an analysis it was 
necessary to obtain the nucleotide sequence of the CCD region in the rat. This was 
achieved by adopting a polymerase chain reaction (PCR) strategy using degenerate primers 
generated by comparison of mouse and human sequences.
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Figure 29. Regions of homology between human and mouse CCD
Region 1 Region 2
The mouse CCD region was sequenced and compared to the published human sequence of this 
region. Two areas of striking sequence conservation were revealed:
CCDP3
mouse: 425 aaat ft f ' h f f h c h q tottaacataacaacca11taaca 484
l l l l l l l l l l l l l l  1 1 I I 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1  I I  M i l l  I I I  M I N I M I
human:92275 aaattttgttgtctcctgcgcccccgtgaggtcagtgggcagcatgacacccatttggcc 92216
mouse: 485 actgaggtggggttcctgggggggatg§B B H H H »illliiil£C qagcC C atgct£ ||c  542
I I I I I I II I I I I 1111 I I I I II I I I II I I I II I I II I I I I I I I II
human:92215 actgaggtggggctcctagggggggtgcaggtgggaagcgaccccagccccctcccgc 92240
Region 1. Contains the DNasel hypersensitive sites (shaded). It shows 83% homology with the 
human sequence over 118 nucleotides. There are no gaps.
CCDP1 
 ►
mouse: 1629 ctcagatctgacggggccagagccaggacagaggaagagggctgtacagccagcccagct 1688
I I I I I I I I I I I I I  I I I I I I I I  I I  I I I I I I I I I 1 1 1 1  I I  I I I  I I I I I I  I I I
human: 90770 ctcagatctgccggggccagggctggggcagaggaag-gggc-gtgcagtgagcccagct 90713
mouse: 1689 gggacagcaaacaaacctctggggtctctcctttcccttgcctgcccaccacaggggtct 1748
I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I llllll II
human: 90712 gggacagcaaacaggcctctggggtctctcctttcccttgcctgcccactgcagggggct 90635
mouse: 1749 ggctggggccagagctgggggagacttcctcgatttatctctgcagccggtggccagccc 1808
I I I  1 1 1 1 1 1 I I  I I  1 1 1 1 1 1 1 1 I I 1 1 1 I I I I I I I 1 1 1 1 1 1 I I 1 1 1 1  I I I  M i l l
human: 90652 ggccggggccagggccgggggagacttcctcgatttatctctgcagccagcggacagcct 90593 
mouse: 1809 taagcctggaatcccgggtcaagctaaggtttgcctgccctgctgtgagcagcttggagc 1868
I I I I  I I I I I I I 1 1 1 1  I I I I  I I I I I I I I I I  I I I I I I I I I I I I I I I I I I  I I I
human: 90592 acagcctggaatctggggttaggctgaggtttgcgtgtcctgctgtgagcagcttgcagc 90533
CCDP2
mouse: 1869 tggtcagaagg 1879
II I I I I I I I
human: 90532 aggacagaagg 90522
Region 2. Shows 86% sequence homology over 251 base pairs. There are two single nucleotide 
gaps inserted into the human sequence at the beginning of this region. Both in the mouse and 
human this region is predicted to encode an open reading frame, though no database matches to the 
resulting protein sequence have been found. Primers (CCDP1, CCDP2 and CCDP3) designed to 
amplify the CCD region in the rat are illustrated by arrows above their respective sequence.
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Isolation of the rat CCD
Primers for PCR analysis were generated in regions of the CCD which were known to be 
the most highly conserved (based on the human/mouse comparison). In order to obtain the 
maximum length of sequence, primers were designed to amplify from Region 1 to the 
terminal end of Region 2. The Primer Designer (Scientific and Educational Software, 
Version 2) package was used to identify candidate primer sites in the mouse sequence, then 
these sequences were modified at nucleotides that were not conserved between mouse and 
human to include degenerate nucleotides. The resulting primer pair, CCDP2 and CCDP3 
would be expected in the mouse to amplify a region of approximately 1.5kb, containing the 
majority of nucleotides in Region 1 and all of the nucleotides in Region 2. An additional 
primer, CCDP1 was designed at the internal end of Region 2, to be used with CCDP2 in 
order to amplify only the most conserved region (approximately 0.2kb in size), should 
amplification of the longer fragment prove problematic. The position of these primers with 
reference to the mouse CCD is illustrated by shading in Figure 29.
Genomic DNA was prepared from the liver of a Sprague-Dawley rat as and from 
mouse tissue, and PCR was carried out using primer pairs CCDP1 and CCDP2, as well as 
CCDP3 and CCDP2. An initial experiment (shown in Figure 30a) demonstrated that both 
primer pairs were able to give rise to amplification of fragments of the correct size from 
both mouse and rat genomic DNA. Under these conditions, the mouse sequences were 
amplified more readily than rat sequences, and many contaminating fragments were 
present in each sample. Optimisation of the PCR protocol led to a very successful 
amplification of a 1.5kb fragment from rat genomic DNA with primers CCDP3 and 
CCDP2 (shown in Figure 30b). This fragment was subsequently purified and inserted into 
a cloning vector.
Verification of the rat CCD clone
Southern blotting of mouse and rat genomic DNA with a mouse CCD probe after digestion 
with a panel of restriction enzymes revealed a number of restriction fragment length 
polymorphisms between the mouse and rat CCD regions. Figure 31 shows the results of 
this analysis for digestion of rat and mouse genomic DNA with the enzymes PvuII and 
BamHI. The expected fragment sizes from restriction digestion with these enzymes is 
shown in Table 18. The mouse CCD contains two sites for the enzyme PvuII, giving rise to 
a 0.9kb fragment when hybridised to the mouse CCD probe, and no BamHI sites, giving 
rise to large fragments due to digestion outside the CCD region. The rat CCD region lacks
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one of the two PvuII sites, giving rise to a 2.5kb fragment, and contains an internal BamHI 
site, resulting in hybridisation of a 3.5kb and a 6kb fragment to the probe. Restriction 
mapping of plasmids containing both the mouse and the rat CCD fragments confirms the 
presence of these restriction sites (see Figure 32 and Figure 33, and Table 18). The 
amplified 1.5kb fragment therefore originated from rat genomic DNA, and was not 
amplified as a result of contamination with mouse DNA.
Sequencing the rat CCD
The 1440bp rat CCD sequence was assembled from 11 fragments of approximately 600bp 
each, obtained from sequencing primed using external primers in the cloning vector, and 
internal CCD primers (the 77, SP6, CCDP1 and CCDP4 primers, see Materials and 
Methods). The majority of the CCD sequence was thus obtained from comparison of at 
least three independent sequencing reactions. The 1440bp consensus sequence was created 
by the GELASSEMBLE program of the GCG software package, and verified manually. 
The full sequence of the rat CCD is shown in Appendix 2.
Evolutionary conservation between mouse and rat
The overall level of sequence conservation between the mouse and rat CCD is 83%. As 
with the mouse-human comparison, the majority of this sequence similarity is confined to 
two domains, corresponding to the previously described Region 1 and Region 2. Region 1 
shares 86% sequence identity between mouse and rat, over 93 nucleotides. The 93bp 
represents approximately 3U of Region 1, the rest missing due to the design of the primers 
for PCR amplification. Region 2 shares 97% sequence identity between mouse and rat, 
indeed only 8 of a possible 251 nucleotides differ between the two species. As with the 
human and mouse CCD, the internal end of Region 2 (from nucleotides 1175-1219) 
contains a splice acceptor sequence (79% identity to the optimal mammalian consensus 
sequence) A summary of the comparative sequence data between the rat and mouse and 
the human and mouse CCD sequences is presented in Table 19, and a full alignment 
between the three species is shown in Appendix 2.
Molecular evidence for a coding region at Region 2 of the CCD
The rat sequence, as well as the mouse and human, contains a long ORF at Region 2 of the 
CCD. The mouse and rat sequences also share a conserved ATG at the 5’ end of this ORF.
The putative coding sequence was translated into an amino acid sequence (using 
the TRANSLATE algorithm of the GCG package), using the conserved ATG as a
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convenient start position, and this protein sequence was used as the basis for the 
calculation of the rates of protein evolution discussed below. The following summarises an 
analysis of this putative protein coding region at the CCD conducted by L. Hurst 
(University of Bath), and is illustrated in Figure 34. The putative coding region was found 
to have a rate of protein evolution (Ka) of 0.023 per site. This figure is at the low end of the 
distribution of the rates of protein evolution assembled in a mouse-rat comparison of 422 
genes (as discussed above, where the mean was 0.036), and approximates the average for 
imprinted genes (Ka=0.0224, +0.00487, n=15). Therefore, the rate of evolution of this 
region is what would be expected of a protein coding sequence under stabilising selection.
As the putative coding region, like many imprinted genes (including Igf2) 232  ^has a very 
low rate of evolution at silent sites (Ks=0.044 as compared to a mean of 0.178 for the 422 
genes), the substitution rate of 5’ flanking sequence was taken instead as the background 
rate of evolution in this region. With this modification, a K J K S value of 0.114 is obtained, 
which is a little below the mean for the mouse-rat comparison (Ka/Ks=0.197).
The search for transcripts originating from Region 2
Despite good indirect evidence for an exon encoded by Region 2 of the CCD, no transcript 
corresponding to this sequence has been identified. mRNA from a range of foetal and 
neonatal mouse tissues have been analysed by Northern blotting, and ribonuclease 
protection analysis, using probes designed to be complementary to the putative coding 
region of the CCD (data not shown). While by no means exhaustive, these experiments did 
not uncover any reproducible evidence for a transcript originating from this region. 
Furthermore, searches of nucleotide and protein sequence databases for genes homologous 
to the putative gene have revealed no significant matches.
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Figure 30a. Initial PCR amplification of the CCD region in mouse and rat (rati and rat4 
denote independently prepared genomic DNA samples from rat tissue). Mouse sequences 
amplified more successfully than rat sequences. Many contaminating amplification 
products are present as well as the expected 1.5kb (with primers CCDP2 +CCDP3) and 
0.2kb (with primers CCDP1 +CCDP2) products.
Figure 30b. Optimisation of the PCR protocol for amplification of the ~1.5kb rat CCD 
fragment, performed on rat genomic DNA (samples 1 and 4 as above) with primers 






























Figure 31. Southern blot showing restriction fragment length 
polymorphisms between the rat and mouse CCD region
Rat and mouse genomic DNA was digested with PvuII and BamHI 
and probed with the mouse CCD region. PvuII digestion of mouse 
genomic DNA reveals a major fragment of 0.9kb, and a fragment of 
>8kb, as predicted from the sequence data (see Table 18). The rat 
sequence lacks a second PvuII site, giving rise to an approximate 
2.5kb fragment. The mouse CCD region contains no BamHI sites, 
and therefore the large fragments correspond to digestion outside 
the CCD region. The rat CCD is predicted to contain an internal 




PvuII BamHI PvuII PvuII PvuII p i 75a:4, IHOUSe 2kb CCD
11 i - 1--, I_________ region inserted into the
BSSK+ vector.
PvuII BamHI PvuII PvuII pR12, PClt 1.5kb CCD
---------- 1—i 1 1 i—I  region inserted into the
pGEM T-Easy vector.
Figure 32. Schematic o f the mouse and rat CCD regions in the context o f  their 
respective cloning vectors. The position o f the restriction enzyme sites is based 
on sequencing o f these regions. The rat and mouse CCD regions differ with respect 
to the position o f several restriction sites. Polymorphic BamHI and PvuII sites are 
shown above. The predicted polymorphism at the sequence level compares favourably 
to an analysis o f  the same restriction sites in genomic DNA samples, examined by 
Southern blotting (see Figure 31). The open rectangles represent CCD sequences 
whereas the line represents vector sequence.
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Table 18. Predicted restriction fragment sizes o f mouse and rat plasmid and genomic 
DNA based on sequencing information. All sizes are rounded to the nearest 0.05kb.
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Figure 33. Restriction fragment length polymorphisms between the rat 
and mouse CCD region.
Mouse (pl75a:4) and rat (r 12) plasmid DNA was digested with PvuII 
and BamHI. pl75a:4 is digested at a single site within the vector 
sequence of the plasmid, giving rise to a single fragment length of 4.9kb. 
pl75a:4 is digested at four sites by PvuII, giving rise to fragment sizes of 
0.5kb, 2.5kb, and a doublet at 0.9kb. r 12 is cut once by BamHI within the 
rat CCD sequence, fiving rise to a fragment of 4.5kb. PvuII digests r 12 at 
three sites, giving rise to fragment sizes of 2.6kb, 1.5kb and 0.35kb.
These fragment sizes correspond to those predicted from the sequencing 
data, and are summarised in Figure 32 and Table 18
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Region analysed Human Rat






number o f gaps /  % 306/19% 71/4%






number of gaps /  % no gaps 2 /2%
Region 2 Length of sequence 
compared




number o f gaps /  % 2 / <1% no gaps
Table 19. Summary of the data obtained from multiple species analysis of the CCD 
sequence. The sources of the mouse and rat sequences are detailed above. The human 
sequence was obtained from the NCBI database, accession number AC004556.
Alignments, and the resulting percentage sequence identities, and gap scores were obtained 
using the ‘BLAST 2 Sequences’ algorithm at NCBI. Region 1 extends from 425bp-542bp 
of the mouse sequence (relative to the most 7g/2-proximal nucleotide of the 2kb EcoRI 
clone). Region 2 extends from 1629bp-1879bp of the mouse sequence. The two regions 
were initially delineated as regions of significant homology to the human 1 lpl5.5 region 
when a BLAST search was conducted with the mouse CCD nucleotide sequence, against 
the NCBI nr database. The sequence of the CCD from all three species, and their alignment 












H2 : M : 84
Figure 34. The amino acid sequence of a putative protein encoded by the ORF at Region 2 
of the CCD. The mouse (Ml), rat (Rl) and human (H2) were translated from the position 
in the nucleotide sequence corresponding to a conserved ATG in the mouse and rat 
sequence. The asterisk above the sequence indicates where the consensus splice acceptor 
site present in all three species would dictate the beginning of the exon. The human 
sequence is frame shifted with respect to the mouse and rat sequence, due to the presence 
of two gaps in the alignment at nucleotides 1968bp and 1973bp of the human sequence 
(see Appendix 2). This frame-shift also accounts for the poor conservation at the amino- 
acid level between the human and mouse/rat sequences in the beginning of this putative 
protein. The mouse and rat putative proteins share 84 amino acids of 87, a level of 




The aim of the work discussed in this chapter was to answer the following questions: i) 
Does the Igf2/H19 locus in species other than the mouse contain a region homologous to 
the CCD? ii) Are specific sequence motifs within the CCD region common to a range of 
species, and if so, what can the nature of such motifs tell us of CCD function?
The full sequence of a 2kb fragment containing the mouse CCD region was 
obtained and used to search a database (using the NCBI’s sequence similarity search tool 
BLAST). The only hit from this search that displayed a significant level of similarity to the 
mouse CCD was a PAC genomic clone corresponding to human chromosome 11, region 
p i5.5, which contains the H19 gene and surrounding sequences. The mouse CCD region 
displayed high sequence identity to a region of this PAC at approximately 30kb upstream 
of the H19 gene. The CCD is known to reside 32kb upstream of the H19 gene in the mouse
The human Igf2/H19 locus therefore contains a region, which is homologous to the 
mouse CCD, in the same relative location. The commonality of location between the 
mouse and human CCD regions suggests that the sequences homologous to the CCD 
identified by cross-hybridisation analysis 151 in further mammalian species will also be 
found in the intergenic region between Igf2 and HI 9. The conservation of its location in at 
least two mammalian species strengthens the proposal that the CCD contains an element 
that is important in the mechanism of regulation of Igf2 and/or HI 9. It would be interesting 
to discover whether CCD-like sequences are also present in non-mammalian organisms,
for example in chickens, where Igf2 is known to be biallelically expressed 233
The alignment of human and mouse CCD sequences revealed that the majority of 
the sequence identity was confined to two short regions. Region 1 lies at the most Igf2- 
proximal end of the CCD, and extends over approximately 120 nucleotides. Human and 
mouse Region 1 sequences share 83% sequence identity. The rat CCD sequence isolated 
by this study shares 86% sequence identity with the mouse in Region 1 (see Table 18). The
DNasel hypersensitive sites demonstrated by Koide et. al. 151 to lie within the CCD have 
been mapped to the mouse CCD at nucleotides 432-460 and 512-541 (Dr J. F-X. 
Ainscough, pers. comm., see Figure 29), both of which lie within Region 1.
Region 1 bears several characteristics of a regulatory region. Firstly, nuclease 
hypersensitive sites are thought to mark sequences involved in gene regulation (as
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discussed in the Introduction). Secondly, Region 1 extends over a relatively short region, 
which suggests that sequence blocks such as those required for protein binding are 
conserved. A comparison of the region containing H19 enhancer 2 between mouse and 
human (Accession numbers: mouse M23358IMUSH19END, human AF091107), using the 
same search parameters as those used to compare CCD sequences (not shown), reveals a 
similar pattern of sequence conservation. The human and mouse enhancer regions share 
83% sequence identity over 81 nucleotides. The mouse H19 enhancer region has also been 
shown to be nuclease hypersensitive 151.
The delineation of a 120bp motif at Region 1 of the CCD by comparative sequencing will 
allow further investigation of this element. The use of techniques such as DNA-protein 
mobility assays with nuclear extracts can provide information about trans-acting factors 
that may interact with this region to bring about downstream events. The identification of 
such proteins could provide clues as to the role of the CCD region in the regulation of 
Igf2/H19 expression and/or imprinting.
The role of Region 2 of the CCD is less clear. Region 2 extends over approximately 250 
nucleotides, at the most H19-proximal end of the CCD (see Figure 29). Comparisons 
between mouse, rat and human sequences reveal that this region is very highly conserved 
(mouse: human, 87%; mouse: rat, 97%). The extended homology throughout this region 
between mouse and human sequences suggested that it might contain a coding region. In 
both species, Region 2 contains an open reading frame that almost spans the entirety of the 
region.
The rat CCD sequence was obtained by PCR amplification using degenerate primers 
designed at two parts of the CCD that are highly conserved between mouse and human (in 
the middle of Region 1 and at the //79-proximal end of Region 2). The purpose of 
obtaining the sequence of the rat CCD was to enable a comparison of the rate of protein 
evolution at the ORF to a database of rates of evolution between 422 mouse-rat orthologs
compiled by McVean and Hurst 68. if the ORF at Region 2 is a coding region, its rate of 
protein evolution between mouse and rat would be predicted to lie within the distribution 
of the values obtained for the 422 orthologues.
The rat CCD, as well as the mouse and human contains a long ORF at Region 2. The 
mouse and rat sequences also share a conserved ATG at the 5’ end of the ORF. Using this 
ATG as a start site, the mouse and rat sequences were translated in silico into a protein 
sequence, 87 amino acids in length. The rate of protein evolution and silent site evolution
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was calculated, and compared to the mouse/rat database by L. Hurst (University of Bath). 
The putative coding region was found to have a rate of protein evolution at the low end of 
the distribution of the 422 genes. The rate of evolution is what would be expected of a 
protein coding sequence under stabilising selection. A complication of the analysis was 
that the silent sites too were found to have a low rate of evolution. There are several 
possible explanations of this finding. Firstly, Region 2 is not a coding region, and the 
conservation of all nucleotides is therefore is independent of their proposed codon position. 
Selection is instead acting on, e.g. nuclear factor binding sites. Secondly, the CCD may 
encode a transcript that is not translated, thus selection would be acting to conserve the 
secondary structure of the RNA, and therefore all nucleotides are equally likely to be 
conserved. Thirdly, Region 2 may encode a protein with a low rate of evolution at silent
sites, as has previously been reported for imprinted genes 232 indeed, the rate of 
synonymous substitution of the putative gene is very similar to that of the neighbouring 
Igf2 gene.
While the conserved ATG between rat and mouse was used as an initiation site for the 
translation of the nucleotide sequence, Region 2 may instead encode an internal exon. The 
CCD-internal end of Region 2 is predicted to act a splice acceptor site in all three species 
examined in this study. If Region 2 is but part of a gene, further sequences would be 
predicted to be conserved between species, which correspond to additional exons. Koide 
et. al. performed cross-hybridisation analysis on a series of non-overlapping clones that
spanned the region between the Igf2 and H I9 genes As well as demonstrating that the 
CCD region from the mouse was able to hybridise to genomic DNA in a number of 
mammalian species, this study also demonstrated that a second region in the mouse (the 
A22 clone) was able to hybridise to human genomic DNA. However, this region lies 
approximately 15kb upstream of the H I9 gene (i.e. downstream of the Region 2 putative 
exon), and therefore would not be predicted to encode the initiating exon for the putative 
gene, based upon the splice-site consensus data. No conserved regions were found 
upstream of the predicted Region 2 exon.
Sequence comparisons of mouse, rat and human Region 2 have been unable to unravel the 
function of this region, but raise a strong possibility that the CCD contains a coding region. 
Indirect evidence for the presence of a gene in this region must be supported by direct 
evidence provided by the identification of transcripts. Probes designed to detect the 
presence of transcripts from the ORF at Region 2 have been used in Northern hybridisation
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and ribonuclease protection experiments to analyse RNA from a variety of samples of 
mouse tissues. To date, no transcripts originating from Region 2 have been identified (this 
study, and Koide et. al.l^l). a  complication of such an analysis is that the putative gene 
could be active in a very narrow time window of development, in a small subset of tissues, 
or transcribed at very low abundance, making it difficult to equivocally rule out the 
existence of a gene at the CCD. Further work could be to screen cDNA libraries (which 
provide good coverage of expressed transcripts) for clones homologous to the ORF; or by a 
program of analysis of RNA by Northern hybridisation, ribonuclease protection or 
Reverse-Transcription PCR, with an aim to cover the widest possible range of tissues and 
developmental stages.
In summary, comparative sequencing of the CCD between mouse, rat and human has 
revealed that the location of the CCD is conserved (at least between mouse and human). 
Furthermore, two highly conserved regions within the CCD have been identified, one of 
which displays several features of a regulatory region (Region 1). Region 2 contains an 
ORF that is highly conserved between the three species at both the nucleotide and amino- 
acid level. However, no direct evidence of a transcript originating from this region has 
been obtained.
The comparative sequencing approach has provided a valuable tool in isolating highly 
conserved regions within the CCD that may well correspond to the minimal sequences 
required for its function. The identification of these minimal sequences will aid further 
analysis of possible fra«s-interactions between nucleotide sequences and the effector 
proteins that are required for the function of this element.
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C h a pter  9 : C o n c l u sio n s
T issu e  sp e c if ic  e x p re s s io n
As was discussed in the Introduction, the spatial and temporal expression patterns of the 
Igf2 and H19 genes is complex, and relies upon interactions between the promoters of 
these genes with multiple enhancer and silencer elements. The similarity in the expression 
patterns of the two genes implies that they share at least some of these regulatory elements. 
Indeed, in the case of expression in tissues with an endodermal component (e.g. liver and
gut), both genes have been shown to be regulated by a common set of enhancers 104.
The developmental timing by which the two genes become monoallelically 
expressed differs, and is tissue specific. For example, Igf2 is expressed with a paternal bias
from the earliest stages of its expression 86, and biallelic expression of this gene is limited
to the exchange tissues of the brain 70. H19 is expressed equally from both parental alleles
during early developmental stages 86f and shows biallelic expression in some placental cell
types but is imprinted in the exchange tissues of the brain 98. jn the case of both 
genes, their imprinting status is dependent upon tissue type, and therefore the mechanisms 
that confer tissue-specific expression might also play a role in the imprinting mechanism.
The CCD was initially characterised by Koide et. al. 151 as a region approximately 
midway between Igf2 and H19 that displayed enhanced sensitivity to the nuclease DNase I, 
and was conserved in a number of mammalian species. The CCD provides a strong 
candidate for an additional enhancer or imprinting control element at this locus. Both the 
Igf2 and H19 genes are expressed at high levels during development in mesodermal tissues
95, 78 An initial hypothesis during the course of this study was that the CCD might 
harbour an enhancer of expression in tissues of mesodermal origin. A 130kb YAC 
transgene that contained sequences from PI of the Igf2 gene to approximately 35kb
downstream of the H19 gene 56 demonstrated the appropriate expression of both an Igf2- 
LacZ fusion gene, and H19 in several mesodermal tissues, including skeletal muscle and 
the tongue. Sequences responsible for gene expression in these tissues therefore lie in the 
immediate vicinity of the two genes. Three strains of transgenic mice bearing a construct 
containing the CCD in-cis to a P3-luciferase reporter (the H  construct, see Figure 3 in 
Chapter 1) were examined for reporter gene expression in the tongue and skeletal muscle 
of neonatal mice. Very low levels of luciferase gene activity were observed in these
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tissues, demonstrating that the CCD is not an enhancer of P3 in these mesodermal tissues. 
Appropriate expression patterns were observed from transgenic lines constructed with the 
A  construct (see Figure 3). This construct contains the reporter gene in-cis to the H19 
enhancers, and in this system these enhancers upregulated gene expression from P3 in liver 
and kidney, but not in tongue and skeletal muscle. To test for any possible interactions 
between the CCD and the H19 enhancers, gene expression levels were quantitated in 
tissues from a transgenic line bearing both elements (Q lines, see Figure 3), and compared 
to mean expression levels in the same tissues from A or H  lines. In three independent Q 
lines, no new expression patterns were observed in any of the tissues analysed, and 
expression levels were found to be quantitatively similar between Q and A  lines in the 
endodermal tissues, and between all three lines in the mesodermal tissues. The possibility 
of synergy between the CCD and the H19 enhancers was tested at an additional time point, 
el4.5. In the bodies of transgenic mice at el4.5, the median level of gene expression from 
the three Q lines was slightly elevated over the median expression level from A lines. 
However, due to the variation in expression levels between transgenic lines bearing a 
particular construct, and the small number of lines tested, the significance of this result is 
unclear.
In agreement with a previous report 108, the CCD was shown to drive reporter 
gene expression in the brains of transgenic mice at D1. The major sites of Igf2 and H I9
expression in the brain are the choroid plexus and leptomeninges 97, 98 Gene expression 
from reporter constructs was found to be localised to the exchange tissues, and was not 
then thought to be a result of ectopic gene expression. In addition to the CCD, the H19 
enhancers were also found to have some activity in the exchange tissues, in agreement with 
a previous report of expression from these enhancers in the meninges but not the choroid 
plexus 109
In parallel with the in vivo study of reporter gene activity in the tissues of 
transgenic mice, a series of in vitro assays were performed. A number of immortal cell 
lines were transiently transfected with the same reporter constructs as used to create the 
transgenic lines (M, H, A  and Q, see Figure 3, Chapter 1), in order to determine the 
effects of the CCD and the H19 enhancers on the levels of reporter gene activity from the 
P3 promoter. The cell lines were chosen to be representative of those tissues analysed in- 
vivo, i.e., the hepatocyte cell line Hep3B, the kidney line, Cos7, and the skeletal muscle 
cell line C2. The relative levels of expression from reporter constructs in vitro largely
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reflected the expression patterns of the constructs in vivo. As has been shown previously, 
the H19 enhancers elevate the levels of reporter gene expression above basal promoter 
levels in Hep3B cells In all other cell lines examined, the H19 enhancers did not drive 
reporter gene activity over basal levels observed with P3 alone. This result confirms the
tissue specificity of the enhancers shown in this study, and previously 103 The CCD did 
not upregulate P3 in any cell line examined, again in agreement with the in vivo analysis of 
transgene expression in liver, skeletal muscle and kidney, and confirming that the CCD 
does not contain an enhancer for these tissues.
As the CCD appeared to be active in a limited number of cell types, expression of 
reporter constructs from one of these cell types, the choroid plexus, was analysed in an in 
vitro system. This necessitated the optimisation of a new technique for the creation of 
primary cultures of choroid plexus tissue. With several modifications, an existing protocol 
for the primary culture of porcine choroid plexus was adapted for the culture of neonatal 
mouse tissue. The identity of the cultured cells was confirmed as choroid plexus epithelium 
by analysis of cell morphology and gene expression. Importantly, Igf2 was shown to be 
expressed in these cells. However, due to technical problems with transient transfection of 
the primary cultures, differences in the levels of gene expression between reporter 
constructs could not be confirmed. Verification of CCD-mediated expression in an in vitro 
choroid plexus culture system awaits further work.
A second purpose of developing an in vitro model in which CCD activity could be 
demonstrated was in order to isolate minimal functional sequences within this region with 
activity. Once minimal sequences had been identified, they could be used to perform 
DNA-protein binding assays to characterise trans- acting proteins. The CCD did not affect 
reporter gene activity in any in vitro system tested, so this analysis could not be carried out.
Another method by which to localise sequences that may have a regulatory function 
is by searching for conserved regions between different species. Genomic DNA with 
homology to the CCD was shown to exist in a number of mammalian species by cross­
hybridisation analysis 1^1. in this study, the full sequence of the mouse CCD was 
obtained, and used to screen a nucleotide database for similar sequences in other 
organisms. The only significant hit from this search was found to a region of human 
chromosome 1 lp l5.5, approximately 30kb upstream of the H I9 gene. The human 
Igf2/H19 domain thus contains an element homologous to the CCD. The sequence identity 
between the CCDs from mouse and human largely resides in two regions. Region 1
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comprises approximately 120 nucleotides, and contains the DNasel hypersensitive sites
Region 2 spans approximately 250 nucleotides, and bears several characteristics of a 
coding region. Region 2 contains a long open reading frame in mouse, rat and human, and 
is flanked at the 5’ end with a 40 nucleotide sequence that could act in all three organisms 
as a splice acceptor site. The rate of divergence of this sequence between rat and mouse is 
compatible with that of a coding region under stabilising selection. However, no transcripts 
originating from this region have been identified in this study, or in others 151, 229 The 
CCD thus potentially contains at least two distinct regions, which may represent regulatory 
and/or coding activity.
Recently 229  ^the role of Region 1 of the CCD was investigated by the analysis of 
the effect of its deletion in the context of a 130kb Igf2IH19 YAC transgene. At low copy 
number an Igf2-LacZ fusion construct displays expression in a wide subset of tissues 
known to express Igf2. The YAC also contains a copy of the HI 9 gene, and both genes are 
imprinted appropriately. Deletion of a 1 kb region containing CCD Region 1 (in this study, 
the most 5’ lkb of the CCD clone) was carried out by Cre-mediated recombination 
between flanking loxP sites. The expression of both genes from the deleted YAC was 
indistinguishable from the parent construct until e l7. At this stage, the previously silent 
Igf2-LacZ fusion gene was activated on the maternal allele in a highly specific subset of 
tissues, including the intrinsic muscles of the tongue, the craniofacial muscles, as well as 
other skeletal muscles throughout the body. H19 gene expression from the YAC was not 
effected. The authors concluded that this region contains a silencer that limits the 
expression of the Igf2 gene in late embryogenesis in skeletal muscle.
The deleted YAC construct continued to express the LacZ fusion gene in the 
choroid plexus and meninges of the bran. This suggests that the brain enhancer activity of 
the CCD demonstrated in this study does not reside in the first lkb of the CCD that 
contains Region 1. The second half of the CCD must contain the enhancer activity, with 
Region 2 providing a good candidate.
In another recent study, several additional candidate regulatory elements for Igf2
and H19 have been identified by a comparative sequencing approach 234 This study 
determined and compared the sequences of the human and mouse H I9 region over 4 lkb 
(extending from 8kb upstream to 30kb downstream of the H I9 gene). Ten evolutionarily 
conserved segments were identified; two of which were co-incident with the known 
endodermal enhancers. The remaining eight were inserted into LacZ reporter constructs,
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and used to create transgenic mice. Reporter assays showed that five of the eight elements 
functioned as enhancers in specific mesodermal and ectodermal tissues (including the limb 
buds, myotome, rib primordia and intercostal muscles, at e l2.5). These elements would all
be predicted to lie on the 130kb YAC transgene 36, and presumably are responsible for the 
temporal and spatial expression patterns of Igf2-LacZ and H19 from that transgene. It 
would appear then that the majority of the embryonic enhancers for Igf2 and H19 lie 
downstream of the H19 gene, though the action of these enhancer elements on their target 
genes can only be confirmed by the analysis of the effects of deleting these elements from 
their normal genomic location. The ten conserved elements characterised in the 
comparative study did not include an enhancer for the exchange tissues of the brain. The 
CCD region thus provides the only cis element identified to date that can drive gene 
expression in the choroid plexus.
P a ren t o f  o r ig in -sp ec ific  e ffe c ts
A previous investigation of the mode of expression of the P3-luciferase transgenes detailed 
in this report demonstrated that the H19 enhancers regularly conferred a parental bias on 
the levels of gene expression from the reporter construct. In the presence of the H I9 
enhancers, luciferase expression levels were found to be 2-3 fold higher following 
maternal transmission of the transgene, as compared to levels following paternal 
transmission of the transgene 108. in this report, gene expression levels were compared 
following maternal versus paternal transmission of A, H  and Q transgenes, to determine if 
the phenomenon was repeatable. In addition, since the CCD might act to override the 
imprinting signal, the analysis of Q lines was to test for an interaction between the H19 
enhancers and the CCD. A comparison of three transgenic lines bearing each construct 
demonstrated that the H19 enhancers regularly imposed a maternal bias on gene 
expression, in both the presence and the absence of the CCD, at two different time points. 
However, a strong paternal bias was seen in some lines in some tissues. H  lines never 
conferred reproducible parental origin-specific effects at a high level of statistical 
significance, demonstrating that this element cannot mediate imprinting effects alone in the 
tissues analysed here. As in the previous study 108f the maternal bias was generally modest 
(2-5 fold). In addition, the levels of reporter gene activity were found to be largely 
independent of gross levels of reporter gene and promoter methylation. The H19 enhancer 
region was also examined for methylation differences following maternal or paternal
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transmission of the transgene, but the methylation status of only a single CpG dinucleotide 
was detectable by the assay. As with the luciferase reporter gene and promoter region, no 
gross changes in methylation were observed between samples.
The mechanism of imprinting of the Igf2 and H19 genes appears to be linked to the 
tissue specificity of these genes. Expression of both genes can be blocked by the action of
tissue-specific silencers 176, 229} 164 Jh addition, the endodermal expression of Igf2 is 
prevented by the action of a methylation-sensitive boundary element that prevents the 
access of the Igf2 promoters to distal enhancers *70^  169} 155 T h e  ‘imprint’ that leads to 
inactivation of the appropriate parental allele of these genes does not reside in a single 
element, and instead is the consequence of the action of multiple sequences that act in 
different tissues, possibly through direct interaction with tissue-specific enhancer elements. 
The modest imprinting effect observed with the H19 enhancers suggests that enhancer 
elements themselves play a direct role in the imprinting process. The H I9 enhancers have 
previously been implicated in the mechanism of imprinting. In a study of H I9 transgenes
37 containing an internally deleted H I9 gene region, 4kb of 5’ and 8kb of 3’ flanking DNA 
was found to be necessary to maintain the imprinting status of the reporter gene. If the 3’ 
flanking region containing the enhancers was not present in the transgene construct, the 
reporter gene was not expressed, and in addition, was not appropriately methylated at the 
5’ flanking region.
How does Igf2 escape imprinting in the choroid plexus and leptomeninges? The 
identification of the CCD as an enhancer of Igf2 in these tissues may lead to the 
understanding of how Igf2 achieves biallelic gene expression. It appears that the majority 
of enhancer elements for Igf2 may lie on the opposite side (from Igf2) of a boundary 
element ^ 3 j 234? 170^  169? 155 The CCD lies between this boundary and Igf2, so 
presumably is not affected by it. Indeed, when the H19 enhancers were relocated to the 
intergenic region, approximately 50kb upstream of the H I9 gene, Igf2 expression became
biallelic in the tissues in which this element is active 1^3 The CCD may therefore confer 
biallelic expression to Igf2 as a result of its position. However, the differentially 
methylated regions of the Igf2 gene (DMR1 and DMR2, see Figure / ,  Chapter 1) are
methylated on both parental alleles in the choroid plexus 7, suggesting that an additional 
epigenetic mechanism may also be involved.
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F urther w o rk
A full investigation of the role of the CCD has been prevented by the failure to establish 
in-situ patterns of reporter genes in the presence of the CCD. The strategy of 
immunohistochemical staining for luciferase protein was employed to gain this 
information, but was not successful. The expression patterns of reporter genes from 
existing luciferase transgenic lines could be visualised by the technique of in-situ 
hybridisation for luciferase mRNA. This technique was not adopted during the course of 
this investigation for the reasons discussed in Chapter 3, and instead work was begun to 
construct a new series of transgenic lines utilising the reporter gene LacZ. A construct was 
created that contained the LacZ gene driven from P3, in the presence of the CCD (C lines, 
see Figure 3). This construct was microinjected into 1-cell embryos, and the injected 
embryos implanted into the uterus of a pseudopregnant foster mother. To date, two 
offspring have been recovered in which the transgene successfully integrated, at least one 
of which transmits the transgene through the germline (data not shown). Time constraints 
have prevented any further analysis of these transgenics, but in future it will be interesting 
to visualise the action of the CCD on gene expression at the single cell level.
The primary cultures of choroid plexus epithelium developed in this investigation 
provide a resource in which to study Igf2 expression in the choroid plexus, as well as 
determining how this gene escapes imprinting in this tissue. The parental alleles of Igf2 can 
be identified by culturing cells from the offspring of a cross between parents that are 
polymorphic for a marker within the Igf2 gene (for example, a restriction fragment length 
polymorphism between two mouse strains). As discussed above, the methylation status of 
Igf2 at DMR1 and DMR2 is unusual in the choroid plexus, in that both alleles display the
paternal epigenotype 7. Whether this is a cause or consequence of the biallelic mode of 
Igf2 expression can be tested by treating choroid plexus cells, with distinguishable parental 
alleles, with the DNA demethylating agent 5-aza-2’ -deoxycytidine. In a tumour cell line 
that displayed loss of imprinting of Igf2, this state was reverted to monoallelic expression
by the addition of 5-aza-2’ -deoxycytidine to the culture medium 235 jn addition, 
chromatin modifications such as histone acetylation may play a role in the biallelic 
expression of Igf2. The histone acetylation status of DNA can be manipulated in a cell
culture system by the addition of the histone deacetylase inhibitor Trichostatin A ^ ^ .
The creation of an immortal cell line from choroid plexus cultures would greatly 
facilitate the execution of the experiments suggested above. There are a number of reasons
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to suppose that choroid plexus cultures derived from mice lacking p53 and pRB family 
function would be immortal. A cell line has recently been developed from primary cultures
of rat choroid plexus, by treating the cultures with the immortalising SV40 T-antigen 236} 
which inactivates these two proteins 231. Saenz Robles et. al. 231 have created a 
transgenic mouse line that express T-antigen in the choroid plexus epithelium (under the 
control of the transthyretin promoter). The creation of a cell line from the choroid plexus 
of these mice will have the advantage that the only immortal cells present in the population 
will be those of the choroid plexus epithelium, and therefore contaminating cells will be at 
a selective disadvantage.
The identification of an element that drives Igf2 expression in the exchange tissues 
of the brain, and the creation of a protocol by which to isolate and culture choroid plexus 
cells from mouse tissue will allow further study of the mechanism by which Igf2 escapes 
imprinting. These studies may in turn aid in the identification of the mechanisms by which 
Igf2 becomes biallelically expressed in pathological circumstances.
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A ppen d ix  1
construct line copy
number
Mean luciferase specific activity 






A Ayah 1-2 2 .3 6 x l0 '3 6 .5 4 x l0 '2 7.52 +++
Archy 4-6 1 .52x l0 '2 4 .7 2 x l0 '5 25.66 -
Alicia 1-2 1 .21x l0 '2 1 .82x l0 '2 4.74 +++
Axe 10 nd nd
Q Quark 2-4 1.69x10'* 2 .1 0 x l0 '4 2.68 -
Quasar 1-2 0.72 8 .8 4 x l0 '3 10.41 -
Quiche nd 0.32 6 .5 8 x l0 '2 14.12 nd
H Hamish nd 2.39x10^ 3.20X10-4 5 .1 0 x l0 't’ nd
Harold 2 0.14 9 .8 6 x l0 '2 3.00X1C4 nd
Holly 3 0.29 6 .8 0 x l0 '3 4.00x1 O'4 nd
Appendix 1. Transgenic lines used in this study, correlated to copy number (determined by 
visual estimation of the signal on Southern blots, in comparison with a single-copy
endogenous gene signal, 108 and data not shown), reporter gene specific activity, and 
methylation status (+++, highly methylated, -, not methylated). There appears to be no 
correlation between transgene copy number, gene expression levels, and the methylation 
status of the transgene.
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A p p e n d i x  2
Pileup of mouse, human and rat CCD sequences (see Chapter 8). Grey shading indicates 
agreement between two species, black shading indicates agreement between three species. 
The positions of PCR primers used to clone the rat CCD are shown as arrows above the 
sequence. Conserved sequence blocks discussed in the text as Region 1 and Region2 are 
noted below the sequence. The ATG codon chosen as the start site for analysis of protein 
sequence homology between mouse and rat is indicated as an asterisk above the sequence. 
The position of a consensus splice acceptor site is indicated as a thick black line above the 
sequence, with the intron/exon boundary indicated as a white box. The origin of 1.47kb of 
rat CCD sequence and 2kb of mouse CCD sequence is described in Chapter 8, and the 
human CCD sequence was obtained from the NCBI database, accession number 
AC004556. The sequence displayed here represents the reverse complement of nucleotides 
90481-92700. The alignment was performed using the Pileup algorithm of the Wisconsin 
Package Version 8.0, using the default parameter settings.
r a t  : ----------------------------------------------------------------------------------------------------------------- :
mouse : -GAATTCCAd^CCASTig g ^ cST^CAGCT^CT^ATGSSA ^ g CTCSAGCTSSlGTAg : 58
human : CTTTGGAGTCS3CAGCS^SSS'IS CSSAGCTCS TGSGCASSGSSSACAS CTGG!SBCCC2  : 59
r a t  :-------------------------------------------------------------------------------------------------------------------  :
m ouse : CAG|AAAGAA0|GCTG2G3gTGCgTGTCT^TAG2GTG^AGTGG|GgTTGGTc2gTGSg : 117
human : GGC^CTTCCC^AGC'I^cSiGC'I^CCCTCSGCT^CCTSgGACC'I^TgGCCCCTggGcSS : 118
r a t  :-------------------------------------------------------------------------------------------------------------------  :
m ouse : t^SSctagS gSatacagaaaagtatSStcttcSa^tgcctSgcSBctgagaagSI^Sgaa : 176
human : C^»TGCAiAScCCTTCCTCCCGCc8ScACCG5cScCAGGfAG5BTCAGTCCc8^?CCT : 177
r a t  :-------------------------------------------------------------------------------------------------------------------  :
mouse : lGG G AA^G^^GG* S I GGGTGi TCS ! TS l (^ iG'IS AGSEIGA2G T C ^ ^ |G A icC C ,l i |  : 235
human : !eTCTGG!5»r ig*gcc!iSgcCCAA^GA^?G!5gAlgTG!ggGAg!STG!eAGA,g g 3 ^ AG!gGAGAlg : 236
r a t  : ----------------------------------------------------------------------------------------------------------------  :
m ouse : A^AAG|CAAGA|GAAGGGA^g^G|AcS^AG^GGCA|AA^AC^TT|GA|GCgggA : 294
human : C^CCr[fGGGA(^AGGACAG^|CASGAS@SGC^CAAC^TC^GC^AC|jT'I^T'I®gG : 295
r a t  : ----------------------------------------------------------------------------------------------------------------  :
m ouse : |AACCG!|CA|G||GTAjggATGCCT|TCAGSAAG|ST^ScCAigGAGTGC^gTCTCCAGCAGA : 353
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r a t  : 
mouse : 
human :
G ^T G dgqfA A i^T ^T gB gdSA G A ST cS G S T C T S gggG G T T C T G G SdgT A S^C A A A C T G S : 4 1 2  
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